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ENzymES AS NATurE’S CATALySTS
Each living organism relies on very specific catalysts, known as enzymes. Enzymes 
are proteins whose structure determines the shape of an active site and therefore 
the accepted substrates. Because of their regio- and stereospecificity, enzymes 
are extremely powerful catalysts. Furthermore, they can perform almost any 
type of chemical reaction, usually under mild conditions. Increasing demands 
to reduce pollution make biocatalysts an interesting and green alternative 
to current industrial applications [1–3]. For example, proteases and lipases are 
widely used in laundry detergents. Amongst other applications glucose oxidase is 
utilized for the determination of glucose concentration and is one of the most widely 
applied analytical enzymes [4]. In recent years research focussing on the discovery 
and engineering of enzymes has intensified to assist the development of new 
biorefinery processes, for example enzymes for the production of biodegradable 
polymers or biofuels.
The exquisite specificity of enzymes has probably evolved from the delicate 
physiological role they play. This property makes them interesting tools in synthetic 
chemistry. However, the limited number of suitable substrates and enzyme-catalysed 
reactions has so far been their major drawback. Two strategies are employed to 
broaden the capability of already known enzymes. The first method is to search for 
new activities in various environments and to screen available enzyme collections 
(databases), the latter having gained more popularity in recent years. The other 
possibility is the introduction of the required properties into already existing 
enzymes, such as substrate scope and specificity, activity, stability and the expression 
level. Depending on the extent of knowledge about the target enzyme, two main 
approaches are generally available. If the understanding of the sequence-structure-
function relationship is limited, the random approach is the most suitable [5]. 
The drawback is that it creates a large number of variants and therefore requires 
a high-throughput screening method. The opposite, the rational approach, depends 
on the structural information and typically involves relatively small libraries. 
Therefore, extensive screening is not necessary in the latter approach, but it still 
often suffers from low predictability and reliability. The efficacy can be improved 
by employing more powerful computational design methods [6]. This is not only 
the result of an increase in computational power, but also from improvement 





Enzymes are divided in six classes, depending on the type of reaction they catalyse. 
Enzymes that transport electrons between molecules are called oxidoreductases, 
or redox enzymes and they belong to the first class of enzymes (E.C. 1.x.x.x). 
While a number of cofactor-independent oxidoreductases is known, most of them 
make use of (in)organic cofactors for the reaction they catalyse [9]. This is because 
the chemical functionality of amino acids is limited, but the use of cofactors 
can broaden the scope of enzyme-catalysed reactions [9]. The most well-known 
cofactors used by redox enzymes are flavins, metal ions, hemes and nicotinamides. 
They are discussed in more detail in Chapter 2.
Reactions catalysed by oxidoreductases are very diverse and include the 
oxidation of amines, alcohols and aldehydes, the epoxidation of alkenes, Baeyer-
Villiger oxidations, the hydroxylation of aromatic and aliphatic compounds and 
others. Based on the reaction they catalyse and their cofactor dependency they 
are usually divided into oxidases, oxygenases, dehydrogenases, peroxidases and 
peroxygenases. While dehydrogenases typically depend on a redox coenzyme 
(e.g. NAD(P)H or NAD(P)+) to donate or accept electrons, oxidases, peroxidases 
and peroxygenases use molecular oxygen or peroxides as an electron acceptor. 
Since oxidases and monooxygenases will be the subject of this thesis, they are 
discussed in more detail below.
Oxidases catalyse two- or four-electron oxidations of substrates such as 
amines and alcohols and they are able to perform oxidative ring closure, oxidative 
decarboxylation and hydroxylation reactions [10]. The use of molecular oxygen 
as an electron acceptor is an energetically unfavourable strategy, because transfer 
of energy-rich electrons to dioxygen results in the formation of H2O2 or H2O. 
Instead, the transfer of electrons to for instance NAD(P)+ would produce a reduced 
coenzyme that can subsequently be used in other anabolic pathways. This is probably 
why oxidases are rather rare enzymes compared to dehydrogenases and they are 
typically involved in catabolic routes. Though, this is also the reason why they 
are well-suited for biotechnological applications because the use or regeneration 
of expensive nicotinamide coenzymes is not needed. Oxidases use flavin, copper 
or multi-redox centres as cofactor.
In contrast to oxidases that use oxygen as an electron acceptor, oxygenases 




substrate. For this purpose oxygen has to be activated and this is usually achieved 
with electrons from the substrate itself or from an external electron donor such 
as NAD(P)H. Oxygenases are present in almost all kinds of living cells and 
are typically involved in detoxification, degradation pathways or the synthesis 
of secondary metabolites [11]. The specific oxyfunctionalisation reactions feasible 
with oxygenases are very interesting in industrial chemical synthesis [12]. 
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Figure 1.1. The structure of naturally occurring flavin cofactors. 
 
The solubility of riboflavin in water is relatively low (<10-4 M) while the solubility of FMN and FAD 
is high (approximately 0.1 M), caused by the latter two having negatively charged phosphorylated side 
chains. The chemical properties of flavins are determined by the three fused ring systems, namely 
xylene, pyrazine and pyrimidine. The xylene ring moiety is relatively rich in electrons compared to the 
electron deficient pyrimidine moiety. Most of the flavin chemistry occurs on the bridging ring, the 
pyrazine moiety. The electronegativity of the 4a-position originates from the four nitrogen atoms and 
two carbonyl groups in the pyrazine and pyrimidine rings. The pyrimidine ring moiety is hydrophilic and 
can interact with protein residues as a hydrogen donor or acceptor, influencing the properties of the 
pyrazine ring in this way. The xylene moiety is hydrophobic and the typical interactions found for this 
part of the isoalloxazine ring are stacking interactions with side chains of protein aromatic amino acids. It 
is interesting to note that the protons on the 8-methyl position are much more labile to exchange than 
expected, when compared to the 7-methyl group protons. This originates from a very strong inductive 
effect of the N5 position [13]. The midpoint redox potential of the flavin is approximately -210 mV 
against a standard hydrogen electrode, but is slightly dependant on the nature of the substitution at the 
N10 position and strongly dependant on the substitutions and modifications in the pyrimidine ring as 
well as the benzene moiety at positions 8 and 6. Furthermore, the midpoint redox potential can be 
largely modified by the protein environment (see Chapter 4). 
The most useful information about flavin-protein interactions can be obtained from the 
structural data, but also other sources are available, for instance the influence of substituting the native 
flavin with its analogue in the protein. In order to do so, the protein has to be (partially) unfolded in a 
non-destructive way and incubated with a flavin analogue which should result in a functional 
reconstituted holo protein. The situation is more challenging in the case of flavoproteins that bind the 
cofactor covalently. Here, the strategy depends on the stability of the apo form of the protein. If the 
stability is not an issue, the protein can be expressed in a riboflavin-auxotrophic strain and purified in its 
























Figure 1.1. The structure of naturally occurring flavin cofactors.
FLAvOprOTEiNS
Flavin cofactors
One type of cofactor commonly used by oxidoreductases is the flavin cofactor, 
although this metal-f ee cofactor can also be found in enzymes catalysing non-redox 
reactions. Discovered at the end of the XIX century and chemically characterized 
in the 1930’s, flavins are able to catalyse both one- and two-electron transfer 
processes. Their name originates from the Latin word “flavus”, which means 
“yellow”, and also denotes the colour of flavoproteins. The two types of flavin 
cofactors most oft n found in nature, nam ly flavin adenine dinucleotide (FAD) 
and flavin mononucleotide (FMN) (Fig. 1.1), are both synthesized from riboflavin 
(vit min B2). They are composed of the isoalloxazine ring moiety, which is 
responsible for the yellow colour in the oxidized state. On the other hand, two-




colourless. The oxidized forms of FAD and FMN can also accept a single electron 
at a time forming a half-reduced flavin called semiquinone which has distinctive 
spectral properties. In addition to exhibiting absorbance, the oxidized flavins 
are characterized by fluorescence emission spectra with a maximum of emission 
at approximately 520 nm. The fully reduced or semiquinone flavin is nonfluorescent 
in aqueous medium at ambient temperatures.                          
The solubility of riboflavin in water is relatively low (<10-4 M) while the 
solubility of FMN and FAD is high (approximately 0.1 M), caused by the latter 
two having negatively charged phosphorylated side chains. The chemical properties 
of flavins are determined by the three fused ring systems, namely xylene, pyrazine 
and pyrimidine. The xylene ring moiety is relatively rich in electrons compared 
to the electron deficient pyrimidine moiety. Most of the flavin chemistry occurs 
on the bridging ring, the pyrazine moiety. The electronegativity of the 4a-position 
originates from the four nitrogen atoms and two carbonyl groups in the pyrazine 
and pyrimidine rings. The pyrimidine ring moiety is hydrophilic and can interact 
with protein residues as a hydrogen donor or acceptor, influencing the properties 
of the pyrazine ring in this way. The xylene moiety is hydrophobic and the typical 
interactions found for this part of the isoalloxazine ring are stacking interactions 
with side chains of protein aromatic amino acids. It is interesting to note that the 
protons on the 8-methyl position are much more labile to exchange than expected, 
when compared to the 7-methyl group protons. This originates from a very strong 
inductive effect of the N5 position [13]. The midpoint redox potential of the flavin 
is approximately -210 mV against a standard hydrogen electrode, but is slightly 
dependant on the nature of the substitution at the N10 position and strongly 
dependant on the substitutions and modifications in the pyrimidine ring as well 
as the benzene moiety at positions 8 and 6. Furthermore, the midpoint redox 
potential can be largely modified by the protein environment (see Chapter 4).
The most useful information about flavin-protein interactions can be obtained 
from the structural data, but also other sources are available, for instance the 
influence of substituting the native flavin with its analogue in the protein. In order 
to do so, the protein has to be (partially) unfolded in a non-destructive way and 
incubated with a flavin analogue which should result in a functional reconstituted 
holo protein. The situation is more challenging in the case of flavoproteins that 
bind the cofactor covalently. Here, the strategy depends on the stability of the apo 




in a riboflavin-auxotrophic strain and purified in its apo form and subsequently 
reconstituted with the flavin. In the second case, a riboflavin-auxotrophic strain 
has to be supplied with the riboflavin analogue in order to express the studied 
flavoprotein as a holo protein. The approach of flavin substitution has proven to 
be of great value, because flavin analogues can be used as probes for (covalent) 
flavin-binding and protein environment analysis, as well as for the investigation 
of flavoenzyme activity and mechanism (see reviews: [14–18]). Additionally, the 
combination of artificial flavins with different protein scaffolds can result in the 
formation of enzymes with new catalytic activity [19,20] (and Chapter 2).
Flavin-containing oxidases
One of the cofactors used by oxidases is a flavin and therefore these enzymes are 
referred to as flavin-containing or flavoprotein oxidases. Flavoprotein oxidases 
utilize FAD as a prosthetic group more often than FMN [21] and usually it is the only 
cofactor. A comparison of currently available sequences and structures indicates 
that flavoprotein oxidases belong to several structurally distinct families [22]. 
Here, only two of them will be discussed, namely the vanillyl-alcohol oxidase 
(VAO) and the amine oxidase (AO) families.
The VAO family has been named after the fungal flavoprotein oxidase, VAO 
[23,24]. It was the first flavoprotein with a covalently bound flavin for which 
the crystal structure was elucidated [25]. Covalent flavin binding is relatively 
abundant in this family, which also includes all recently discovered flavoproteins 
with two covalent bonds to the flavin [26]. VAO-type oxidases are catalytically 
diverse, because they can perform not only alcohol oxidations, which lead 
to aldehydes and ketones [27–29], but also amine oxidations, hydroxylations 
of aromatic compounds, decarboxylations, and ether bond cleavage [30,31]. 
All these reactions typically exhibit excellent chemo-, regio- and 
enantioselectivity [32]. These examples suggest that the VAO-type of protein fold is 
capable of performing a great number of diverse oxidation reactions. A large number 
of new VAO-type  enzymes were found and studied recently [24,33], including 
reticuline oxidase (see below). The VAO-family also contains the first discovered 
flavoprotein with  a covalent linkage, namely 6-hydroxy-D-nicotine oxidase 
(6HDNO) [34,35], which is the subject of Chapter 4. For a long time, 6HDNO 




Prototype oxidases for the AO family are microbial amino acid oxidases 
and eukaryotic monoamine oxidases. In addition to the oxidation of primary and 
secondary amines, a few members of the family have been found to oxidize alcohols 
and thioethers, but usually an individual enzyme is restricted to only one type 
of reaction. Human monoamine oxidases A and B (MAO A and MAO B) have been 
the subject of intense studies for a long time, because they catalyse oxidation 
of endogenous amine neurotransmitters like serotonin and dopamine, as well as 
many amines present in food and drugs. Although they have the same overall 
structure, MAO A has a more open active site [36,37] and for this reason 
a small difference in substrate scope is observed. A number of MAO inhibitors have 
been developed for clinical use for treatment of depression and neurodegenerative 
diseases like Alzheimer and Parkinson. However, their many side effects have shifted 
the interest into the design of inhibitors specifically targeting each form 
of MAO [36,38]. In this thesis, a bacterial member of the MAO family, putrescine 
oxidase, will be discussed.
Flavoprotein oxidases have been successfully applied in the biotechnological 
industry, mostly because of their interesting catalytic properties owing to a wide 
variety of oxidative reactions with excellent chemo-, regio- and/or enantioselectivity. 
Furthermore, they use molecular oxygen as a mild oxidant. In addition to the 
previously mentioned glucose oxidase, several other flavin-containing oxidases have 
been applied in a variety of processes. D-amino acid oxidase has been employed in 
the synthesis of antibiotics [39] and fungal monoamine oxidase in the production 
of enantiopure fine chemicals [32]. Interestingly, flavoprotein oxidases have been 
found to not only catalyse relatively simple oxidations, such as the conversion 
of alcohols to aldehydes and ketones, but also more complex reactions. For example, 
the plant enzyme reticuline oxidase (also known as berberine bridge enzyme) 
takes part in an oxidative C-C bond formation in (S)-reticuline, creating the 
intramolecular bond between a methyl group and an aromatic carbon, resulting in 
(S)-scoulerine (Fig. 1.2) [40,41].
Flavoprotein monooxygenases
Another group of interesting flavin-containing enzymes for biocatalytic purposes 




are difficult to obtain with chemical routes. Flavoprotein monooxygenases can be 
encoded by a single gene or can have multiple components. Based on sequence and 
structural data they can be divided into 6 distinct classes, where classes A and B are 
the most interesting as biocatalysts, because they are single component enzymes 
that contain a tightly bound flavin cofactor [42]. Within class B four subclasses 
are found: (1) Baeyer-Villiger monooxygenases (BVMOs) performing Baeyer-
Villiger oxidations and heteroatom-containing compounds oxygenations [43]; 
(2) type I [44–47] and recently discovered (3) type II [48,49] flavin-containing 
monooxygenases (FMOs) oxidizing heteroatom-containing compounds and (4) 
N-hydroxylating monooxygenases (NMOs) converting long-chain primary amines 
by N-hydroxylation [50]. Due to the eukaryotic origin and membrane association, 
FMOs were initially not considered for their use as biocatalysts. This has changed 
recently with the discovery and soluble expression of microbial FMOs, one of them 




oxidant. In addition to the previously mentioned glucose oxidase, several other flavin-containing 
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Another group of interesting flavin-containing enzymes for biocatalytic purposes are flavoprotein 
monooxygenases. They can perform specific oxygenations, which are difficult to obtain via chemical 
routes. Flavoprotein monooxygenases can be encoded by a single gene or can have multiple 
components. Based on sequence and structural data they can be divided into 6 distinct classes, where 
classes A and B are the most interesting as biocatalysts, because they are single component enzymes 
that contain a tightly bound flavin cofactor [42]. Within class B four subclasses are found: (1) Baeyer-
Villiger monooxygenases (BVMOs) performing Baeyer-Villiger oxidations and heteroatom-containing 
compounds oxygenations [43]; (2) type I [44–47]and recently discovered (3) type II [48,49] flavin-
containing monooxygenases (FMOs) oxidizing heteroatom-containing compounds and (4) N-
hydroxylating monooxygenases (NMOs) converting long-chain primary amines by N-hydroxylation [50]. 
Due to the eukaryotic origin and membrane association, FMOs were initially not considered for their use 
as biocatalysts. This has changed recently with the discovery and soluble expression of microbial FMOs, 
one of them being described in this thesis. 
 
COVALENT FLAVIN BINDING 
 
Many cofactor-containing proteins bind their cofactor in a non-covalent manner. However, some 
specific cofactors, like lipoic acid and biotin, are always bound covalently to the polypeptide amino acids. 
Heme and flavin cofactors are the only cofactors that can be bound either covalently or noncovalently, 
depending on the enzyme. Although most flavoproteins contain a noncovalently bound flavin, it has 
Figure 1.2. Oxidative C-C bond formation catalysed by reticuline oxidase.
COvALENT FLAviN BiNdiNg
Many cofactor-containing proteins bind their cofactor in a non-covalent manner. 
However, some specific cofactors, like lipoic acid and biotin, are always bound 
covalently to the polypeptide amino acids. Heme and flavin cofactors are the 
only c factors that ca  be bound either covalently or non al ntly, depending 
on the enzy e. Although most flavoproteins contain a noncovalently bound 
flavin, it has been estimated that approximately 10% of them bind the cofactor 
covalently [26]. Furthermore, several different types have been discovered so far: 




8α-O-tyrosyl-FAD, 8α-O-aspartyl-FAD, 6-S-cysteinyl-FMN, 8α-N1-histidyl-6-S-




been estimated that approximately 10% of them bind the cofactor covalently [26]. Furthermore, several 
different types have been discovered so far: 8α-N3-histidyl-FAD/FMN, 8α-N1-histidyl-FAD/FMN, 8α-S-
cysteinyl-FAD/FMN, 8α-O-tyrosyl-FAD, 8α-O-aspartyl-FAD, 6-S-cysteinyl-FMN, 8α-N1-histidyl-6-S-
cysteinyl-FAD/FMN and threonyl-FMN (Fig. 1.3). 
 
 
Figure 1.3. Possible modes of covalent flavinylation. 
 
The first experimental data suggesting the existence of covalent flavoproteins appeared in the 
1950s and the evidence was obtained from the work on succinate dehydrogenase which contains an 8α-
N3-histidyl-FAD cofactor [51,52]. The histidyl FAD type of linkage is the most common and can be found 
for example in VAO and alditol oxidase [28,53]. The most extensively studied flavoproteins with a 
cysteinyl linkage are monoamine oxidase, monomeric sarcosine oxidase (MSOX) and trimethylamine 
dehydrogenase (TMADH) [54–56]. The so-called bi-covalent flavoproteins constitute a relatively new 
group of enzymes in which the bond between FAD and the polypeptide chain involves 8α-His and 6-S-Cys 
linkages. These enzymes are very interesting for biocatalytic applications, because they can catalyze 
bulky substrates, such as oligosaccharides, alkaloids and antibiotics [29,41,57,58]. The reason for that is 
because the two covalent bonds between the flavin and the protein can properly position the flavin in a 
very open active site towards the substrate. 
The covalent flavin binding seems to have more than onefunction and most information comes 
from site-directed mutants analysis. Covalent flavinylation increases the redox potential of the flavin and 
it has been shown that the flavin-histidyl linkage is directly responsible for this phenomenon [26]. The 
increased redox potential boosts the oxidative power of the enzyme and for this reason most of the 
(bi)covalent flavoenzymes are oxidases. Furthermore, covalent flavinylation might be necessary for some 
proteins to enhance their stability or to prevent the flavin dissociating from the binding site. In the case 
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[29,41,57,58]. The reason for that is because the two covalent bonds between the 
flavin and the protein can properly position the flavin in a very open active site 
towards the substrate.
The covalent flavin binding seems to have more than one function and most 
information comes from site-directed mutants analysis. Covalent flavinylation 
increases the redox potential of the flavin and it has been shown that the flavin-
histidyl linkage is directly responsible for this phenomenon [26]. The increased redox 
potential boosts the oxidative power of the enzyme and for this reason most of the 
(bi)covalent flavoenzymes are oxidases. Furthermore, covalent flavinylation might 
be necessary for some proteins to enhance their stability or to prevent the flavin 
dissociating from the binding site. In the case of trimethylamine dehydrogenase, 
the 6-S-cysteinyl-FMN precludes formation of 6-hydroxy-FMN, which leads to the 
enzyme inactivation [59].
In contrast to many other covalently linked cofactors which require 
the assistance of proteins to form a covalent cofactor-protein bond, in most cases 
the covalent flavinylation is catalysed by the flavoprotein itself. The proposed 
mechanism of this process was derived from studies on several monocovalent 
flavoproteins, like p-cresol methylhydroxylase (PCMH), 6HDNO, MSOX 
and TMADH [56,60–62]. For the 8α position, the first step of the proposed 
mechanism is the deprotonation of the C8 methyl group which leads to methide 
iminoquinone flavin formation (Fig. 1.4) [60,62–65]. The intermediate is expected 
to be stabilized at the N1-C2=O2 locus by a positively charged amino acid. 
This is followed by an attack on the 8α position from the residue that will form 
the covalent bond. In the last step the reduced flavin is reoxidized by molecular 
oxygen or another electron acceptor.  The covalent flavinylation at the C6 position 
could proceed via a similar mechanism or by a direct attack of the cysteinyl group 
on the FMN. In the latter case formation of the iminoquinone methide intermediate 
would be omitted [56]. The bicovalent flavinylation has been studied to a lesser 
extent. The experiments on site-directed single mutants abolishing one of the 
covalent bonds have shown that the two bonds can be formed independently from 
each other [66,67]. Therefore both previously mentioned mechanisms could be 
valid for bicovalent flavoproteins, but it is unknown in which order these steps 






of trimethylamine dehydrogenase, the 6-S-cysteinyl-FMN precludes formation of 6-hydroxy-FMN, which 
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Figure 1.4. Proposed mechanism for covalent flavinylation at 8α position in the isoalloxazine ring. B1-B3 represent 
active site bases potentially involved in covalent flavinylation and L stands for the ligand amino acid that covalently 
binds to the flavin and it can be histidine, tyrosine, cysteine or aspartate. 
 
Figure 1.4. Proposed mechanism for covalent flavinylation at the 8α position in the isoalloxazine 
ring. B1-B3 represent active site bases potentially involved in covalent flavinylation and L stands for 
the ligand amino acid that covalently binds to the flavin and it can be histidine, tyrosine, cysteine 
or aspartate.
KiNETiC mEChANiSm OF FLAvOprOTEiN OxidASES
Flavoprotein oxidases abstract two electrons and two protons from 
the substrate and these are further transferred on to a second substrate, which 
is molecular oxygen. Therefore, this catalytic mechanism can be divided into 
two half-reactions, namely a reductive and an oxidative half-reaction [68]. 
In the reductive half-reaction the flavin cofactor is reduced by a bound substrate, 
which is concomitantly oxidized to the product. The exact mechanism by which 
the two electrons and two protons are transferred to the flavin is still a matter 
of a debate for some flavoprotein oxidases. In the case of flavin-containing amine 
oxidases, three types of mechanism gained popular support: the concerted polar 
nucleophilic mechanism [69–71], the direct hydride transfer mechanism [72,73] 
and the single electron transfer mechanism [72,74]. However, the hydride transfer 
mechanism (Fig. 1.5) is the most consistent with the structural, mechanistic and 
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Figure 1.5. Hydride transfer mechanism proposed for the reductive half-reaction of flavin-dependent amine 
oxidases. 
 
In order to close the catalytic cycle, the reduced flavin is reoxidized by molecular oxygen in the 
oxidative half-reaction, which results in the formation of hydrogen peroxide. The free reduced flavin 
reacts rather poorly with oxygen (2.5 x 102 M-1s-1 [81]), while in flavoprotein oxidases this reaction can be 
increased by a 10,000-fold or more, as for example in glucose oxidase (1.6 x 106 M-1s-1 [82]). This low 
reactivity of free reduced flavin can be explained by the law of spin conservation, because it involves the 
reaction of a singlet-reduced flavin with dioxygen in the triplet state. It has been proposed that in order 
to overcome this restriction, two one-electron transfers take place from the reduced flavin to oxygen 
instead of a single two-electron transfer [83,84]. The ability of a flavoprotein oxidase to use molecular 
oxygen is believed to be determined by the thermodynamic driving force formed by the flavin and O2/O2- 
couple redox potentials, diffusion of oxygen into the active site, flavin stereochemistry and ligand 
binding [84,85]. 
Oxidases catalyze reactions starting with two substrates and resulting in two products. 
Therefore, they can follow several different kinetic mechanisms, for example a ping-pong or a ternary 
complex mechanism (Fig. 1.6). Flavoprotein oxidases can follow different types of mechanism and 
sometimes one enzyme can employ different mechanisms for different substrates. The kinetic 
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(2.5 x 102 M-1s-1 [81]), while in flavoprotein oxidases this reaction can be increased 
by a 10,000-fold or more, as for example in glucose oxidase (1.6 x 106 M-1s-1 
[82]). This low reactivity of free reduced flavin can be explained by the law 
of spin conservation, because it inv lves the reaction of a singlet-reduced flavin 
with dioxygen in the triplet state. It has been proposed that in order to overcome 
this restriction, two one-electron transfers take place from the reduced flavin 
to oxygen instead of a single two-electron transfer [83,84]. The ability of a flavoprotein 
oxidase to use molecular oxygen is believed to be determined by the thermodynamic 
driving force formed by the flavin and O2/O2
- couple redox potentials, diffusion 
of oxygen into the active site, flavin stereochemistry and ligand binding [84,85].
Oxidases catalyse reactions starting with two substrates and resulting in 
two products. Therefore, they can follow several different kinetic mechanisms, 
for example a ping-pong or a ternary complex mechanism (Fig. 1.6). 
Flavoprotein oxidases can follow different types of mechanism and sometimes 
one enzyme can employ different mechanisms for different substrates. The kinetic 
mechanisms can be studied by analysing the reductive and oxidative half-reactions 
and this is usually done by using stopped-flow techniques. Flavoprotein oxidases are 
very convenient enzymes for this method, because their spectral properties depend 
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Figure 1.6. Typical kinetic mechanisms with two substrates (adapted from [86]): (a) ping-pong mechanism and (b) 
ternary complex mechanism. E is an enzyme, F is a modified enzyme, A and B represent substrates, P and Q 
represent products and intermediate enzyme complexes are in parentheses. 
 
OUTLINE AND AIM OF THE THESIS 
 
The aim of this thesis was the engineering of flavoprotein oxidases through cofactor binding and 
active site redesign. Furthermore, the biocatalytic scope of a bacterial flavin-containing monooxygenase 
was explored. Parallel to this, we aimed to prepare an isotopically labelled flavin to enable covalent 
flavinylation investigations. 
The majority of this thesis focuses on flavin cofactor binding study and redesign. Chapter 2 
reviews the current knowledge about (in)organic cofactors, with the focus on redox cofactors, in 
particular nicotinamide, heme and flavin cofactors. Furthermore, novel approaches to cofactor and 
cofactor-containing enzymes redesign are presented. 
Chapter 3 describes the first structural analysis of a bacterial amine oxidase, namely putrescine 
oxidase from Rhodococcus erythropolis. Furthermore, the crystal structure is a basis for the investigation 
of enzyme affinity towards the flavin, as well as for the design of artificial covalent cofactor binding. 
In Chapter 4, a second covalent flavin-protein bond is introduced to a monocovalent 
flavoprotein, turning 6-hydroxy-D-nicotine oxidase into a bicovalent flavoprotein. This work indicates a 
histidine is necessary for the formation of a second bond and presents the new properties of the 
modified enzyme. 
Chapter 5 is dedicated to the synthesis of isotopically labelled flavins and the conditions for 
specific flavin deuterations are presented. 
In Chapter 6, a conserved amino acid in the active site of putrescine oxidase is mutated. With a 
single residue substitution, the narrow substrate specificity of putrescine oxidase is broadened towards 
diamines with a longer carbon chain. 
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The aim of this thesis was the engineering of flavoprotein oxidases through 
cofactor binding and active site redesign. Furthermore, the biocatalytic scope 
of a bacterial flavin-containing monooxygenase was explored. Parallel to this, 
we aimed to prepare an isotopically labelled flavin to enable covalent flavinylation 
investigations.
The majority of this thesis focuses on flavin cofactor binding study and redesign. 
Chapter 2 reviews the current knowledge about (in)organic cofactors, with 
the focus on redox cofactors, in particular nicotinamide, heme and flavin cofactors. 
Furthermore, novel approaches to cofactor and cofactor-containing enzymes 
redesign are presented.
Chapter 3 describes the first st uctural analysis of a bacterial amine xidase, 
namely putrescine oxidase from Rhodococcus e ythropolis. Furthermore, the crystal 
structure is a basis for the investigation of enzyme affinity towards the flavin, 
as well as for the design of artificial covalent cofactor binding.
In Chapter 4, a second covalent flavin-protein bond is introduced to 
a monocovalent flavoprotei , turning 6-hydroxy-D-nicotine oxidase into 
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Chapter 5 is dedicated to the synthesis of isotopically labelled flavins 
and the conditions for specific flavin deuterations are presented.
In Chapter 6, a conserved amino acid in the active site of putrescine oxidase 
is mutated. With a single residue substitution, the narrow substrate specificity 
of putrescine oxidase is broadened towards diamines with a longer carbon chain.
Chapter 7 deals with a detailed pre-steady state kinetic study on putrescine 
oxidase. The enzyme reoxidation rate is increased by ligand binding in the active 
site. Mechanistic calculations suggest that putrescine oxidase follows a bifurcated 
mechanism and the ratio between the two contributing mechanisms depends 
on the oxygen concentration.
Chapter 8 describes the biocatalytic study on a flavin-containing 
monooxygenase from Methylophaga sp. (mFMO). The applicability of the enzyme 
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ABSTrACT
Many enzymes make use of one or more cofactors such as flavin, heme 
or metal ions. These cofactors have been acquired by enzymes in order to broaden 
the chemical possibilities of amino acids. Natural cofactors can be divided into 
inorganic and organic cofactors and they are mostly used by oxidoreductases. 
Iron is the most popular inorganic cofactor and it is most probably due to its 
relatively high ambient concentrations before the increase of oxygen concentration 
in the atmosphere. Furthermore, iron is the only transition metal which redox 
potential can be easily modulated by the environment. Organic cofactors vary 
a lot in their structure and chemical properties. Three most common redox 
organic cofactors are nicotinamide (NAD(P)), heme and flavin. NAD(P) plays 
a central role in all living cells metabolism and, therefore, many enzymes depend 
on this cofactor. Many modified nicotinamide cofactors have been synthesized and 
their chemical potential with different enzymes has been evaluated. Heme can be 
found in proteins with various functions, including oxygen- and electron-storage 
and transport, as well as catalysis. Intensive heme engineering has been performed 
in order to understand fundamental functions of heme proteins, but also to investigate 
their potential biocatalytic applications as “artificial metalloenzymes”. In order to 
produce them, modified hemes have been reconstituted to protein scaffolds like 
myoglobins and albumins. The flavin  cofactor is chemically diverse and is involved in 
a variety of redox and non-redox reactions. Engineering of the flavin cofactor 
included its covalent attachment to a protein scaffold, modifications in the 
isoalloxazine ring and reconstitution to a flavoprotein in a holo form or to a non- 
flavoprotein scaffold. The purpose for these studies was to understand the 
fundamental function and features of flavin-containing enzymes, but also to 
produce biocatalysts with new catalytic properties.




Enzymes catalyse a wide range of chemical reactions in Nature, for which helper 
molecules – cofactors – are often employed. Cofactors are non-protein small 
molecules or atoms that are required in the active site of enzymes and are directly 
involved in catalysis. Cofactors thus extend the scope of chemistry in Nature 
beyond what is feasible when using only amino acids. Although more than half 
of all known enzymes use such “helper molecules” [1] the actual number of natural 
cofactors is, nevertheless, limited. In order to broaden the catalytic potential 
of enzymes, recent protein engineering approaches have been expanded to develop, 
and subsequently employ, enzymes containing redesigned cofactors.
It is assumed that many natural organic cofactors have evolved from ribozymes, 
which are catalytic RNA molecules. The discovery of RNA-based catalysis brought 
an end to the idea that enzymes are the only natural catalytic machineries, and placed 
RNA before DNA and proteins in the evolution of life [2,3] It is hypothesized that 
around four billion years ago, in the so-called “RNA world,” a collection of RNAs 
or RNA-like molecules could function as a carrier of genetic information and 
as a catalyst of essential chemical reactions [4-6]. It is interesting to note that 
some of the most common contemporary enzyme cofactors, such as nicotinamide 
adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD), are derivatives 
of ribonucleotides. Furthermore, it has been found that several of the most 
ubiquitous cofactors can be targets for riboswitches [7-17], which are functional 
RNA molecules able to directly sense and regulate levels of cellular metabolites [18]. 
Therefore, it is speculated that cofactors were actually first utilized by ribozymes. 
For example, it has been proposed that NAD+ and NADP+ were adopted by 
ribozymes as redox cofactors [19]. Metal ions – especially divalent cations – have 
also been shown to facilitate the folding of ribozymes in order to form an active site 
and to stabilize the transition state [20,21].
As it seems quite likely that ribozymes were able to carry out a variety of 
important reactions, the question might be asked as to why – and how – did 
proteinogenic enzymes take over their functions? Clearly, the 20 common amino 
acids can offer any catalytic machinery a much more diverse set of functional groups 
than can four RNA nucleotides. Yet, the generally accepted answer – that proteins 
are catalytically more versatile than nucleic acids – is not quite sufficient, as evolved 




to a proposal by Szathmáry, amino acids were initially adopted by ribozymes as 
cofactors. For example, the chemical advantage of using lysine as a cofactor is that 
it carries a positive charge at neutral pH, and it can act as a general base, assisting 
a water-mediated nucleophilic attack [23]. Moreover, amino acid cofactors could 
bind reversibly to the specific sequences of ribozymes through conventional base-
pairing, forming so-called “coding coenzyme handles” [22,24,25]. The amino acids 
could later be linked to polypeptides, while the handles turned into adaptors (transfer 
RNA; tRNA) such that many ribozymes lost their original enzymatic activity 
and became messenger RNA (mRNA) molecules, which ultimately evolved into 
the translational system. In this way, the coded protein enzymes could provide 
specific substrate binding sites that were not available in ribozymes.
In this Chapter, an overview is provided of the occurrence and role of natural 
enzyme cofactors. In addition, approaches to cofactor redesign are discussed, with 
emphasis being placed on the most frequently encountered redox cofactors, namely 
nicotinamide, flavin and heme.
NATurAL COFACTOrS: TypES, OCurrANCE ANd ChEmiSTry
According to the International Union of Pure and Applied Chemistry (IUPAC) [26], 
cofactors are “...organic molecules... or ions... that are required by an enzyme 
[for] its activity”. The definition also explains that “...a cofactor binds with its 
associated protein (apoenzyme), which is functionally inactive, to form the active 
enzyme (holoenzyme).” However, quite often this definition is further refined by 
a requirement that a cofactor must be present in the catalytic site, which excludes 
examples of constitutive allosteric regulation [27]. Furthermore, the IUPAC definition 
divides cofactors into two types: those attached to an enzyme loosely (coenzymes), 
and those attached tightly (prosthetic group). When a cofactor is incorporated into 
a cofactor-dependent enzyme, the reactivity of the cofactor is influenced by the protein 
environment. Hence, a holoenzyme can attain substrate and product selectivities and 
rates and yields that would not be possible for either the apoenzyme or cofactor alone.
When examining their chemical composition, cofactors can be divided into 
two main groups:
•	 Inorganic cofactors, such as metal ions and iron-sulfur clusters [28,29].
•	 Organic cofactors, such as flavin and heme cofactors [30,31].
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In general, metal ions are most active in the area of electrostatic stabilization 
and are more potent than amino acids – but not than organic cofactors – in pair 
and single-electron shuttling. Organic cofactors are able to support a wide range 
of reaction types, with many organic cofactors being involved in electron-transfer 
processes. This is in agreement with the fact that 80% of all oxidoreductases employ 
an organic cofactor.
A given cofactor can perform a mechanistically identical reaction in various 
enzyme scaffolds (e.g., NAD for hydride transfer), or its mechanism of action can 
depend on the protein (e.g., S-adenosylmethionine as a methyl donor or radical 
generator) [27]. It is also possible that some cofactors occur only in one enzyme, 
such as dipyromethane in hydroxymethylbilane synthase (see Table 2.1), while 
some enzymes or enzyme complexes employ several cofactors. For example, 
formylmethanofuran dehydrogenase is composed of three subunits containing, 
respectively, a flavin, an iron-sulfur cluster, and two molybdopterin guanine 
dinucleotide cofactors coordinated to a tungstate [32].
iNOrgANiC COFACTOrS
Information concerning the properties and roles of metal ions involved in catalysis 
of metal-dependent enzymes is available in the Metal-MACiE database [29]. 
An analysis of specific chemical functions of metal cofactors, based on the database 
and structural information, has been summarized by Andreini et al. [28], according 
to whom oxidoreductases (EC 1) mostly use metals, especially iron, as their redox 
centres. When a metal is used as a redox catalyst, it is usually bound to an organic 
cofactor (e.g., iron in heme), but this is not the case in non-redox catalysis. Metal ions 
in transferases (EC 2) are mostly electrostatic stabilizers and/or activators, and 
increase the electrophilicity of the substrate so that nucleophilic substitution/addition 
becomes possible. Transferases most often utilize magnesium as their cofactors.
In the case of hydrolases (EC 3) and lyases (EC 4), no redox-active metals 
are employed. Rather, metals in hydrolases either activate the substrate or stabilize 
the electrostatic charge, with zinc appearing to be the most suitable metal 
for both functions. The role of metals in lyases is to induce proton transfer from 
the substrate; magnesium and zinc are each used for this purpose, based on their 




Isomerases (EC 5) can be divided into two groups: (i) cobalamin-dependent, 
generating radical species; and (ii) metal ion-containing isomerases. Members 
of the latter enzyme group – the metal-dependent ligases (EC 6) – prefer magnesium 
to perform an SN2 nucleophilic attack of the substrate on ATP (or an analogue).
The domination of iron in redox systems is most likely the consequence 
of relatively high ambient concentrations of Fe(II), before atmospheric oxygen levels 
were increased due to the development of photosynthesis, and which resulted in 
the formation of insoluble Fe(OH)3. The redox potential of iron also depends very 
much on the protein microenvironment, which means it can be easily modulated 
[33], though this is not the case with other transition metals. In iron-containing 
enzymes the metal can be found in either mononuclear or binuclear sites [34].
The function of mononuclear iron in enzymes is to activate dioxygen with 
a high-spin ferrous (Fe[II]) site or to activate substrates with a high-spin ferric 
(Fe[III]) site [34]. The process of dioxygen activation is kinetically hindered, 
however, because it requires singlet oxygen, whereas atmospheric O2 exists mostly 
as triplet oxygen. Iron, as well as copper, is able to overcome this kinetic barrier 
because it can form a coordination bond, which is directly followed by the transfer 
of a second electron to the oxygen. Reduction is achieved by an auxiliary redox 
active cofactor (α-ketoglutarate-dependent dioxygenases, pterin-dependent 
hydroxylases, and Rieske dioxygenases) or a redox-active substrate, which supplies 
the necessary reducing equivalents for oxygen activation (e.g., extradiol-cleaving 
catechol dioxygenase [35]).
Substrate-activating enzymes include the lipoxygenases and the intradiol 
dioxygenases. In binuclear iron enzymes, a diferrous site is involved in the reversible 
binding of oxygen (hemerythin [36]) and oxygen activation (ribonucleotide 
reductase	 [37-40],	 methane	 monooxygenase	 [41-43]	 and	 Δ9 desaturase [44]). 
In the case of oxygen activation, however, the second electron required for this 
process is derived from the second metal located within, or in close proximity to, 
the catalytic site. As a representative example, in methane monooxygenase, 
dioxygen binds to the Fe(II)–Fe(II) cluster to enable the ready formation 
of a Fe(III)–Fe(III)-peroxo-adduct [45,46].
Another group of small inorganic cofactors includes the iron-sulfur (Fe–S) 
clusters, which are thought to be among the earliest catalysts in the evolution 
of molecules [47,48]. (Fe–S) species are built from iron and bridging sulfur 
elements at various molar ratios [49], with the rhombic (2Fe-2S) and the cubane 
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(4Fe-4S) types being most common, while (3Fe-4S) and (8Fe-7S) have also been 
identified. In most proteins, the iron elements are coordinated to cysteine residues, 
although histidine, serine, aspartic acid residues, or back-bone amides can also act as 
ligands [50-53]. These can serve in biological electron transport due to their ability 
to delocalize electron density over Fe and S atoms [54-56], and consequently, they 
are major components in the photosynthetic and respiratory electron transport 
chains. Moreover, they are able to transport electrons in many membrane-
bound and soluble redox enzymes, and constitute the redox-active centres 
in ferredoxins, one of the largest classes of mobile electron carriers in biology [57]. 
Whereas the (Fe–S) species are one-electron carriers, the double-cubane (8Fe-7S) 
cluster, which is found only in nitrogenases, has the potential to act as a two-
electron carrier [58].
OrgANiC COFACTOrS
An overview of the molecular properties of organic cofactors has been produced by 
Fischer et al. [27], while details are also available in the CoFactor database [30,31] 
(see Table 2.1). Organic cofactors vary the most in terms of polarity and size, and 
less in flexibility. The porphyrin-like molecules, such as heme, B12, siroheme, 
cofactor 430, menaquinone 7 (MQ7), and ubiquinone 10 (U10), are larger and 
more hydrophobic than average. The dinucleotide cofactors (NAD, NADP, FAD, 
coenzyme A, and molybdopterin guanine dinucleotide) form the second group 
of cofactors, which are rich in heteroatoms and are of medium to high molecular 
weight. The remaining cofactors are smaller in size, with a lower hydrogen-bonding 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































For each type of cofactor there is a bias of its occurrence in enzymes 
of a particular EC class. The distribution of a certain cofactor, as well as 
the number of enzymes employing it, can differ significantly (Table 2.1). 
For example, coenzyme A (CoA) is used by a large number of enzymes (n = 237) 
from many EC classes, while NAD is found almost exclusively in oxido 
reductases (EC 1). In contrast, some cofactors are used by only a few enzymes 
from one enzyme class, such as biopterin (six oxidoreductases) or menaquinone 
(one lyase).
The distribution of organic and inorganic cofactors among all enzyme 
classes is as follows. The oxidoreductases (EC 1) are an enzyme class that depend 
mostly on organic cofactors, while hydrolases (EC 3) use such cofactors very 
rarely. Approximately one-third of enzymes from the remaining enzyme classes – 
the transferases (EC 2), lyases (EC 4), isomerases (EC 5), and ligases (EC 6) – 
employ organic cofactors.
This distribution can be explained by the complexity of the reactions that 
the enzymes catalyse. For example, the catalytic mechanism of hydrolases is 
relatively simple, and these enzymes quite often use metal ions as cofactors, 
as they can activate water for an initial nucleophilic attack [27]. Redox functions 
are rather unique to organic cofactors, including hydride, proton, single-electron 
and electron-pair transfer, and even covalent catalysis [27].
One organic cofactor, adenosine 5'-triphosphate (ATP), was not included 
in the CoFactor database, and thus is not described in Table 2.1. ATP typically 
serves as a coenzyme, facilitating phosphate group transfer. The hydrolysis of ATP, 
leading to the formation of ADP and inorganic phosphate, yields energy that is 
typically used to drive a thermodynamically unfavourable reaction. ATP also serves 
as a building block for RNA. As a coenzyme, ATP is used primarily by kinases 
(EC 2.7) in order to phosphorylate alcohols, and by some ligases (EC 6.5) in order 
to activate carboxyl groups, forming acyl-phosphate intermediates.
rEdOx COFACTOrS
Redox enzymes (oxidoreductases) catalyse reduction and oxidation reactions. 
As noted above, the chemical functionality of amino acids is limited, and for this 
reason redox enzymes typically need to employ redox-active transition metals or 
organic cofactors. Oxidoreductases can be divided into several groups, according 
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to the reaction that they catalyse and to the cofactor they use (Fig. 2.1). In many 
cases, oxidoreductases rely on a redox coenzyme such as NAD(P), which acts as an 
electron-shuttling cosubstrate that has to be regenerated. The redox reaction can 
also be coupled with the reduction of hydrogen peroxide to water (peroxidases), 
the reduction of oxygen to hydrogen peroxide or water (oxidases), and the reduction 
and incorporation of oxygen (some dioxygenases). The characteristics of three 
of the most common redox cofactors, nicotinamide, heme, and flavin, and related 




classes – the transferases (EC 2), lyases (EC 4), isomerases (EC 5), and ligases (EC 6) – employ organic 
cofactors. 
This distribution can be explained by the complexity of the reactions that the enzymes 
catalyse. For example, the catalytic mechanism of hydrolases is relatively simple, and these enzymes 
quite often use metal ions as cofactors, as they can activate water for an initial nucleophilic attack [27] 
[27]. Redox functions are rather unique to organic cofactors, including hydride, proton, single-electron 
and electron-pair transfer, and even covalent catalysis [27]. 
One organic cofactor, adenosine 5′-triphosphate (ATP), was not included in the CoFactor 
database, and thus is not described in Table 2.1. ATP typically serves as a coenzyme, facilitating 
phosphate group transfer. The hydrolysis of ATP, leading to the formation of ADP and inorganic 
phosphate, yields energy that is typically used to drive a thermodynamically unfavourable reaction. 
ATP also serves as a building block for RNA. As a coenzyme, ATP is used primarily by kinases (EC 2.7) in 
order to phosphorylate alcohols, and by some ligases (EC 6.5) in order to activate carboxyl groups, 




Redox enzymes (oxidoreductases) catalyse reduction and oxidation reactions. As noted above, 
the chemical functionality of amino acids is limited, and for this reason redox enzymes typically need to 
employ redox-active transiti  metals or organic cofactors. Oxidoreductases can be divided into several 
groups, accordi t  the reaction t t hey catalys  nd to the cofactor they use (Fig. 2.1). In many 
cases, oxidoreductases rely on a redox coenzyme such as NAD(P), which acts as an electron-shuttling 
cosubstrate that has to be regenerated. The redox reaction can also be coupled with the reduction of 
hydrogen peroxide to water (peroxidases), the reduction of oxygen to hydrogen peroxide or water 
(oxidases), and the reduction and incorporation of oxygen (some dioxygenases). The characteristics of 
three of the most common redox cofactors, nicotinamide, heme, and flavin, and related cofactor 








Figure 2.1. Classification of oxidoreductases and their respective most commonly found cofactors.
Nicotine cofactor engineering
Nicotinamide adenine dinucleotide (NAD) is the central redox cofactor in all living 
cells. It serves as hydride-mediator in biocatalytic redox mechanisms, shuttling 
between its oxidized form, NAD(P)+, and its reduced form, NAD(P)H (Fig. 2.2).
NAD exists in both a phosphorylated (NADP) and a non-phosphorylated 
form (NAD), with the variants being used either for catabolic or anabolic 
redox reactions in the living cell. Hence, most native enzymes are usually highly 
specific for either NAD or NADP. Since its discovery and initial characterization 
in the early twentieth century [59,60], investigations into modified, (semi-)
synthetic NAD analogues have been conducted in approximately two “waves,” 
with different motivations. First, during the 1950s to 1970s, attention was focused 
on identifying a fundamental understanding of the biological role and chemistry 
of NAD. Subsequently, more practical implementations were highlighted. 




of pioneering experiments to elucidate the steric and electronic requirements 
of the nicotinamide moiety of NAD [61-66]. By using pig brain NADase 
(E.C. 3.2.2.5), it was found that the native nicotinamide (pyridine-3-carboxamid) 
moiety could be replaced by other pyridine derivatives, thus enabling investigations 
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Figure 2.2. Redox chemistry of NAD(P) (upper) and general structure of NAD(P) (lower). 
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native nicotinamide (pyridine-3-carboxamid) moiety could be replaced by other pyridine derivatives, 





Scheme 2.1. Enzymatic synthesis of modified NAD analogues (mNAD) using NADase. 
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By using this methodology, a wide range of modified nicotinamide cofactors 
(mNADs) have been synthesiz d and evaluated for their acceptance, especially 
with alcohol dehydroge ases (ADHs) [61,63,64,67-73] (a detailed discussion 
of these modified cofactors is beyond the scope of this chapter). Th  majority 
of mNADs evaluated exhibited significantly decreased enzyme activities, 
as expressed by KM and Vmax values. In addition, mechanistic studies [69,70,74], 
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molecular mechanics simulations [75], and crystallographic investigations [76] were 
conducted to shed light on the interaction of NAD and its analogues with enzymes. 
In some cases, however, an increased ADH activity was also observed, amongst 
which 3-acetylpyridine-, 3-thioacetamide-, and 3-isobutyrylpyridine- derivatives 
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Figure 2.3. Selection of mNADs exhibiting significant activity with various ADHs. 
 
In one very interesting study, Kazlauskas [77] examined the horse liver-ADH-catalysed oxidation 
of various alcohols by mNADs. In this case, electron-poor mNAD+s exhibited an up to ninefold 
acceleration of the hydride transfer from the alcohol to mNAD+ but, surprisingly, product inhibition by 
the corresponding aldehydes and ketones was drastically decreased. This observation could not be 
rationalized, however, and the same was true for the change in enantioselectivity observed upon 
substituting NAD with mNADs [78]. More recently, mNADs have been rediscovered as biomedical probes 
and agents [79-82]. For example, masked, enzymatically inactive mNADs have been synthesized which 
can be reactivated photochemically. Likewise, a covalent inhibition of ADHs was achieved with 
photoactivatable arylazide-substituted NADs [83], whereby modifications at the adenine dinucleotide 
moiety (AD; Fig. 2.2) generally led to a significantly decreased activity of the resulting mNAD [84-86]. An 
example of this was reported by Sicsic et al., who evaluated truncated NAD models such as 
nicotinamide mononucleotide and its dephosphorylated analogue nucleotinamide nucleoside [87,88]. In 
this case, the use of horse liver-ADH led to a dramatic decrease in enzyme activities which, to some 
extent, could be recovered by the addition of adenine. 
With the emergence of White Biotechnology (i.e., the application of biotechnology to 
industrial processes) during the 1980s, economic issues in enzyme-mediated technologies have 
begun to gain importance. Indeed, the (still) high price of natural nicotinamide cofactors has triggered 
the development of efficient systems to regenerate cofactors that can then be used in catalytic 
quantities [89]. In order to create nicotinamide cofactors that were compatible with well-known 
enzyme membrane reactors (EMRs), thereby enabling their use in continuous production systems, 
polymer -modified NADs have been developed by Kula and Wandrey [90]. As a consequence, 
polyethylene glycol-modified NAD (PEG-NAD) derivatives were shown to be applicable to a broad range 
of dehydrogenase-catalysed reactions in EMRs [90-100]. An alternative approach to utilizing fully 
synthetic (and hence cheaper) nicotinamide analogues was proposed by Loewe and coworkers (Fig. 2.4) 
[101-108], and involved linking nicotinamide covalently to triazine dyes. However, on the evaluation of 
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to regenerate cofactors that can then be used in catalytic quantities [89]. In order 
to create nicotinamide cofactors that were compatible with well-known enzyme 
membrane reactors (EMRs), thereby enabling their use in continuous production 
systems, polymer-modified NADs have been developed by Kula and Wandrey [90]. 
As a consequence, polyethylene glycol-modified NAD (PEG-NAD) derivatives 
were shown to be applicable to a broad range of dehydrogenase-catalysed reactions 
in EMRs [90-100]. An alternative approach to utilizing fully synthetic (and hence 
cheaper) nicotinamide analogues was proposed by Loewe and coworkers (Fig. 2.4) 
[101-108], and involved linking nicotinamide covalently to triazine dyes. However, 
on the evaluation of these artificial NAD analogues the catalytic performance 
proved to be rather poor. More recently, Fish and coworkers suggested the use 
of N-benzyl nicotinamide derivatives (Fig. 2.4) for ADH-catalysed reductions 
[109] and monooxygenase-catalysed oxyfunctionalization reactions [110,111]. 
Unfortunately, the catalytic performance of these artificial mNADs was inferior, 
by several orders of magnitude, to the natural nicotinamide cofactors. Furthermore, 
when a flavin-dependent monooxygenase was used, a drastic increase in the 
uncoupling of flavin-reduction (mediated by mNAD) from product hydroxylation 
was observed [110]. This effect was considered due to a stabilizing H-bonding 
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Figure 2.4. Synthetic mNADs proposed by Loewe (left) and Fish (right). 
 
Overall, the studies of (semi-)synthetic analogues of the native nicotinamide cofactors have 
enriched the present understanding of the catalytic mechanism of NAD-dependent reactions. Whilst 
practical applications may arise from the therapeutic use of some mNADs, the promise of cell-free 
biocatalytic applications of oxidoreductases being cheaper by using mNADs has not yet been fulfilled. 
Rather, the high specificity of wild-type oxidoreductases for their natural redox cofactor, which results 
in highly unfavourable enzyme kinetics with mNADs, largely outweighs any cost benefits. Nonetheless, 
it is conceivable that protein engineering might offer a suitable solution to this problem, and in this 
respect Zhao and coworkers [113] have described an interesting concept of bioorthogonal redox 
reactions. Due to the central role of native nicotinamide cofactors in cellular metabolism, NAD(P)-
dependent whole-cell biotransformations are difficult to control and optimize. However, it was shown 
that modified cofactors (at the AMP moiety), together with engineered production and regeneration 
enzymes, could be used for redox biocatalysis. Hence, the desired redox reaction would be independent 
of the cellular NAD(P) metabolism, allowing straightforward optimization. 
 
Heme cofactor engineering 
 
In Nature, heme proteins fulfil central functions in diverse roles such as oxygen- and electron-
storage and transport, as well as catalysis. Consequently, the biological importance and chemical 
versatility of heme proteins has triggered intensive research on “heme engineering.” Besides seeking a 
more fundamental understanding of heme proteins, these efforts have been driven also by the 
potential catalytic applications of “artificial metalloenzymes.” In particular, various research groups 
[114-119] have been inspired to combine the “best of two worlds,” by incorporating chemical catalysts 
into biological scaffolds, such that a combination of the chemical versatility of these catalysts with 
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Overall, the studies of (semi-)synthetic analogues of the native nicotinamide 
cofactors have enriched the present understanding of the catalytic mechanism 
of NAD-dependent reactions. Whilst practical applications may arise from the 
therapeutic use of some mNADs, the promis  of cell-free biocatalytic applications 
of oxidoreductases being ch aper by using mNADs has not yet been fulfilled. 
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Rather, the high specificity of wild-type oxidoreductases for their natural redox 
cofactor, which results in highly unfavourable enzyme kinetics with mNADs, 
largely outweighs any cost benefits. Nonetheless, it is conceivable that protein 
engineering might offer a suitable solution to this problem, and in this respect 
Zhao and coworkers [113] have described an interesting concept of bioorthogonal 
redox reactions. Due to the central role of native nicotinamide cofactors in cellular 
metabolism, NAD(P)-dependent whole-cell biotransformations are difficult to 
control and optimize. However, it was shown that modified cofactors (at the AMP 
moiety), together with engineered production and regeneration enzymes, could be 
used for redox biocatalysis. Hence, the desired redox reaction would be independent 
of the cellular NAD(P) metabolism, allowing straightforward optimization.
heme cofactor engineering
In Nature, heme proteins fulfil central functions in diverse roles such as oxygen- 
and electron-storage and transport, as well as catalysis. Consequently, the biological 
importance and chemical versatility of heme proteins has triggered intensive 
research on “heme engineering.” Besides seeking a more fundamental understanding 
of heme proteins, these efforts have been driven also by the potential catalytic 
applications of “artificial metalloenzymes.” In particular, various research groups 
[114-119] have been inspired to combine the “best of two worlds,” by incorporating 
chemical catalysts into biological scaffolds, such that a combination of the 
chemical versatility of these catalysts with typical enzyme characteristics, such as 
stereodifferentiation and rate enhancements, is envisaged. Whilst an exhaustive 
discussion of this thriving area of research is beyond the scope of this chapter, 
the topic has been well summarized in excellent recent reviews [114-119]. At this 
point, attention is focused on the (re)constitution of natural heme proteins and 
non-heme proteins with artificial heme derivatives.
Reconstitution of myoglobin
Myoglobin (Mb) represents an excellent model system for the evaluation of artificial 
heme moieties. Due to its essential role as an oxygen-storage protein it has been 
well characterized and reliable protocols have been prepared for the generation 
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typical enzyme characteristics, such as stereodifferentiation and rate enhancements, is envisaged. Whilst 
an exhaustive discussion of this thriving area of research is beyond the scope of this chapter, the topic 
has been well summarized in excellent recent reviews [114-119]. At this point, attention is focused on 
the (re)constitution of natural heme proteins and non-heme proteins with artificial heme derivatives. 
 
Reconstitution of myoglobin 
Myoglobin (Mb) represents an excellent model system for the evaluation of artificial heme 
moieties. Due to its essential role as an oxygen-storage protein it has been well characterized and 
reliable protocols have been prepared for the generation of apo-Mb [120][121]. For example, Hayashi 
and cowork s have conducted extensive investigation into the substitution of native heme with 
modified, highly charged derivatives (Fig. 2.5) [122-125]. 
 
 
Figure 2.5. Natural heme b of Mb vs. the highly anionic and cationic derivatives. 
 
As expected, the interaction of such a modified Mb with other proteins such as cytochrome c 
was significantly modulated [124,126], although the catalytic features of the artificial metalloproteins 
were also influenced by the modification [127]. For example, the peroxidase activity of an anionic 
modified Mb was greatly enhanced towards positively charged substrates such as (Ru[NH3]6)2+, or 
phenolics such as catechol, due to favourably enhanced Km and Vmax values. Negatively charged 
substrates were, in contrast to native Mb, hardly converted at all. When combined with engineered Mb 
variants, peroxidation efficiencies similar to horseradish peroxidase were achieved [128], as well as 
improved oxyfunctionalization activities [129]. Interestingly, the reconstitution of apo-Mb with iron 
porphycene, a structural analogue of native heme, resulted in an Mb variant that exhibited a superior 
oxygen-binding capacity [130]. 
Due to their importance in chemical catalysis [131], it is not surprising that salen complexes have 
also been evaluated within the Mb scaffold. For example, Watanabe and coworkers reconstituted apo-
Mb with Cr- and Mn-salophen complexes, and then evaluated the resulting hybrid catalysts for 
hydrogen peroxide-driven sulfoxidation reactions [132]. In this case, noteworthy enhancements in 
rate compared to the Mb-free catalysts and, more importantly, a significant chiral induction, were 
achieved (enantiomeric purities of the product up to 13% enantiomeric excess; e.e.). The 
chemoselectivity of the sulfoxidation was also influenced by the protein, as overoxidation to the (achiral) 
sulfone was efficiently prevented [133]. This effect was rationalized by the rather hydrophobic protein 
environment around the bound catalyst, which significantly hampered binding of the polar sulfoxide. 
These findings were corroborated by crystallographic data [134], and this led to the 
development of Mb variants with increased enantiospecificities [135]. In-depth mechanistic studies 
Figure 2.5. Natural heme b of Mb vs. the highly anionic and cationic derivatives.
As expected, the interaction of such a modified Mb with other proteins such 
as cytochrome  was significantly modulated [124,126], although the catalytic 
features of the artificial metalloproteins were also influenced by the modification 
[127]. For example, the peroxidase activity of an anionic modified Mb was greatly 
enhan d towards positively charged substrates such as (Ru[NH3]6)
2+, or phenolics 
such as catechol, due to favourably enhanced KM and Vmax values. Negatively charged 
substrates were, in contrast to native Mb, hardly converted at all. When combined 
with engineered Mb variants, p roxi a io  effici ncies similar to horseradish 
peroxidase were achieved [128], as well as improved oxyfunctionalization 
activities [129]. Interestingly, the reconstitution of apo-Mb with iron porphycene, 
a structural analogue of native heme, resulted in an Mb variant that exhibited 
a superior oxygen-binding capacity [130].
Du  to their impo tance in ch mical catalysis [131], it is not surprising that salen 
complexes have also been evaluated within the Mb scaffold. For example, Watanabe 
and coworkers reconstituted apo-Mb with Cr- and Mn-salophen complexes, and then 
evaluated the resulting hybrid catalysts for hydrogen peroxide-driven sulfoxidation 
reactions [132]. In this case, noteworthy enhancements in rate compared to the 
Mb-free catalysts and, more importantly, a significant chiral induction, were 
achieved (enantiomeric purities of the product up to 13% enantiomeric excess; 
e.e.). The chemoselectivity of the sulfoxidation was also influenced by the protein, 
as overoxidation to the (achiral) sulfone was efficiently prevented [133]. This effect 
was rationalized by the rather hydrophobic protein environment around the bound 
catalyst, which significantly hampered binding of the polar sulfoxide.
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These findings were corroborated by crystallographic data [134], and this 
led to the development of Mb variants with increased enantiospecificities [135]. 
In-depth mechanistic studies also gave rise to a greater molecular understanding 
of the factors influencing the activity/stability/specificity of these hybrid catalysts 
[135,136]. The enantiospecificities achieved using these (reversible binding-based) 
approaches remained rather limited, but it was proposed by Lu and coworkers that 
this might be due to the high conformational flexibility of the Mb-bound catalyst. 
Hence, Mb-mutants were designed that were capable of covalently binding 
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Figure 2.6. Modified Mn-salophene complex capable of double covalent linkage to a double Cys-Mb mutant 
(L72C/Y103C-Mb). 
 
Indeed, the enantiospecificity was increased from 12% e.e. to 51% e.e. from the single to double 
covalent attachment; in fact, in a recent study that included additional mutations, e.e.-values of up to 
83% were achieved [138]. Besides the aforementioned Cr– and Mn–salen complexes, Fe- [139], Cu– 
[140], and Rh–salen complexes [141] have also been incorporated into Mb. 
Besides chemical modifications at the porphyrin ring, metal exchanges have also been reported 
that clearly enable a drastic broadening of the chemical reactivity of the reconstituted Mbs. For 
example, Willner and coworkers exchanged the natural Fe(II)-heme of Mb with the Co(II)-homolog [142-
144] such that, after covalent modification of the reconstituted Mb with the photosensitizer eosin, an 
artificial photoactivated reductase was obtained (Fig. 2.7). An efficient electron transfer from the 
photoexcited eosins occurred efficiently only when these were covalently attached to the reconstituted 
Mb. Nevertheless, in that case an intermediate Co(III)–H-species was formed that was capable of 
efficiently catalysing syn-hydrogenations of C–C-double and triple bonds. 
Figure 2.6. Modified Mn-salophene complex capable of double covalent linkage to a double 
Cys-Mb mutant (L72C/Y103C-Mb).
Indeed, the enantiospecificity was increased from 12% e.e. to 51% e.e. from 
the single to double covalent attachment; in fact, in a recent study that included 
additional mutations, e.e.-values of up to 83% were achieved [138]. Besides the 
aforementioned Cr– and Mn–salen complexes, Fe- [139], Cu– [140], and Rh–salen 
complexes [141] have also been incorporated into Mb.
Besides chemical modifications at the porphyrin ring, metal exchanges have 
also been reported that clearly enable a drastic broadening of the chemical 
reactivity of the reconstituted Mbs. For example, Willner and coworkers 
exchanged the natural Fe(II)-heme of Mb with the Co(II)-homolog [142-144] such 
that, after covalent modification of the reconstituted Mb with the photosensitizer 
eosin, an artificial photoactivated reductase was obtained (Fig. 2.7). An efficient 
electron transfer from the photoexcited eosins occurred efficiently only when 
these were covalently attached to the reconstituted Mb. Nevertheless, in that case 
an intermediate Co(III)–H-species was formed that was capable of efficiently 









Figure 2.7. Co(II)-porphyrin-reconstituted Mb covalently modified with two eosin photosensitizers (upper) and its 
application in photobiocatalytic reduction of C-C multiple bonds or protons. 
 
Artificial metalloproteins based on serum albumins 
Serum albumins (SAs) represent the most abundant proteins in vertebrate blood, serving 
as transporters for small, hydrophobic molecules such as fatty acids, bile acids, bilirubin, and 
hemin [145]. In terms of hydrophobicity, the “SA hemin binding site” is comparable to the 
hemin binding site of Mb, which suggests a “reconstitution” of SAs with porphyrin- and salen-
catalysts. Hence, it is not too surprising that SAs have been applied as chiral ligands for a range of 
chemical reactions [146]. During the early 1990s, Ohkubo and coworkers described the dioxygenase 
activity of a Mn(III)–porphyrin covalently attached to SA [147,148]. Later, Gross and coworkers 
systematically screened SAs from different origins combined with Fe(III)– and Mn(III)–corroles as 
sulfoxidation catalysts [149,150]. In particular, the Mn(III)–corrol–SA conjugate showed a high catalytic 
activity (up to 33 h-1) and high stereospecificity (optical purities up to 74% e.e.) in the peroxide-driven 
sulfoxidation of thioanisole. Similar to previous observations with Mbs, the SA–salen conjugate-
catalysed sulfoxidation also proceeded chemoselectively to the sulfoxide [151]. Again, it was considered 
that the rather hydrophobic protein environment would efficiently exclude binding of the sulfoxide. 
Later, Reetz described a SA-supported phthalocyanine–Cu(II) complex for enantiospecific Diels –Alder 
reactions (Fig. 2.8) [152]. In this case, while the endo : exo ratio was largely determined by the catalyst 
used, the high stereoselectivity (up to 93% e.e.) observed for the major endo-diastereomer was due to 
the chiral protein scaffold. 
 
Figure 2.7. Co(II)-porphyrin-reconstituted Mb covalently modified with two eosin photosensitizers 
(upper) a d its application in photobioca alytic reduction of C-C multiple bonds or protons.
Artificial metalloproteins based on serum albumins
Serum albumins (SAs) represent the most abundant proteins in vertebrate blood, 
serving as transporters for small, hydrophobic molecules such as fatty acids, bile 
acids, bilirubin, and hemin [145]. In terms of hydrophobicity, the “SA hemin 
binding site” is comparable to the hemin binding site of Mb, which suggests 
a “reconstitution” of SAs with porphyrin- and salen-catalysts. Hence, it is not too 
surprising that SAs have been applied as chiral ligands for a range of chemical 
reactions [146]. During the early 1990s, Ohkubo and coworkers described the 
dioxygenase activity of a Mn(III)–porphyrin covalently attached to SA [147,148]. 
Later, Gross and coworkers systematically screened SAs from different origins 
combined with Fe(III)– and Mn(III)–corroles as sulfoxidation catalysts [149,150]. 
In particular, the Mn(III)–corrol–SA conjugate showed a high catalytic activity 
(up to 33 h-1) and high stereospecificity (optical purities up to 74% e.e.) in the 
peroxide-driven sulfoxidation of thioanisole. Similar to previous observations 
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with Mbs, the SA–salen conjugate-catalysed sulfoxidation also proceeded 
chemoselectively to the sulfoxide [151]. Again, it was considered that the rather 
hydrophobic protein environment would efficiently exclude binding of the 
sulfoxide. Later, Reetz described a SA-supported phthalocyanine–Cu(II) complex 
for enantiospecific Diels-Alder reactions (Fig. 2.8) [152]. In this case, while the endo 
: exo ratio was largely determined by the catalyst used, the high stereoselectivity 






Figure 2.8. Cu(II)-phthalocyanine-BSA conjugate for enantiospecific Diels-Alder-reactions. 
 
Flavin cofactor engineering 
 
Cofactors containing 7,8-dimethyl-10-alkylisoalloxazine, termed “flavins,” are relatively abundant 
in Nature and are involved in a multitude of redox and non-redox reactions. Flavin-containing proteins 
are extremely diverse in the reactions that they catalyse, including dehydrogenations [153], oxidations 
[154-156], monooxygenations [157-159], halogenations [160-162], reductions [163,164], and biological 
sensing [165-172]. Riboflavin (vitamin B2) is a biosynthetic precursor for the two most common flavin 
cofactors, namely flavin adenine dinucleotide (FAD) [173,174] and flavin mononucleotide (FMN) [175] 
(Fig. 2.9). It should be noted that, from a chemical point of view, FMN and FAD are not nucleotides as the 
bond between the ribose and isoalloxazine ring is not glycosidic. Unlike other cofactors, the reactions 
catalysed by flavins do not share mechanistic pathways [176]; rather, the only shared feature of flavins 
is the fact that the redox-active centre is always located in the isoalloxazine ring system. The 
amphipathic character of the system derives from three rings: the hydrophobic dimethylbenzene; the 
more polar pyrimidine; and joining them the central phenylenediamine ring. Electrons are delivered to, 
and removed from, the flavin through this central moiety, while the pyrophosphate moiety functions as 




Figure 2.9. Structural formulas of the flavin cofactors FMN and FAD. 
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biological sensing [165-172]. Riboflavin (vitamin B2) is a biosynthetic precursor for 
the two most common flavin cofactors, namely flavin adenine dinucleotide (FAD) 
[173,174] and flavin mononucleotide (FMN) [175] (Fig. 2.9). It should be noted 
that, from a chemical point of view, FMN and FAD are not nucleotides as the bond 
between the ribose and isoalloxazine ring is not glycosidic. Unlike other cofactors, 
the reactions catalysed by flavins do not share mechanistic pathways [176]; rather, 
the only shared feature of flavins is the fact that the redox-active centre is always 
located in the isoalloxazine ring system. The amphipathic character of the system 
derives from three rings: the hydrophobic dimethylbenzene; the more polar 




delivered to, and removed from, the flavin through this central moiety, while the 
pyrophosphate moiety functions as a component of molecular recognition, and the 
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Figure 2.9. Structural formulas of the flavin cofactors FMN and FAD. 
 
Figure 2.9. Structural formulas  e flavin cofactors FMN and FAD.
The biochemical function of flavin cofactors is based on their redox-active 
isoalloxazine ring system, which is able to catalyse (light-induced) either one- or 
two-electron transfer reactions, as well as dioxygen activation [178]. The ability 
to participate in one-electron transfer reactions implies that a flavin can exist 
in a radical form, termed a “semiquinone.” Indeed, this is one of the features that 
set flavins apart from nicotinamide cofactors, as the semiquinone can exist in two 
ionic forms – neutral and anionic – which show different spectral properties [179]. 
The flexible redox behaviour of flavins has translated into a wide range of different 
flavoenzymes that are very versatile in terms of substrate acceptance and type 
of reaction catalysed.
In contrast to NAD(P) cofactors, flavin cofactors are usually tightly associated 
with the host protein. Although most flavoenzymes contain non-covalently bound 
FAD or FMN, some have been found to be covalently bound [180]. It appears that 
a covalent attachment of FMN is relatively rare when compared to FAD [181]. 
FMN is linked either via the 8α-position (to a histidine) or via the 6-position 
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(to a cysteine) of the isoalloxazine ring [182]. In the case of FAD, a covalent bond 
typically involves the 8α-position, which binds to N1 or N3 of a histidine, a cysteine 
thiol, a tyrosine hydroxyl, or an aspartate carboxyl group [182,183]. The results 
of recent studies have shown that, in some cases, the FAD cofactor is even bicovalently 
tethered via the 8α-position and the 6-position of the isoalloxazine ring [184]. 
The natural occurrence of covalent protein–flavin linkages has inspired research 
aimed at creating artificial covalent flavoproteins. In fact, the covalent anchoring 
of a flavin cofactor can result in a more stable enzyme with better or new redox 
properties [101-108]. The first attempts to create flavin–protein hybrids were 
reported back in the 1970s and 1980s [185], when a flavin group was incorporated 
into the hydrolytic enzyme, papain, to create a new semi-synthetic oxidoreductase. 
The active site cysteine residue was used to form a covalent linkage with a highly 
reactive brominated flavin, while the redox activity of flavopapains created in 
this way was determined using N-benzyl-1,4-dihydronicotinamide. One of the 
flavopapains showed a 50-fold rate acceleration compared to the respective free 
flavin, a finding rationalized by the favourable interaction of a flavin carbonyl group 
with papain that correctly positions the flavin cofactor in the papain active site. 
The importance of the exact structure of the flavin derivative attached to papain was 
further investigated [186] by preparing a series of flavopapains that showed widely 
different rate enhancements (zero to three orders of magnitude) in catalysing 
oxidation of the above-mentioned substrate. The differences were explained by 
different geometries in the active sites of the semisynthetic enzymes, where subtle 
differences contributed greatly to the resulting specificity.
In Nature, formation of the flavin–protein covalent bond is a post-translational, 
autocatalytic process (termed covalent flavinylation) that has been investigated 
in many flavoenzymes by preparing the apo enzyme and performing subsequent 
reconstitution studies in vitro [187-192]. Recently, it was also shown feasible 
to introduce a covalent linkage in vivo into a flavoprotein, putrescine oxidase (PuO). 
Originally, this bacterial amine oxidase did not contain such a covalent cofactor– 
protein interaction [193,194]. PuO is highly homologous to monoamine oxidase 
B (MAO-B) but, in contrast to MAO-B, native PuO binds FAD in a noncovalent 
manner. In MAO-B, the bond is formed between the C8α-methyl group of the 
isoalloxazine ring and a cysteine residue. Based on this observation, a Cys residue 
was introduced into a corresponding position in PuO, and the resulting isolated 




Two additional mutations were introduced in PuO to boost the covalent FAD 
binding, and the subsequently obtained triple mutant did indeed show 
an increased level of covalent flavin–protein bond formation [194]. These study 
findings supported the suggestion that covalent flavinylation depends on a correct 
cofactor environment [195-201] and also showed that it is feasible to turn natural 
noncovalent flavoproteins into the covalent variants by protein engineering. 
Moreover, such an approach avoids the use of highly reactive flavin analogues, 
which are difficult to prepare and form a covalent protein–flavin bond upon 
reconstitution with apo proteins in vitro [101-108].
Both, FMN and FAD cofactors are typically tightly bound by virtue of the 
tight interaction with the phosphate or ADP moieties, respectively. Consequently, 
it is often possible to replace a flavin cofactor with an analogue which has been 
modified on the isoalloxazine moiety. Similar to the initial biochemical studies 
performed with NAD derivatives (see above) during the 1950s to 1970s, many 
flavin derivatives were prepared and analysed as probes to study the role and 
function of flavins in flavoproteins. In fact, much of the current knowledge 
relating to flavoproteins originates from these flavin replacement studies 
(for a comprehensive review, see Ref. [202]).
The variety of modifications that have been studied in flavoproteins 
is illustrated in Fig. 2.10. While such flavin derivatives have been useful for 
elucidating the mechanistic details of how flavoenzymes function, very little 
attention has been focused on using flavin derivatives to create flavoproteins 
with novel catalytic properties. Very recently, however, such an approach proved 
to be successful when using alkylated flavin derivatives. It had been shown during 
the 1970s, that N5-alkylated flavins form remarkably stable 4a-peroxyflavins 
upon reaction with hydrogen peroxide, and thus represent powerful oxidizing 
catalysts [203-205]. Recently, a selection of N5-alkylated riboflavin and lumiflavin 
derivatives was prepared and used to replace the riboflavin in riboflavin-binding 
protein (RfBP), an avian protein that serves as a vitamin storage protein in chicken 
eggs but displays no catalytic activity. However, when the natural riboflavin was 
replaced with alkylated flavins, an artificial enzyme was created that was able to 
perform peroxide-driven enantioselective sulfoxidations [206]. Unfortunately, the 
newly created “flavozyme” proved to be a far-from-perfect biocatalyst, and could 
not be optimized by protein engineering (RfBP cannot be produced recombinantly 
[207]). Consequently, more suitable apo flavoproteins should be targeted for 
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generating improved variants of these artificial flavin-containing peroxygenases. 
Based on the outcome of recently developed methods of flavoprotein periplasmic 
expression in Escherichia coli, as well as the availability of riboflavin auxotrophic 
strains, the direct expression of apo proteins capable of binding externally added 
flavin derivatives should soon be possible [192,208]. Notably, this would open 
the door to the creation of not only new biocatalysts but also of recombinant 





Figure 2.10. Reported sites of flavin modifications. The location and size of the arrows indicate the position and 
frequency of modifications of flavins that have been incorporated in flavoproteins (202). 
 
A rather newly proposed role for redesigned flavins is based on the use of reactive flavin 
derivatives to develop a new drug targeting system, or to create noninvasive molecular imaging 
biomarkers. The strategy is based on a (as yet unknown) mechanism of riboflavin transport into cells 
[209], which appears to be related to the human riboflavin carrier protein. The transport protein has 
been shown to be highly upregulated in several types of tumour cell [210-213], most likely due to the 
relatively high energy demands of cancer cells that require the activation of numerous catabolic 
enzymes, many of which contain a flavin cofactor. This selective import of flavins makes the targeting of 
tumour cells possible with the use of flavin derivatives. Very recently, when riboflavin was conjugated 
with a novel type of (polyamidoamine) dendrimer, the result was a series of nontoxic, 
nonimmunogenic nanoparticles with an extended duration of circulation [214-217]. Moreover, a large 
number of primary amines present on the nanoparticle surface allowed for conjugation not only of 
riboflavin but also a variety of ligands, including the cytotoxic agent methotrexate, or fluorescein as a 
fluorescent marker [218]. The investigators confirmed that such conjugates could undergo a specific 
cellular association in cervical carcinoma HeLa cells, with a subsequent potent inhibition of tumour 
cell growth, by using a methotrexate conjugate. Alternately, fluorescein could be delivered as an 




In this Chapter, an overview was provided of the breadth of chemical reactions that are catalysed 
by cofactor-containing enzymes. Generally, cofactors are exploited by oxidoreductases, the class of 
enzymes that perform the redox reactions that are especially valuable, in selective fashion, for 
industrial processes because they are not easily accessible by conventional chemical approaches. Yet, in 
order to extend the capabilities of cofactor-containing enzymes, a series of schemes have been 
undertaken either to redesign natural cofactors, or to design new cofactor types. Clearly, such 
engineering efforts will benefit from the previously developed methods that have been used to engineer 
protein scaffolds, and to accept and tightly bind modified or new ligands. However, the main benefit of 
this field of enzyme engineering – which combines protein engineering and cofactor redesign – is that it 
will inevitably lead to the generation of totally new biocatalysts. 
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A rather newly proposed role for redesigned flavins is based on the use of 
reactive flavin derivatives to develop a new drug targeting system, or to create 
noninvasive molecular imaging biomarkers. The strategy is based on a (as yet 
unknown) mechanism of riboflavin transport into cells [209], which appears 
to be related to the human riboflavin carrier protein. The transport protein has 
been shown to be highly upregulated in several types of tumour cell [210-213], 
most likely due to the relatively high energy demands of cancer cells that require 
the activation of numerous catabolic enzymes, many of which contain a flavin 
cofactor. This selective import of flavins makes the targeting of tumour cells possible 
with the use of flavin derivatives. Very recently, when riboflavin was conjugated with 
a novel type of (polyamidoamine) dendrimer, the result was a series of nontoxic, 
nonimmunogenic nanoparticles with an extended duration of circulation [214-217]. 
Moreover, a large number of primary amines present on the nanoparticle surface 
allowed for conjugation not only of riboflavin but also a variety of ligands, 




[218]. The investigators confirmed that such conjugates could undergo a specific 
cellular association in cervical carcinoma HeLa cells, with a subsequent potent 
inhibition of tumour cell growth, by using a methotrexate conjugate. Alternately, 
fluorescein could be delivered as an imaging agent for diagnostic purposes.
CONCLudiNg rEmArKS
In this Chapter, an overview was provided of the breadth of chemical reactions that 
are catalysed by cofactor-containing enzymes. Generally, cofactors are exploited 
by oxidoreductases, the class of enzymes that perform the redox reactions that 
are especially valuable, in selective fashion, for industrial processes because they 
are not easily accessible by conventional chemical approaches. Yet, in order to 
extend the capabilities of cofactor-containing enzymes, a series of schemes have 
been undertaken either to redesign natural cofactors, or to design new cofactor 
types. Clearly, such engineering efforts will benefit from the previously developed 
methods that have been used to engineer protein scaffolds, and to accept and tightly 
bind modified or new ligands. However, the main benefit of this field of enzyme 
engineering – which combines protein engineering and cofactor redesign – is that 
it will inevitably lead to the generation of totally new biocatalysts.
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ABSTrACT
Putrescine oxidase (PuO) from Rhodococcus erythropolis is a soluble homodimeric 
flavoprotein, which oxidizes small aliphatic diamines. In this study, we report the 
crystal structures and cofactor binding properties of wild-type and mutant enzymes. 
From a structural viewpoint, PuO closely resembles the sequence-related human 
monoamine oxidases A and B. This similarity is striking in the flavin-binding site 
even if PuO does not bind covalently the cofactor, differently from monoamine 
oxidases. A remarkable conserved feature is the cis peptide conformation of the Tyr 
residue which recognizes the substrate. The structure of PuO in complex with the 
reaction product reveals that Glu324 is crucial in recognizing the terminal amino 
group of the diamine substrate and explains the narrow substrate specificity of the 
enzyme. The structural analysis also provides clues for identification of residues that 
are responsible for the competitive binding of ADP versus FAD (~50% of wild-
type PuO monomers isolated are occupied by ADP instead of FAD). By replacing 
Pro15, which is part of the dinucleotide-binding domain, enzyme preparations were 
obtained that are almost 100% in the FAD-bound form. Furthermore, mutants 
have been designed and prepared that form a covalent 8α-S-cysteinyl-FAD linkage. 
These data provide new insights into the molecular basis for substrate recognition 
in amine oxidases and demonstrate that engineering of flavoenzymes to introduce 
covalent linkage with the cofactor is a possible route to develop more stable protein 
molecules, better suited for biocatalytic purposes.




Flavin cofactors FMN and FAD are essential for the catalytic function of a wide 
range of proteins. In most cases they are tightly bound to proteins as prosthetic 
groups by dedicated cofactor-binding domains. Analysis of the available crystal 
structures of FAD-containing proteins reveals several structural classes [1]. 
The majority of these FAD-containing proteins contain a distinct domain that 
binds tightly but in a non-covalent manner the ADP moiety of the FAD molecule. 
In many cases this is a Rossmann fold dinucleotide-binding domain which can 
be easily recognized at sequence level by the canonical GxGxxG sequence motif. 
Another layer of complexity concerning flavin cofactor binding is added by 
the observation that some flavoproteins contain a covalently bound flavin 
cofactor. Several types of covalent protein-FAD linkages have been found [2]. 
The most common covalent bond involves the C8α-methyl moiety of the flavin 
cofactor and a histidine or cysteine residue. The role of the covalent flavin-protein 
bond appears to vary from protein to protein. In some flavoproteins the covalent 
linkage is required for tuning the redox properties of the flavin or for increasing 
protein stability. Flavin incorporation has been shown to be an auto-catalytic 
process which is in contrast with other covalently bound cofactors, e.g. heme in 
cytochrome c, that depend on dedicated enzymes that catalyse covalent cofactor 
incorporation [3-7].
Putrescine oxidase from Rhodococcus erythropolis (PuO) is a recently discovered 
amine oxidase which contains a non-covalently bound FAD molecule [8]. 
It shows a high degree of sequence homology with human and fungal monoamine 
oxidases (MAOs) which all are active on a broad range of aromatic compounds 
[9,10]. Nevertheless, PuO only accepts a few small aliphatic diamines as substrates, 
e.g. putrescine and cadaverine. Protomers of this enzyme are predicted to bind 
one FAD because of the presence of the typical dinucleotide-binding motif (DBM). 
However, PuO is unique among all reported flavoprotein oxidases in that it is 
found to contain one FAD molecule per protein dimer [11,12]. Mass spectrometry 
(MS) analysis has recently revealed that this relatively low FAD content is the 
result of competitive non-covalent binding of ADP into the FAD binding site. 
The sequence-related human MAO A and B bind one covalently linked FAD molecule 
per protomer [13]. This suggests that in some proteins covalent flavinylation may 




In this study, our goal is to identify the residues that tune the cofactor 
binding properties of PuO. For this, the crystal structures of wild-type PuO 
and several mutants have been elucidated. Furthermore, electrospray ionization 
mass spectroscopy (ESI-MS) is used to determine the FAD and ADP contents 
and their distribution in the dimeric protein. The structural data, together with 
enzyme kinetic data, reveal that subtle changes in the FAD binding pocket can 
significantly (1) increase binding of FAD over ADP, and (2) lead to efficient covalent 
incorporation of the FAD cofactor.
ExpErimENTAL prOCEdurES
Chemicals
Oligonucleotides and horse-radish peroxidase were from Sigma-Aldrich. 
PfuTurbo DNA polymerase was from Stratagene. Escherichia coli TOP10 from 
Invitrogen was used as a host for DNA manipulations and protein expression. 
All other chemicals were of analytical grade. Constructs were sequenced at GATC 
Biotech (Konstanz, Germany).
Construction of puO p15i/A394C, puO A394C/v433m and puO 
A394C/A396/ Q431g
The mutants were prepared using the QuikChange site-directed mutagenesis kit 










The sites of mutation are underlined.




Expression and purification of wild-type PuO and its mutants was performed 
as described before [8].
FAd covalent incorporation reaction
To monitor FAD-protein covalent bond formation in PuO, enzyme (50 mM Tris-
HCl, pH 7.5) was diluted in 50 mM sodium carbonate, pH 10.0 (final pH 8.3) and 
incubated	at	17˚C.	No	exogenous	FAD	was	added.	Samples	were	taken	in	time	and	
analysed for activity and amount for covalent FAD.
ESi-mS experiments
For nanoflow ESI-MS analysis under native conditions, enzyme samples were 
prepared in 50 mM ammonium acetate, pH 6.8. For analysis under denaturing 
conditions, enzyme samples were diluted either in 50% acetonitrile with 0.2% 
formic acid or in 5% formic acid. Analysis was performed on a LC-T nanoflow 
ESI orthogonal TOF mass spectrometer (Micro-mass, Manchester, UK). 
All measurements were performed by operating in the positive ion mode and 
by using gold-coated needles, made from borosilicate glass capillaries (Kwik-Fil; 
World Precision Instruments, Sarasota) on a P-97 puller (from Sutter Instruments, 
Novato). The needles were coated with a gold layer, which was performed by 
an Edwards Scancoat six Pirani 501 sputter coater (Edwards Laboratories, Milpitas). 
Mass spectra were calibrated using cesium iodide in water (25 mg/ml).
Analytical methods
Absorbance spectra were recorded in 50 mM Tris-HCl, pH 7.5 or Tris-carbonate, 
pH	 8.3,	 at	 25˚C	 on	 a	 PerkinElmer	 Lambda	 Bio40	 spectrophotometer.	 Enzyme	
concentrations were determined by measurement of absorbance at 280 nm 
using ε280=63370 M
-1cm-1 (http://www.expasy.ch/sprot/) and recalculated for 
monomers containing FAD. Oxidase activity was measured by using a coupled 




covalent FAD concentration (ε450=11.3 mM
-1cm-1), 5% trichloroacetic acid (TCA) 
was used to precipitate the protein and the absorbance spectrum of the supernatant 
was recorded after centrifugation.
Crystallization and structure determination
Crystallization conditions were initially screened using an Oryx8 robot (Douglas 
Instruments) with 96-well plates. Positive results were obtained in vapor microbatch 
under a mixture of 70% paraffin – 30% silicon oils with ammonium sulfate and 
PEG400 precipitants. Conditions were further optimized and crystals of wild-type 
and mutant enzymes used for structure determination were obtained by sitting-
drop vapor diffusion method at 4°C by mixing equal volumes (2-4 µl) of protein and 
reservoir solutions. Protein solutions consisted of 8-10 mg enzyme/ml in phosphate 
buffer pH 7.2 whereas precipitant solutions consisted of 2.0 - 2.4 M ammonium 
sulfate, 0.1 M sodium citrate, and 0.1 M Mes-HCl pH 6.4. Structure of the wild-
type protein in complex with the reaction product was obtained by soaking a crystal 
at 20°C for 1 hour in a solution containing 10 mM 1,4-diaminobutane, 2.5 M 
ammonium sulfate, 0.1 M sodium citrate, and 0.1 M Mes-HCl pH 6.4.
For data collection, crystals were briefly soaked in a cryoprotectant solution 
consisting of 20% (v/v) glycerol, 2.5 M ammonium sulfate, 0.1 M sodium 
citrate, and 0.1 M Mes-HCl pH 6.4. X-ray diffraction data was collected at 100 K 
at the European Synchrotron Radiation Facility in Grenoble (France). Images were 
processed using the CCP4 suite programs [14]. The structure of the wild-type 
enzyme was solved by molecular replacement using the structure of a monomer 
of MAO B as search model (Protein Data Bank entry 2V5Z). All other PUO 
structures were solved by molecular replacement employing the wild-type 
structure as search model. Crystallographic computing and model analysis were 
performed with COOT [15] and programs of the CCP4 package [14]. Pictures were 
generated with the program CCP4mg [16]. Cavity calculations were performed 
with the program VOIDOO [17]. Data collection parameters and final refinement 
statistics are listed in Table 3.1.




Structural properties of wild-type puO
PuO is a stable protein which crystallizes quite readily, yielding different crystal 
forms (Table 3.1). Structure determinations and refinements were done following 
standard crystallographic protocols, taking advantage of the good quality of the 
diffraction data which produced excellent electron density maps. All protein 
residues (except the N-terminal first amino acid and the C-terminal 3-4 residues) 
have well-defined ordered conformations. Atomic superpositions indicate that the 
conformations of the crystallographically independent protein subunits are highly 
conserved across different crystal forms as shown by root-mean-square deviations 
falling in the range of 0.1-0.3 Å (using Cα atoms). This observation implies that 
both ligand binding and side-chain mutations cause minimal or no conformational 
changes with respect to the native wild-type enzyme. On this basis, unless otherwise 
stated, model analysis was carried out with reference the to A subunit of the 
ligand-bound structure obtained by soaking the crystals in a putrescine-containing 
solution (Fig. 3.1A). With the exception of the A394C/A396T/Q431G triple 
mutant (see below), the flavin ring of FAD exhibits well defined electron densities 
and was refined with full occupancy (Fig. 3.1B). This indicates that the FAD-bound 
(rather than ADP-bound) enzyme molecules are preferentially incorporated into 
the crystals because of more ordered and/or rigid conformations.
The overall structure of PuO is similar to those of human MAO A and MAO B, 
which represent the closest structural homologues present in the Protein Data Bank 
[9,18,19] (Fig. 3.1A). Atomic superpositions yield root-mean-square deviations 
of 1.7 and 1.6 Å for 439 and 445 Cα atoms with 30 and 33% sequence 
identities, respectively. The comparative analysis indicates that PuO and MAOs 
share a generally similar backbone conformation with local conformational 
variations but no large alterations due to insertions/deletions or large shifts 
of secondary structures. Furthermore, PuO forms the same dimeric structure 
as found in human MAO B consistent with its elution profile on size-exclusion 
chromatography and MS data [11].
Despite such a clear relation with human MAOs, analysis of the PuO structure 
highlights several interesting features, which deserve a closer description. A first 




of PuO and human MAO A/B. The conformations of the MAO residues involved 
in the covalent bond with the flavin are very similar to those of the corresponding 
region of PuO in which Ala394 replaces the flavinylated Cys of MAOs (Fig. 3.2A). 
This feature is particularly noticeable because the flavinylated Cys of MAOs is 
connected to a Tyr residue through a conformationally unfavourable cis peptide 
bond. Such a Cys-Tyr motif of MAOs is replaced by Ala394-Tyr395 in PuO, which, 
strikingly, exhibits the same cis peptide bond. As a result, Ala394 is positioned 
close to the C8α-methyl group of the flavin, which has profound implications for 
generating a site for covalent flavinylation in PuO, as described below.
Figure 3.1. Overall structure of PuO and quality of the crystallographic data. (A) The protein 
exhibits the same folding topology as MAOs. FAD and bound 4-aminobutanal are shown as ball-
and-sticks with carbons in green, oxygens in red, nitrogens in blue, and phosphorous atoms in 
magenta. The active site cavity is outlined as a semi-transparent red surface. (B) Crystallographic 
data for the P15I/A394C PuO mutant structure (subunit B). The picture shows the final weighted 
2Fo-Fc electron density map for the flavin ring and the double conformation of Cys394. The contour 
level is 1σ. Oxygens are in red, nitrogens in blue, phosphorous atoms in magenta, carbons in gray, 
sulphurs in yellow.
(A) (B)
Cofactor Binding in Putrescine Oxidase
3
75







Space group P21221 P21221 P4122 P21221 I212121










Resolution (Å) 2.0 2.3 1.9 2.5 2.7
Rmerge (%)
¶ 9.5 (31.2) 12.8 (39.4) 12.4 (51.2) 9.7 (24.0) 14.6 (59.8)
Completeness (%)¶ 99.8 (96.2) 99.8 (99.4) 99.8 (99.4)  99.5 (100.0) 99.8 (99.4)
Unique Reflections 96941 66382 54711 51121 31023
Multiplicity 3.7 3.8 14.5 5.0 4.1
Rcryst (%) 17.5 15.7 19.8 18.4 23.0
Rfree (%) 20.1 19.9 24.2 23.1 27.6
rmsd bond length(Å) 0.014 0.023 0.030 0.022 0.015
rmsd bond angles (°) 1.4 2.0 2.1 1.9 1.6
¶ Data for the highest resolution shell are in parentheses.  
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Figure 3.2. Close-up view of the flavin-binding site of PuO in the same orientation as in Fig 3.1. (A) Comparison 
of the structure of wild-type PuO with that of human MAO B. PuO oxygens are in red, nitrogens in blue, 
phosphorous atoms in magenta, carbons in green, sulphurs in yellow. Gly396, Cys397, Tyr398, and Thr399 of 
human MAO B are superimposed and show in light brown. (B) Structure of the P15I/A394C PuO mutant 
(subunit B). Oxygens are in red, nitrogens in blue, phosphorous atoms in magenta, protein carbons in grey, and 
FAD carbons in green. Wild-type Pro15, Ala394, Val433 are superimposed and shown in cyan. Pro15 is located 
at the N-terminus of the α-helix (shown as cylinder) of the βαβ unit which forms the binding site for the 
pyrophosphate group of FAD. Ala394 is in contact with the cofactor C8α-methyl group and is engaged in a cis 
peptide link with Tyr395. The Cys in P15I/A394C mutant has a double conformation, one of them (50% 
occupancy) forming a covalent bond with the flavin. 
 
Another interesting feature concerns the active site. Soaking the crystals in a putrescine-
containing solution led to a well-defined electron density peak which can perfectly be fitted by a 
linear six-atom ligand. We modeled this compound as 4-aminobutanal, assuming that the complex 
corresponds to the product-bound enzyme (Fig. 3.3). However, we cannot rule out that the crystals 
contain bound putrescine or a mixture of substrate and product. PuO exhibits a cavity in front of the 
flavin cofactor with a volume of 300 Å3 (Fig. 3.1a). This cavity has a bipartite shape with 
approximately equal inner and outer chambers. The inner space is occupied by the 4-aminobutanal, 
which extends across the cavity along a direction orthogonal to the re-face of the flavin ring. As often 
observed in flavin amine oxidases, the isoalloxazine ring adopts a non-planar distorted conformation 
[20]. The ligand aldehyde group is in contact with the flavin and is located between the aromatic 
rings of Tyr395 and His432. These two side chains form an “aromatic sandwich” similar to that of 
other amine oxidases [20] (Fig. 3.3). The only difference is that PuO has a His/Tyr pair rather than the 
Phe/Tyr or Tyr/Tyr combination found in polyamine oxidase and in MAOs [9,10,21] although 
mutagenesis data have shown that human MAO B retains activity even with a His/Tyr pair as found in 
PuO [22]. The ligand amino group is engaged in H-bonds with the side chain of Glu324 and the 
carbonyl oxygen of Gly172. These two residues together with Met173 generate the constriction that 
separates the two chambers of the active site cavity (Fig. 3.1a and 3.3). Of particular relevance is the 
role of Glu324, which functions as a sort of active site ruler that determines the distance between 
the flavin and the binding site for the positively-charged amino group of the substrate. This feature is 
a key element to explain PuO’s preference for diamino substrates such as putrescine and cadaverine, 
in which the two amino groups are separated by four and five carbon atoms, respectively. The shape 
Figure 3.2. Close-up view of the flavin-binding site of PuO in the same orientation as in Fig 3.1. 
(A) Comparison of the structure of wild-type PuO with that of human MAO B. PuO oxygens 
are in red, nitrogens in blue, phosphorous atoms in magenta, carbons in gr en, sulphurs in yellow. 
Gly396, Cys397, Tyr398, and Thr399 of human MAO B are superi posed and show in light brown. 
(B) Structure of the P15I/A394C PuO mutant (subunit B). Oxygens are in red, nitrogens in blue, 
phosphorous atoms in magenta, protein carbons in grey, and FAD carbons in green. Wild-type 
Pro15, Ala394, Val433 are superimposed and shown in cyan. Pro15 is located at the N-terminus of 
the α-helix (shown as cylinder) of the βαβ unit which forms the binding site for the pyrophosphate 
group of FAD. Ala394 is in contact with the cofactor C8α-methyl group and is engaged in a cis 
peptide link with Tyr395. The Cys in P15I/A394C mutant has a double conformation, one of them 





Another interesting feature concerns the active site. Soaking the crystals 
in a putrescine-containing solution led to a well-defined electron density peak 
which can perfectly be fitted by a linear six-atom ligand. We modelled this 
compound as 4-aminobutanal, assuming that the complex corresponds to the 
product-bound enzyme (Fig. 3.3). However, we cannot rule out that the crystals 
contain bound putrescine or a mixture of substrate and product. PuO exhibits 
a cavity in front of the flavin cofactor with a volume of 300 Å3 (Fig. 3.1A). This cavity 
has a bipartite shape with approximately equal inner and outer chambers. The inner 
space is occupied by the 4-aminobutanal, which extends across the cavity along 
a direction orthogonal to the re-face of the flavin ring. As often observed in flavin 
amine oxidases, the isoalloxazine ring adopts a non-planar distorted conformation 
[20]. The ligand aldehyde group is in contact with the flavin and is located between 
the aromatic rings of Tyr395 and His432. These two side chains form an “aromatic 
sandwich” similar to that of other amine oxidases [20] (Fig. 3.3). The only difference 
is that PuO has a His/Tyr pair rather than the Phe/Tyr or Tyr/Tyr combination 
found in polyamine oxidase and in MAOs [9,10,21] although mutagenesis data 
have shown that human MAO B retains activity even with a His/Tyr pair as found 
in PuO [22]. The ligand amino group is engaged in H-bonds with the side chain 
of Glu324 and the carbonyl oxygen of Gly172. These two residues together with 
Met173 generate the constriction that separates the two chambers of the active site 
cavity (Fig. 3.1A and 3.3). Of particular relevance is the role of Glu324, which 
functions as a sort of active site ruler that determines the distance between the 
flavin and the binding site for the positively-charged amino group of the substrate. 
This feature is a key element to explain PuO’s preference for diamino substrates 
such as putrescine and cadaverine, in which the two amino groups are separated by 
four and five carbon atoms, respectively. The shape and size of the outer chamber 
of the cavity extending beyond Glu324 provides additional space for binding 
an aliphatic substituent on the distal amino group, which is consistent with the 
ability of PuO to oxidize spermidine (although less efficiently than putrescine; 
Fig. 3.1A). In summary, PuO is a typical amine oxidase in which the local 
conformation and the nature of the residues surrounding the active-site cavity 
dictate the enzyme preferences for small aliphatic di-amines. 
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Figure 3.3. Binding of the active-site ligand present in the structure obtained by crystal soaking 
in a putrescine-containing solution. The ligand has been tentatively modelled as 4-aminobutanal. 
Oxygens are in red, nitrogens in blue, phosphorous atoms in magenta, protein carbons in grey, FAD 
carbons in green. H-bonds are shown as dashed lines.
improving the affinity towards FAd: p15i/A394C and A394C/v433m
In a previous study, the A394C PuO mutant was constructed, purified and 
characterized [11]. The introduced cysteine is structurally analogous to the Cys 
that forms a covalent cysteinyl-FAD linkage in MAO (Fig. 3.2A). The mutant was 
found to retain activity but only a marginal fraction (15%) of the mutant protein 
contained covalently bound FAD, whereas the rest of FAD was still dissociable 
(Tables 3.2 and 3.3). In the framework of the present study, we have solved the 
A394C crystal structure, which turned out to be virtually indistinguishable from that 
of the wild-type enzyme (Table 1). Cys394 is partly disordered and was modelled 
in two alternative conformations, with neither of them forming a covalent bond 
with the flavin. Thus, the crystalline mutant A394C enzyme does not contain 
covalently bound flavin, at least in a detectable level, which is consistent with the 
low degree of covalent flavinylation exhibited by the mutant protein (Table 3.2). 




be introduced at position 394 without any large structural perturbation, supporting 
the idea that further amino acid substitutions might render PuO fully capable 
to efficiently bind FAD in covalent manner.
Table 3.2. Cofactor distribution in PuO variants and amount of FAD covalently bound to the 
monomers before and after FAD covalent incorporation. The numbers represent an average of at 
least 3 measurements with standard error less than 5%.
Cofactor distribution in dimers (%)¶
% PuO monomers with 
FAD covalently bound‡
2ADP ADP+FAD 2FAD FAD:ADP ratio as isolated
48h 
incubation
wild-type 24 35 41 1.4 0 0
A394C 27 38 35 1.2 22 42
P15I/A394C 0 14 86 13.3 16 35
A394C/V433M 3 26 71 5.2 0 nd
A394C/A396T/Q431G 23 39 39 1.4 40 56
¶ The cofactor distribution in dimers was measured with ESI-MS under native conditions.
‡ The amount of monomers with FAD covalently bound for freshly isolated enzyme was measured 
with ESI-MS in denaturing conditions and recalculated for monomers containing FAD and not 
ADP (based on ESI-MS in native conditions). The fractions of monomers with covalently bound 
FAD after 48 hours incubation were measured with the TCA method.
nd – not determined
Table 3.3. Steady state kinetic parameters for PuO variants with putrescine as substrate.













wild-type 19.0±0.6 45.4±2.3 419±21 8.8±0.2 17.7±0.4 497±19
A394C 2.4±0.1 19.7±1.5 123±9 2.4±0 9.2±0.6 261±17
P15I/A394C 0.79±0.01 13.4±0 59±1 0.78±0.01 11.8±1.5 67±8
A394C/A396T/Q431G 0.95±0.01 21.0±1.4 45±3 0.83±0.01 13.7±0.3 60±1
Therefore, we generated other mutants to enhance flavin binding and efficiency 
of covalent linkage formation. To this aim, we compared the PuO structure with 
those of other dinucleotide-binding domains available through the Protein Data 
Bank. Generally, these proteins bear low sequence homologies but all share a 
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GXGXXG phosphate-binding loop which connects the β-strand to the α-helix of the 
characteristic βαβ unit [23] (Fig. 3.2B). This dinucleotide-binding motif is not only 
found in FAD-binding proteins but is also present in e.g. ADP-, ATP-, and NAD(P)-
binding proteins [24]. Inspection of the residues encompassing the dinucleotide-
binding motif in PuO reveals an atypical residue, Pro15, next to the second 
conserved Gly. Sequence comparisons with structurally-related FAD-containing 
amine oxidases reveal that, in most cases, a bulky hydrophobic residue (Phe, Leu 
or Ile) is found at this position [25]. These observations prompted us to determine 
whether this residue may play a role in the unique cofactor binding behaviour 
of PuO, which binds FAD and ADP in a 1:1 ratio (Table 3.2). Thus, P15I/A394C 
PuO double mutant was produced and its cofactor binding characteristics were 
analysed by native ESI-MS [26]. Interestingly, the resulting spectrum reveals 
only two major dimeric species of 99,801 Da and 100,158 Da (Fig. 3.4). 
Minor amounts of some other PuO species (3 kDa larger) were observed which 
are likely to be a result of translation by E. coli using an alternative stop codon 
as observed for wild-type PuO [8,11]. Analysis of the data showed that the majority 
of the protein (86%, theoretical mass of 100,152 Da) is present as a dimer containing 
two FAD molecules (Table 3.2). The other dominant species (14%, 99,801 Da) 
corresponds to dimeric PuO containing one FAD and one ADP (theoretical mass 
of 99,794 Da). No peaks corresponding to apo dimers or dimers with two ADP 
molecules bound were found. The calculated FAD to ADP ratio is 9-10 times 
higher than the one for wild-type PuO confirming that the N-terminal Rossmann-
fold domain plays a crucial role in facilitating effective FAD binding (Table 3.2). 
On the other hand, the P15I/A394C protein did not exhibit any improvement 
in covalent incorporation of the cofactor since only 16% of the incorporated FAD 
molecules are covalently bound to the protein (although this values increases 
to 36% upon prolonged incubation of the protein for two days; see below and 







containing one FAD and one ADP (theoretical mass of 99,794 Da). No peaks corresponding to apo 
dimers or dimers with two ADP molecules bound were found. The calculated FAD to ADP ratio is 9-10 
times higher than the one for WT PuO confirming that the N-terminal Rossmann-fold domain plays a 
crucial role in facilitating effective FAD binding (Table 3.2). On the other hand, the P15I/A394C 
protein did not exhibit any improvement in covalent incorporation of the cofactor since only 16% of 
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Figure 3.4. Mass spectrum of P15I/A394C PuO in its native state. Observed enzyme species are indicated with 
symbols and corresponding masses. Alternative dimer is a dimer with alternative stop codon, as discussed in 
results. 
 
To evaluate the conformational effects of the P15I mutation, the crystal structure of 
P15I/A394C PuO was determined (Fig. 3.2b). The mutant is virtually identical to the wild-type enzyme 
with Ile15 overlapping the position of Pro15. The electron density of subunit B (the crystals contain 
two subunits in the asymmetric unit) indicates that a significant fraction of the protein molecules 
contain Cys394 covalently bound to the flavin C8α atom (about 50% as judged from the refined 
atomic occupancy values; Fig. 3.1b). Crystals growth requires 2-3 days, implying the formation of the 
covalent bond can take place during crystallization This finding allowed us to visualize the actual 
presence of a covalent bond between the protein and the cofactor, clearly supporting the idea that 
covalent bond formation with the flavin is not associated to any significant conformational 
alterations. 
A minor but striking structural change that could be observed in the P15I/A394C structure 
involves Val433, which is pushed by 0.3 Å towards the N1-C2=O2 locus of the flavin ring, to establish 
a closer interaction which may be the cause for the improved FAD binding (Fig. 3.2b). Given that in 
MAO B, a Met is present at the position homologous to Val433 of PuO, we decided to generate 
A394C/V433M. We found that this double PuO mutant has indeed a significantly increased FAD:ADP 
Figure 3.4. Mass spectrum of P15I/A394C PuO in its native state. Observed enzyme species are 
indicated with symbols and corresponding masses. Alternative dimer is a dimer with alternative 
stop codon, as discussed in results.
To evaluate the conformational effects of the P15I mutation, the crystal 
structure of P15I/A394C PuO was determined (Fig. 3.2B). The mutant is virtually 
identical to the wild-type enzyme with Ile15 overlapping the position of Pro15. 
The electron density of subunit B (the crystals contain two subunits in the asymmetric 
unit) indicates that a significant fra tion of he protei  molecules contain Cys394 
covalently bound to the flavin C8α atom (about 50% as judged from the refined 
atomic occupancy values; Fig. 3.1B). Crystals growth requires 2-3 days, implying 
the formation of the covalent bond can take place during crystallization. This finding 
allowed us to visualize the actual presence of a covalent bond between the protein 
and the cofactor, clearly supporting the idea that covalent bond formation with the 
flavin is not associated o any significant conf rmati nal alterations.
A minor but striking structural change that could be observed in the P15I/A394C 
structure involves Val433, which is pushed by 0.3 Å towards the N1-C2=O2 locus 
of the flavin ring, to establish a closer interaction which may be the cause for the 
improved FAD binding (Fig. 3.2B). Given that in MAO B, a Met is present at the 
position homologous to Val433 of PuO, we decided to generate A394C/V433M. 
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We found that this double PuO mutant has indeed a significantly increased 
FAD:ADP ratio when compared to wild-type and A394C proteins (Table 3.2). 
This observation further supports the idea that minor alterations in the flavin 
environment can significantly alter its affinity to the protein cofactor site and 
change the levels of FAD versus ADP incorporation.
improved covalent FAd incorporation: A394C/A396T/Q431g
To identify residues that hamper effective covalent flavinylation in PuO, we 
carefully analysed the differences in active sites of PuO and MAO B. According to 
the proposed self-catalytic mechanism of covalent flavin attachment, the covalent 
coupling is initiated by proton abstraction from the C8α-methyl group of FAD 
(Fig. 3.2) and/or from the residue forming the covalent bond with the flavin, 
suggesting that these deprotonations might limit covalent flavinylation in PuO [3,7]. 
Structural comparisons indicated that a Thr (Thr398) at a distance of 5.0 Å from 
the C8α-methyl group of flavin in MAO B is replaced by an Ala (Ala396) in PuO 
(Fig. 3.5). A Thr at this position may facilitate covalent flavinylation by creating 
a more polar environment and/or a H-bonding network that favours deprotonation 
of Cys394 or flavin C8α [9]. However, further inspection of the PuO crystal 
structure reveals that a Thr side chain in position 396 would probably cause 
an unfavourable contact with the neighbouring polar Gln431, which is a Gly 
in MAO-B. Therefore, we generated a triple mutant (A394C/A396T/Q431G) 
which was comparatively analysed by ESI-MS under denaturing conditions 
to quantify covalent flavinylation. Figure 3.6 shows the ESI-MS spectra of freshly 
purified wild-type, A394C, and A394C/A396T/Q431G proteins. Wild-type PuO 
shows only one species corresponding to the mass of PuO minus the N-terminal 
methionine (49,244 Da, the theoretical value). The mass spectrum of A394C reveals 
instead the presence of two species: 49,275 Da and 50,058 Da, corresponding to 
the calculated values of 49,275 Da and 50,060 Da for A394C without and with 
covalently bound FAD, respectively. Likewise, the mass spectrum of the denatured 
A394C/A396T/Q431G PuO also shows two major species: 49,239 Da and 50,024 Da, 
corresponding to the theoretical 49,234 Da and 50,019 Da, expected for the 
non-covalent and covalent forms of the mutant protein, respectively. However, 
the distribution of the two species differs between A394C and A394C/A396T/Q431G 




binding (40% covalent FAD) when compared to A394C PuO (22% covalent FAD). 
Clearly, the triple mutation favours formation of the covalent bond between Cys394 
and FAD. However, the protein exhibits an overall (covalent and non-covalent) 
level of FAD incorporation similar to that of the wild-type protein as gathered 
from the similar values of FAD:ADP ratio measured by native ESI-MS (Table 3.2). 
This implies that the increased efficiency of flavin-protein covalent bond formation 
is not accompanied by an enhancement in affinity towards FAD compared to ADP.
Figure 3.5. Comparison of the A394C/A396T/Q431G structure with that of the wild-type PuO 
(subunit B). Oxygens are in red, nitrogens in blue, and phosphorous atoms in magenta. The mutant 
carbon atoms are in grey whereas FAD carbons are in green. Wild-type Ala394, Ala396, and Gln431 
are shown in cyan.
As for the other enzyme variants, the triple mutant crystal structure exhibits 
minor conformational changes, with the newly introduced side chains apparently 
causing little perturbations (Fig. 3.5). A394C/A396T/Q431G was the only mutant 
protein to show somewhat less well-defined electron density for the flavin ring. 
This implies that the flavin site is not fully occupied (i.e. the crystalline proteins are 
partly in the ADP-bound form) or that there might be some disorder in the flavin 
conformation. Nevertheless, the electron density for subunit B shows that there is 
a partial (approximately 50% occupancy) covalent attachment of the C8α-methyl 
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group of the flavin to Cys394, in keeping with the enhanced efficiency of covalent 
flavinylation exhibited by the mutant, as indicated by ESI-MS spectra (Fig. 3.6). 
Figure 3.6. Mass spectra of denatured wild-type (A), A493C (B), and A394C/A396T/Q431G (C) 
PuO. Observed enzyme species with covalently bound FAD marked with a dot. Theoretical masses 
correspond to a monomer mass of the PuO variant minus N-terminal methionine.
Kinetics of FAd incorporation and enzymatic activities
In order to assess the time-dependence of C8α-S-cysteinyl bond formation 
in PuO mutants, the covalent incorporation of FAD was monitored over time. 
To facilitate deprotonation and hence flavinylation the experiments were performed 
at relatively high pH values. Enzyme stocks (210-460 µM in 50 mM Tris-HCl, 
pH 7.5) were diluted in a 1:1 ratio with 50 mM sodium carbonate buffer, 
pH 10.0, containing 0.04% sodium azide. The enzyme solutions were incubated 
at	17˚C	for	two	days	and	the	covalent	FAD	content	and	steady-state	kinetics	were	
measured at the beginning and at the end of the incubation (Table 3.3). In order 
to determine the amount of FAD covalently bound to the enzymes after 48 hours, 
the TCA precipitation method was used. Flavin covalently bound to the protein 




release the cofactor in solution upon denaturation. In this way, it is possible to 
estimate the ratio between covalent and non-covalent holoenzyme concentrations. 
As can be seen from Table 3.3, PuO mutants generally increase covalent 
incorporation of FAD during the incubation time, which is not observed for wild-
type PuO. However, the process is very slow and still not all FAD is covalently 
attached. The A394C/A396T/Q431G PuO is the most effective in flavin-protein 
covalent bond formation. After two days it covalently incorporates more than half 
of the FAD. To further confirm this result, the mutant incubated for three days 
was analysed by ESI-MS under denaturing conditions. The spectrum showed again 
two major peaks with the masses of 49,239 Da and 50,022 Da, corresponding 
to the theoretical (see above) masses of the monomer and the monomer with 
covalently bound FAD. The corrected value (the ratio between FAD and ADP did 
not change) for monomers with covalently bound FAD was 66%, which is in line 
with the value obtained with the TCA precipitation method (56% after two days). 
Steady-state kinetic parameters for putrescine were also determined before and 
after the incubation of the PuO variants (Table 3.3). It is apparent that wild-type 
PuO is more active than the mutants. Its catalytic efficiency (kcat/KM) is almost four 
times higher than that of A394C mutant and eight times higher than those of the 
two other mutants. Interestingly, after a two-day incubation, the kcat of wild-type 
PuO is half the original value, whereas it stays at the same level in the mutants. 
This finding suggests that covalent binding of FAD increases protein stability and 
maintenance of enzyme activity.
diSCuSSiON
The crystal structures of PuO reveal that the enzyme possesses all the characteristic 
features of flavin-amine oxidases; an aromatic sandwich, a conserved pattern 
of interactions with the cofactor, a distorted non-planar flavin, and a closed 
cavity for substrate binding, whose shape and H-bonding properties determine 
the substrate specificity [9,10,20] (Fig. 3.1-3.3). Compared to human MAOs, 
the most extensively studied members of the amine oxidase family, an interesting 
feature of PuO is that it lacks a covalent linkage between protein and the flavin 
ring. However, this property is not associated to any structural alterations within 
the cofactor site which is very similar to that of human MAOs. This includes 
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the conservation of the cis peptide bond of the Tyr residue that is part of the 
aromatic cage forming the binding site for the substrate amino group – i.e. the 
site oxidation [20]. This finding suggests that this cis peptide is mainly necessary to 
attain the proper geometry in the active-site cavity and flavin binding region rather 
than for covalent flavinylation (Fig. 3.2). On the other hand, such geometry is 
perfectly tailored to engage the flavin C8α -methyl group in a covalent bond with 
the protein. This is a “natural” event in MAOs whereas it can be “forced” to occur in 
PuO by site-directed mutagenesis, taking advantage of the apparent rigidity of the 
PuO’s cofactor site, which is seemingly pre-organized for the effective introduction 
of the covalent protein-flavin bond. Indeed, the engineered PuO mutants, despite 
the introduced mutations, remain active, which shows that insertion/deletion of the 
covalent linkage is not essential for activity as found in other covalent flavoenzymes 
including MAO A [2,27].
A hypothesis underlying our studies was that by covalent tethering 
of FAD, the enzyme could fully incorporate the flavin cofactor, outcompeting the 
binding of ADP. However, the partially introduced covalent FAD did not result 
in any significant increase in the FAD incorporation into the enzyme (Table 3.2). 
This finding fully supports the proposal by Zhou et al. that the dinucleotide-binding 
motif provides a topological dock for the initial binding of FAD. Only after such 
a binding event, covalent bond formation can occur [28]. Therefore, the role 
of covalent flavinylation does not seem to be that of favouring incorporation of 
FAD compared to other mono- or di-nucleotides that are potentially able to bind 
to the cofactor site on the protein.
Our studies on PuO also support the idea that covalent flavinylation is a self-
catalytic process that critically depends on a proper FAD microenvironment [7,29-34]. 
Indeed, the double P15I/A394C mutant, which exhibits the highest FAD:ADP 
ratio, shows instead a poor level of covalent FAD binding, suggesting a sub-optimal 
environment for covalent bond formation. Conversely, by introducing mutations 
predicted to alter the flavin C8α environment (A394C/A396T/Q431G) 
the degree of covalent flavin attachment was increased (Table 3.2). The in vitro 
process of covalent flavinylation has been studied for several flavoenzymes by 
expressing the respective apo proteins in riboflavin auxotrophic expression strains. 
This has enabled the monitoring of the time-dependent covalent incorporation 
of flavin cofactors. Apo forms of these natural covalent flavoenzymes covalently 




monomeric sarcosine oxidase [36]) or even hours (dimethylglycine dehydrogenase 
[37]). Therefore, the slow formation of the covalent linkage observed in the PuO 
triple mutant is not exceedingly far from the slow flavinylation rates observed 
in certain natural covalent flavoproteins (Table 3.2). Altogether, these findings 
demonstrate that structure-based design of covalent flavinylation is feasible 
although it may require several amino acid replacements, not necessarily confined 
to region in direct contact with the flavin C8α. Employment of flavoproteins 
for biocatalytic processes is often difficult because of their tendency to release 
FAD/FMN in the conditions of relevance for biocatalytic applications. 
The possibility of engineering flavoproteins to incorporate the cofactor through 
a covalent linkage will be critical to make progress in this area.
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ABSTrACT
A recently discovered class of bicovalent flavoproteins is an interesting group 
of enzymes because of their unusual cofactor binding mode, their open active sites 
and bulky substrates they can accept. By a sequence comparison study we have 
identified a conserved sequence region in bicovalent flavoproteins that is different 
from monocovalent flavoproteins. Based on this and the available structural 
information we have designed mutants of the prototype monocovalent flavoprotein, 
6-hydroxy-D-nicotine oxidase (6HDNO), in order to introduce a second cofactor-
protein linkage. Two amino acid replacements, namely histidine 130 to a cysteine 
and leucine 138 to a histidine, were sufficient to create a bicovalent 6HDNO. 
The introduced cysteine forms a covalent bond with FAD as found in natural 
bicovalent flavoproteins, while the second mutation was found to be essential 
to facilitate formation of the cysteinyl linkage. This points to an important role 
of the introduced histidine in stabilizing a negative charge of the isoalloxazine ring 
during covalent flavinylation. The His130Cys/Leu138His 6HDNO is still active 
and shows a higher midpoint redox potential when compared to wild-type 6HDNO. 
This is in agreement with the previous studies that have shown that bicovalent 





Since the discovery of the first “yellow” enzyme in the 1930’s [1], the number 
of known flavoproteins is constantly growing. The yellow colour in flavoproteins 
originates from the flavin cofactor, namely flavin adenine dinucleotide (FAD) 
and flavin mononucleotide (FMN), with FAD being the most common. Enzymes 
utilize cofactors for redox reactions, because the chemical functionality of amino 
acids is limited. Flavin-dependent enzymes are very diverse, because they catalyse 
a great number of redox and non-redox reactions displaying various mechanistic 
pathways [2]. Moreover, they do not have one common mode of cofactor binding. 
In most cases the flavin cofactor is tightly, but non-covalently associated with the 
protein, and can be regarded as a prosthetic group. Yet, approximately 10% of all 
flavoproteins have been confirmed to form a covalent bond with the flavin [3]. 
This variable mode of flavin binding is quite unique because most cofactors bind 
either in a noncovalent or covalent manner. The covalent attachment of FMN is 
rather rare compared to FAD and occurs via the 8α-position (to a histidine) or via 
the 6-position (to a cysteine) of the isoalloxazine ring [4] or via the phosphate group 
(to a threonine) [5,6]. Covalent binding of FAD typically involves the 8α-position 
that binds to a histidine, a cysteine, a tyrosine or an aspartate [4,7]. A more complex 
type of covalent FAD tethering was discovered in 2005 where FAD is bicovalently 
bound via 6-S-cysteinyl and 8α-N1-histidyl linkages [8]. Since then, several more 
bicovalent flavoproteins have been identified [8-16]. Detailed biochemical studies 
have provided information about the role of (bi)covalent flavin binding [10,17-19]. 
It has been shown that a covalent FAD-protein linkage significantly influences 
the redox potential of the enzyme, thereby boosting the oxidative power of the 
respective flavoenzyme. This is clearly illustrated by the observation that bicovalent 
flavoenzymes show the highest redox potentials among all known flavoproteins [20]. 
Other effects of covalent flavin attachment include enhancement of protein stability, 
prevention from cofactor release and protection from flavin deactivation [20].
The vanillyl-alcohol oxidase (VAO) family of flavoproteins consists of enzymes 
with a conserved FAD-binding domain and a covalent flavin binding mode is relatively 
common in this group [21,22]. It is worth noting that all bicovalent flavoproteins 
belong to the VAO family. One of the first covalent VAO flavoenzymes identified 
was 6-hydroxy-D-nicotine oxidase (6HDNO) from Arthrobacter nicotinovorans 




pathway (Fig. 4.1B) and is a monomeric enzyme containing a histidyl-bound 
FAD. The last feature distinguishes 6HDNO from its enantioenzyme, 6-hydroxy-
L-nicotine oxidase (6HLNO) from the same organism. 6HLNO binds FAD 
in a non-covalent manner, indicating that the two enzymes are not related 
at the protein level. 6HDNO was the first flavoenzyme for which covalent FAD 
incorporation to apo protein was demonstrated in vitro [26]. As a result, it has been 
extensively studied as a prototype for a covalent flavoprotein. From these and other 
studies on covalent flavoproteins, it can be concluded that the process of covalent 
attachment of FAD is generally self-catalytic [4,27-31], with the exception of only 
a few flavin-dependent enzymes where the presence of a helper protein has been 
shown to be necessary [6,32-34]. With regard to bicovalent flavoproteins, relatively 
little is known about the mechanism of bicovalent flavinylation, though it has been 
demonstrated that the formation of the two covalent attachments is self-catalytic 
and independent from each other [10,19,35].














Figure 4.1. (A) Structure of 6HDNO in which the covalently bound FAD cofactor is shown in 
yellow (PDB:2BVF). (B) 6HDNO catalyses the oxidation of the pyrrolidine ring of 6-hydroxy-D-
nicotine (top left) to 6-hydroxy-N-methylmyosmine (top right), which in turn decays spontaneously 
by hydration, ring opening and tautomerization to a ketone.
Most of the research on the mechanism and effects of covalent flavinylation 
has focused on creating protein mutants unable to form a covalent bond with FAD, 




have shown that an opposite approach is also viable. By structure-inspired site-
directed mutagenesis we succeeded in introducing a covalent cysteinyl-FAD 
bond in a non-covalent flavoprotein, putrescine oxidase [36,37]. Here we present 
an engineered 6HDNO mutant, which is able to form a 6-S-cysteinyl bond 
with FAD, in addition to the 8α-N1-histydyl bond already present in the wild-
type 6HDNO. We also show how the additional cofactor attachment, rendering 
an engineered bicovalent flavoprotein, changes the properties of the enzyme. 
This work contributes to existing knowledge on bicovalent flavinylation. 
The obtained insights will also help to engineer noncovalent flavoproteins into 
flavoproteins with a covalently anchored flavin cofactor. The ability to design such 
artificial covalent flavoproteins will support engineering of robust biocatalysts.
ExpErimENTAL prOCEdurES
Chemicals
Oligonucleotides were form Sigma and EuroFins. PfuTurbo DNA polymerase was 
from Stratagene. Escherichia coli TOP10 from Invitrogen was used as a host for DNA 
manipulations and protein expression. L-arabinose was from Biosynth. 6-hydroxy-D-
nicotine was a kind gift from prof. Roderich Brandsch. Methylene blue, pyocyanin, 
xanthine, xanthine oxidase, 5,5’dithiobis (2-nitrobenzoic acid) and DL-dithiothreitol 
were from Sigma-Aldrich. Resorufin was from TCI. All other chemicals were of analytical 
grade. Constructs were sequenced at GATC Biotech (Konstanz, Germany).
Construction of mutants
pBAD-6HDNO His130Cys and His130Cys/Leu138His were prepared using the 
QuikChange Site-Directed Mutagenesis kit from Stratagene and pBAD-6HDNO 









Expression and purification 
6HDNO wild-type, His130Cys and His130Cys/Leu138His were expressed 
in E. coli TOP10 cells containing the corresponding pBAD-6HDNO vector. 
The	cells	were	cultivated	for	24	hours	at	30˚C	in	terrific	broth	medium	containing	 
50 µg/ml ampicillin and 0.2% (w/v) L-arabinose. Cells were harvested by 
centrifugation	for	15	min	at	6000	rpm	at	4˚C.	The	supernatant	was	discarded	and	
the pellet was resuspended in 30 ml of 20 mM KH2PO4 pH 7.5 and sonicated for 10 
min in order to break the cells. The cell debris was discarded by centrifugation for 40 min 
at	 15000	 rpm	 at	 4˚C	 and	 the	 resulting	 extract	 was	 subsequently	 applied	 
on a Q-Sepharose anion exchange column. Unbound proteins were washed from 
the column with 20 mM KH2PO4 pH 7.5 and 6HDNO was eluted from the column 
by increasing the KCl concentration. The buffer of eluted 6HDNO fraction was 
changed to 20 mM KH2PO4 pH 7.5, 500 mM NaCl, 15 mM imidazole using 
an Amicon Ultra-15 Centrifugal Filter Unit with an Ultracel-30 membrane 
from Merck Millipore. The enzyme fraction was applied on a Ni-Sepharose 
High	Performance	column	 from	GE	Healthcare	 and	 incubated	 at	4˚C	 for	1.5	h. 
The unbound fractions were released and the column was washed with 
20 mM KH2PO4 pH 7.5, 500 mM NaCl, 30 mM imidazole. 6HDNO 
was eluted with 20 mM KH2PO4 pH 7.5, 500 mM NaCl, 300 mM 
imidazole and desalted on a PD-10 column (GE Healthcare Life Sciences) using 
20 mM KH2PO4 pH 7.5, 150 mM NaCl.
Cysteine determination
The number of sulfhydryl groups of unfolded 6HDNO variants was determined 
according to the method of Ellman [38] with the modifications of Habeeb [39]. 
The assay was performed on 1-5 µM 6HDNO variants in 50 mM Tris-HCl 
pH 7.6, 150 mM NaCl, 1% SDS with a 25-times molar excess of 5,5’dithio-bis 
(2-nitrobenzoic acid) (DTNB). The absorbance of released 5-thio-2-nitrobenzoate 
anion (TNB) was measured at 412 nm, using ε412 = 8.4 mM
-1 cm-1 determined 






Sequence alignment was performed with ClustalW at EBI [40,41]. Solvent 
accessible surface calculations were performed by using the GETAREA server 
at http://curie.utmb.edu/area_man.html [42]. For structural visualization 
and inspection, PyMol was used (Schrödinger, LLC). Flavin absorbance spectra 
of	purified	6HDNO	variants	were	recorded	in	50	mM	Tris-HCl	pH	7.5	at	25	˚C,	
before and after addition of 0.1 % (w/v) SDS, on a PerkinElmer Lambda Bio40 
spectrophotometer. Enzyme concentrations were determined by measuring 
absorbance at 280 nm using ε280 = 47245 M
-1cm-1 [43]. Oxidase activity and 
steady-state	kinetic	parameters	were	determined	at	30	˚C	by	spectrophotometric	
measurement of product formation, as described previously [44], using different 
concentrations of D-6-hydroxynicotine as a substrate. The data were fitted with 
SigmaPlot12.0 (Systat Software, Inc.), using the Michaelis-Menten equation or the 
Michaelis-Menten equation with inhibition by substrate (Eq. 4.1).
 (Eq. 4.1)
To confirm the presence of covalently bound flavin, 5% trichloroacetic acid 
(TCA) was used to precipitate the protein and the pellet and supernatant were 
assessed visually and/or spectrophotometrically. The in-gel flavin fluorescence was 
also confirmed in SDS-PAGE gel after purification of the protein. Performic acid 
was prepared according to [45]. The stability of 6HDNO variants was measured 
with the ThermoFAD [46] and ThermoFluor [47] methods using 10 µM enzyme. 
Fluorescence measurements of native and unfolded 6HDNO variants were 
performed on 10 µM protein in 50 mM Tris-HCl pH 7.6, 150 mM NaCl, without 
or with 1% SDS, respectively, on a Synergy Mx Multi-Mode Reader (BioTek). 
The flavoprotein samples were excited at 450 ±13.5 nm and the 800-480 nm 
emission spectra were collected. The intensity of fluorescence was compared 
at the emission maximum, 522 nm.
Redox potentials were measured by using the method described by Massey 
[48] in 20 mM KH2PO4	pH	7.5,	150	mM	NaCl	at	25	˚C,	with	one	of	the	following	
dyes: methylene blue (+11 mV), pyocyanine (-38 mV) or resorufin (-51 mV). 
A septum tight cuvette containing 6HDNO variant (10 µM), xanthine (400 µM), 







The number of sulfhydryl groups of unfolded 6HDNO variants was determined according to 
the method of Ellman [38] with the modifications of Habeeb [39]. The assay was performed on 1-5 
µM 6HDNO variants in 50 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% SDS with a 25-times molar excess of 
5,5’dithio-bis (2-nitrobenzoic acid) (DTNB). The absorbance of eleased 5-thio-2-nitrobenzoate anion 
(TNB) was measured at 412 nm, using Ɛ412 = 8.4 mM-1 cm-1 determined with DL-dithiothreitol (DTT) in 
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[42]. For structural visualiz t o  and inspection, PyMol was used (Schrödinger  LLC). Flavin 
absorbance spectra of purified 6HDNO variants were recorded in 50 mM Tris-HCl pH 7.5 at 25 ˚C, 
before and after addition of 0.1 % (w/v) SDS, on a PerkinElmer Lambda Bio40 spectrophotometer. 
Enzyme concentrations were determined by measuring absorbance at 280 nm using ε280 = 47245 M-
1cm-1 [43]. Oxidase activity and steady-state kinetic parameters were deter ined at 30 ˚C by 
spectrophotometric measurement of product formation, as described previously [44], using different 
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To confirm the presence of covalently bound flavin, 5% trichloroacetic acid (TCA) was used to 
precipitate the protein and the pellet and supernatant were assessed visually and/or 
spectrophotometrically. The in-gel flavin fluorescence was also confirmed in SDS-PAGE gel after 
purification of the protein. Performic acid was prepared according to [45]. The stability of 6HDNO 
variants was measured with the ThermoFAD (29) and ThermoFluor (30) methods using 10 µM 
enzyme. Fluorescence measurements of native and unfolded 6HDNO variants were performed on 10 
µM protein in 50 mM Tris-HCl pH 7.6, 150 mM NaCl, without or with 1% SDS, respectively, on a 
Synergy Mx Multi-Mode Reader (BioTek). The flavoprotein samples were excited at 450 ±13.5 nm 
and the 800-480 nm emission spectra were collected. The intensity of fluor scence was compared at 
the emission maximum, 522 nm. 
Redox potentials  measured by using the method described by Massey (31) in 20 mM 
KH2PO4 pH 7.5, 150 mM NaCl at 25 ˚C, with one of the following dyes: methylene blue (+11 mV), 
pyocyanine (-38 mV) or resorufin (-51 mV). A septum tight cuvett  ontaining 6HDNO variant (10 
µM), xanthine (400 µM), benzyl viologen (10 µM) and redox dye (10 µM) was made anaerobic by 
flushing with argon. The reaction was started by adding a catalytic amount of argon flushed xanthine 
oxidase and spectra were collected every minute during the reaction using PerkinElmer Lambda 
Bio40 spectrophotometer. The log[ox/red] values of the enzyme were plotted against the log[ox/red] 




with argon. The reaction was started by adding a catalytic amount of argon flushed 
xanthine oxidase and spectra were collected every minute during the reaction 
using PerkinElmer Lambda Bio40 spectrophotometer. The log[ox/red] values 
of the enzyme were plotted against the log[ox/red] values of the reference dye and 
fitted using Nernst equation (Eq. 4.2).
 (Eq. 4.2)
rESuLTS
6hdNO sequence similarity to bicovalent flavoproteins
All recently discovered bicovalent flavoproteins belong to the VAO flavoprotein 
family [49]. They are composed of two distinct domains typical for the family: 
the FAD-binding and the substrate-binding domains. Comparison of the elucidated 
crystal structures of bicovalent flavoproteins reveals that the two FAD-linking 
residues, histidine and cysteine, are located at structurally analogous positions. 
The histidine residue is located in the N-terminal part of the sequence, while 
the cysteine is found around 60 residues C-terminal from the linking histidine 
(Fig. 4.2A&B). Multiple sequence alignment analysis shows that the linking histidine 
is preceded by two strictly conserved glycines. A similar sequence characteristic 
has been observed for the monocovalent VAO-type proteins (Fig. 4.2A). 
The FAD-linking cysteine residue in bicovalent flavoproteins is not directly flanked 
by conserved residues. However, a remarkably glycine-rich region a few residues 
C-terminal from the cysteine can be identified in bicovalent flavoprotein sequences 
(7 conserved glycines in a stretch of 12 residues). Sequence analysis of VAO-type 
monocovalent flavoproteins reveals a much lower degree of conservation in this 
region (Fig. 4.2A). This suggests that the glycine-rich region, together with the 
conserved cysteine, can be used to identify bicovalent flavoprotein sequences. 
In case of the prototype monocovalent flavoprotein 6HDNO, FAD is covalently 
linked via His71 [25], which is the counterpart of the FAD-linking histidine 
in bicovalent flavoenzymes (Fig. 4.2A&B). However, in place of the cysteine 
forming the second covalent bond in bicovalent flavoproteins, 6HDNO has 
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6HDNO sequence similarity to bicovalent flavoproteins 
 
All r cently discovered bicovalent flavoproteins belong to the VAO flavoprotein family [46]. 
They re composed of two distinct omains typical for the family: the FAD-binding and the substrate-
binding domains. Comparison of the eluci ate  crystal structures of bicovalent flavoproteins reveals 
that the two FAD-linking residues, histidine and cysteine, are located at structurally analogous 
positions. The histidine residue is located in the N-terminal part of the sequence, while the cysteine 
is found around 60 residues C-terminal from the linking histidine (Fig. 4.1a). Multiple sequence 
alignment analysis shows that the linking histidine is preceded by two strictly conserved glycines. A 
similar sequence characteristic has been observed for the monocovalent VAO-type proteins (Fig. 
4.1a). The FAD-linking cysteine residue in bicovalent flavoproteins is not directly flanked by 
conserved residues. However, a remarkably glycine-rich region a few residues C-terminal from the 
cysteine can be identified in bicovalent flavoprotein sequences (7 conserved glycines in a stretch of 
12 residues). Sequence analysis of VAO-type monocovalent flavoproteins reveals a much lower 
degree of conservation in this region (Fig. 4.1a). This suggests that the glycine-rich region, together 
with the conserved cysteine, can be used to identify bicovalent flavoprotein sequences. In case of the 
prototype monocovalent flavoprotein 6HDNO, the FAD is covalently linked via His71 [25], which is 
the counterpart of the FAD-linking histidine in bicovalent flavoenzymes. However, in place of the 
cysteine that forms the second covalent bond in bicovalent flavoproteins, 6HDNO has a histidine 
residue (His130), prohibiting formation of a cysteinyl linkage as second covalent attachment. 
Knowing that (bi)covalent flavinylation is a self-catalytic process and the two bonds can be formed 
independently, we wanted to study whether it is feasible to create a bicovalent flavoprotein out of a 
monocovalent one. 
As a first attempt to create a bicovalent 6HDNO, a single mutant was prepared in which only 
the linking cysteine was introduced: His130Cys 6HDNO. As we have experienced from our previous 
study on putrescine oxidase that introducing a covalent flavin-protein bond may need multiple 
mutations, we also decided to make a double mutant: His130Cys/Leu138His 6HDNO. The second 
mutation was inspired by the observation that the known bicovalent flavoproteins typically have a 
histidine residue within the glycine-rich region. This histidine is absent in wild-type 6HDNO (Fig. 4.1). 
Recent studies have shown that a positive charge near the isoalloxazine moiety of the FAD cofactor is 
required for stabilization of the negative charge formed at the flavin ring system during the 
formation of the covalent bond [20,47]. The proposed mechanism of covalent flavinylation, studied 
in monocovalent flavoproteins [27,31,48], starts with a proton abstraction from the C8α-methyl 
group of the flavin and subsequent formation of the negative charge at the N1-C2=O locus of the 
isoalloxazine ring [20]. Possibly the introduced histidine in the double mutant could take up such role 
in facilitating formation of the covalent Cys-FAD linkage. Inspection of the crystal structure of 6HDNO 
revealed that the positions of both targeted residues, His130 and Leu138, are compatible with their 
anticipated roles (Fig. 4.1b). The C  of His130 is only at a distance of 3.5 Å from the C6 of the FAD 





as the second covalent attachment (Fig. 4.2A&B). Knowing that (bi)covalent 
flavinylation is a self-catalytic process, we wanted to study whether it is feasible to 
create a bicovalent flavoprotein out of a monocovalent one.
As a first attempt to create a bicovalent 6HDNO, a single mutant was 
prepared in which only the linking cysteine was introduced: His130Cys 6HDNO. 
As we have experienced from our previous study on putrescine oxidase that 
introducing a covalent flavin-protein bond may require multiple mutations, we also 
decided to make a double mutant: His130Cys/Leu138His 6HDNO. The second 
mutation was inspired by the observation that the known bicovalent flavoproteins 
typically have a histidine residue within the glycine-rich region. This histidine is 
absent in wild-type 6HDNO (Fig. 4.2A). Recent studies have shown that a positive 
charge near the isoalloxazine moiety of the FAD cofactor is required for stabilization 
of the negative charge formed at the flavin ring system during the formation of the 
covalent bond [20,50]. The proposed mechanism of covalent flavinylation, studied 
in monocovalent flavoproteins [27,31,51], starts with a proton abstraction from the 
C8α-methyl group of the flavin and subsequent formation of the negative charge 
at the N1-C2=O locus of the isoalloxazine ring [20]. Possibly the histidine 
introduced in the double mutant could take up such role in facilitating the formation 
of the covalent Cys-FAD linkage. Inspection of the crystal structure of 6HDNO 
revealed that the positions of both targeted residues, His130 and Leu138, are 
compatible with their anticipated roles (Fig. 4.2B). The Cβ of His130 is only 
separated by 3.5 Å from the C6 of FAD while Leu is less than 3.5 Å away from 






domains. Comparison of the elucidated crystal structures of bicovalent flavoproteins reveals that the 
two FAD-linking residues, histidine and cysteine, are located at structurally analogous positions. The 
histidine residue is located in the N-terminal part of the sequence, while the cysteine is found around 
60 residues C-terminal from the linking histidine (Fig. 4.2A&B). Multiple sequence alignment analysis 
shows that the linking histidine is preceded by two strictly conserved glycines. A similar sequence 
characteristic has been observed for the monocovalent VAO-type proteins (Fig. 4.2A). The FAD-
linking cysteine residue in bicovalent flavoproteins is not directly flanked by conserved residues. 
However, a remarkably glycine-rich region a few residues C-terminal from the cysteine can be 
identified in bicovalent flavoprotein sequences (7 conserved glycines in a stretch of 12 residues). 
Sequence analysis of VAO-type monocovalent flavoproteins reveals a much lower degree of 
conservation in this region (Fig. 4.2A). This suggests that the glycine-rich region, together with the 
conserved cysteine, can be used to identify bicovalent flavoprotein sequences. In case of the 
prototype monocovalent flavoprotein 6HDNO, FAD is covalently linked via His71 [25], which is the 
counterpart of the FAD-linking histidine in bicovalent flavoenzymes (Fig. 4.2A&B). However, in place 
of the cysteine forming the second covalent bond in bicovalent flavoproteins, 6HDNO has a histidine 
residue (His130) prohibiting the formation of a cysteinyl linkage as the second covalent attachment 
(Fig. 4.2A&B). Knowing that (bi)covalent flavinylation is a self-catalytic process, we wanted to study 
whether it is feasible to create a bicovalent flavoprotein out of a monocovalent one. 
 
(A) 
dbv29     86   VRSGGHCFEDF (52) GVCGGVGVGGHICGGGYG 166  
TamL      57   VRSGGHCYEDF (52) GACPDVGAGGHILGGGYG 137  
AknOx    108   VRSGGHCFEGF (52) GVCPQVGVGGHVLGGGYG 188  
GilR      60   CRSGGHCGQDF (52) GACSAVGMGGLVAGGGYG 140  
BBE       99   LRSGGHSYEGL (54) GWCPTVGTGGHISGGGFG 181  
THCAs     82   TRSGGHDAEGM (54) GYCPTVGVGGHFSGGGYG 164  
GOOX      90   AKGGGHSYGSY (52) GTCPAVGVGGHVLGGGYG 170  
CHITO     89   AKSGGHSYTSL (52) GTCPGVGLGGHALHGGYG 169  
Consensus      xxSGGHxxxxx      GxCxxVGxGGHxxGGGYG      
6HDNO     65   VRSGGHNPNGY (53) GMHPKVGFCGLALNGGVG 146 
CHO       64   PRGAMHGWTPL (57) NLPAPGVLSIGGALAVNA 150 
ALDO      40   VLGSGHSFNEI (57) HISVAGSVATGTHGSGVG 127 
ENCM      72   VRGGGHSMAGH (49) GVVSHTGLGGLVLGGGFG 152 
CKX       99   FRGRGHSLMGQ (58) DYLYLTVGGTLSNAGISG 187 







Figure 4.2. (A) Sequence alignment of monocovalent and bicovalent flavoproteins. Covalent 
flavinylation sites are in red, and the conserved histidine in bicovalent flavoproteins is in green. 
Consensus sequences for the mono- and bicovalent flavoprotein sequences are shown. Bicovalent 
flavoproteins: dbv29 - primary alcohol oxidase (UniProt nr. Q7WZ62); TamL - FAD-dependent 
tirandamycin oxidase TamL (UniProt nr. D3Y1I2); AknOx - aclacinomycin oxidoreductase (UniProt 
nr. Q0PCD7); GilR - GilR oxidoreductase (UniProt nr. Q7X2G7); BBE - reticuline oxidase 
(UniProt nr. P30986); THCAs - tetrahydrocannabinolic acid synthase (UniProt nr. Q8GTB6); 
GOOX - glucooligosaccharide oxidase (UniProt nr. Q6PW77); CHITO - chitooligosaccharide 
oxidase (UniProt nr. I1S2K2). Monocovalent flavoproteins: 6HDNO - 6-hydroxy-D-nicotine 
oxidase (UniProt nr. P08159); CHO - cholesterol oxidase (UniProt nr. Q7SID9); ALDO - alditol 
oxidase (UniProt nr. Q9ZBU1); EncM - EncM oxygenase (UniProt nr. Q9KHK2); CKX - cytokinin 
dehydrogenase 1 (UniProt nr. Q9T0N8). (B) View on the FAD cofactor as monocovalently bound 
in wild-type 6HDNO (PDB:2BVF). The cofactor is shown in yellow sticks while the protein part 
is in cyan. The linking histidine (His71) and the two residues targeted in this study (His130 and 







Wild-type, His130Cys and His130Cys/Leu138His 6HDNO were constructed, 
expressed and purified as described in the Experimental procedures section. 
All proteins were found to be able to bind FAD as evidenced by the yellow 
appearance of the proteins. In addition, the measured 272/450 absorbance ratio 
ranged between 7-9, which agrees well with the value of 7.6 previously published 
for purified wild-type 6HDNO [44]. The purified proteins were tested for covalent 
attachment of the FAD cofactor by precipitation with 5% TCA. The obtained 
supernatant did not show any absorbance in the UV/Vis region, confirming the 
presence of a covalent bond between the cofactor and the protein in each 6HDNO 
variant. Also in-gel flavin fluorescence of all three purified proteins was detected 
upon SDS-PAGE, which further confirmed the ability of covalent flavinylation 
in all three proteins.
UV-visible absorption spectra were collected before and after unfolding 
of all three variants (Fig. 4.3). The spectrum of the native wild-type enzyme 
resembles the one previously published with absorbance maxima at 450, 355 and 
272 nm and a shoulder at 475 nm [44]. The native and unfolded spectra of both, 
wild-type and His130Cys 6HDNO, do not differ significantly and they represent 
typical flavoprotein absorbance spectra of a histidyl-bound FAD. On the other hand, 
the spectra of the double mutant His130Cys/Leu138His differ markedly from the 
wild-type 6HDNO and are very unusual. In the native and unfolded state, the near 
UV absorbance peak at around 360 nm is not present (native state) or is much 
lower (unfolded state) when compared to wild-type and His130Cys 6HDNO, 
while a prominent peak in the native and unfolded state was observed at 436 and 
439 nm, respectively. This suggests a significant change in the flavin binding mode. 
Intriguingly, very similar spectra have been previously reported for bicovalent 
flavoenzymes: the primary alcohol oxidase Dbv29 [52], chitooligosaccharide 
oxidase [53] and berberine bridge enzyme [35]. Altogether, the spectral features of 




Figure 4.3. Absorption spectra of the native (A) and unfolded (B) 6HDNO variants. 
Solid lines represent data for wild-type, dotted lines for His130Cys and dashed lines for His130Cys/
Leu138His enzyme. All spectra were normalized to a protein concentration of ~65 µM.
Wild-type 6HDNO binds FAD via an 8α-N1-histidyl bond, involving His71, 
as evidenced from the crystal structure [54]. From the absorbance spectral analysis, 






His130Cys/Leu138His 6HDNO is able to form the second covalent attachment 
involving the introduced Cys130. In order to confirm this, the Ellman method 
was chosen to measure the number of free thiol groups in the peptides of unfolded 
6HDNO variants. According to the amino acid sequence of wild-type 6HDNO, 
6 cysteines should be determined. Both mutants have one cysteine introduced 
with the mutation, but in the double His130Cys/Leu138His mutant the additional 
cysteine cannot be detected, if it forms the covalent bond with the flavin. 
The results obtained show that in His130Cys/Leu138His 6HDNO, as well as 
in the wild-type, indeed only 6 cysteines can be detected (Table 4.1). 
However, in the single mutant only 6 cysteines were measured as well. This can 
be explained by the proximity of the thiol group of the introduced cysteine 
to the active site on the flavin isoalloxazine moiety and its high degree of solvent 
accessibility. This renders the cysteine prone to oxidation and would prevent it 
from being detected with Ellman’s reagent.
Table 4.1. Characterization of 6HDNO variants. Cysteine content of the SDS-unfolded proteins 
was determined using the Ellman’s method. Redox potentials were measured using a reference 
dye (specific dye and midpoint redox potential in brackets). Steady state kinetic parameters were 
determined using D-6-hydroxynicotine as a substrate. Melting temperatures were determined using 
the ThermoFAD and ThermoFluor methods for wild-type enzyme, yielding identical temperature 
for each enzyme variant, while for the double mutant only the ThermoFluor could be used.
6hdNO
wild-type h130C h130C/L138h







E0 [mV] -36.5±2.9 -35.0±1.4 +11.8
Kinetic parameters
kcat [s
-1] 20.7±0.8 6.7±0.4 0.89±0.2
KM [µM] 22.1±1.9 52.6±1.6 99.9±21
Ki [µM] 840±82 - -
kcat/KM [mM
-1s-1] 943±83 126±4 9.0±1.3
Melting temperature [˚C] 50 47 48
In order to confirm that the double mutant forms an additional covalent 




of both native and unfolded proteins were measured. It is well known that flavin 
fluorescence is quenched in folded flavoproteins and it changes upon unfolding 
and exposing the flavin to the solvent. However, in proteins that have a flavin 
covalently bound to a cysteine, this specific amino acid–flavin linkage quenches 
flavin fluorescence [55,56]. It is apparent from the Figure  4.4 that the fluorescence 
increases significantly in wild-type and single mutant 6HDNO upon unfolding with 
SDS, while the change in the double mutant is much less pronounced. As reference 
a typical bicovalent flavoprotein, chitooligosaccharide oxidase, was also analysed 
concerning its fluorescence properties. This revealed very similar fluorescence 







Figure 4.3. Fluorescence emission intensity at 522 nm of native and unfolded wild-type, His130Cys and 
His130Cys/Leu138His compared to bicovalent chitooligosaccharide oxidase. 
 
It has been shown that the flavin fluorescence of cysteinyl-FAD can be restored after 
cleavage of the covalent cofactor-protein linkage. According to Walker et al. [45], the Cys-flavin bond 
can be cleaved by oxidation with performic acid. After SDS-PAGE and spraying the gel with performic 
acid, clear fluorescent bands were observed for all three 6HDNO variants. That was not the case, 
when the performic acid treatment step was omitted. Then, only wild-type and His130Cys 6HDNO 
bands were clearly fluorescent, while the His130Cys/Leu138His band was very faint in fluorescence. 
The quenching of in-gel fluorescence of the double mutant again confirms that the flavin-cysteine 
covalent bond was formed. 
 
Redox potential determination 
 
It is well known that modifications of the flavin cofactor as well as changes in the flavin 
microenvironment can influence the redox potential of the cofactor. For many flavoenzymes 
midpoint redox potentials have been determined and it was shown that (bi)covalent cofactor binding 
can dramatically increase the potential of a flavin cofactor [20]. The redox potentials measured for 
bicovalent flavoproteins are among the highest ever observed for flavoproteins, typically in the 0 – 
+200 mV range. In contrast, noncovalent flavoproteins typically exhibit redox potentials in the -400 – 
0 mV range. In line with this, it has been observed that removal of a covalent flavin-protein bond by 
site-directed mutagenesis induces a drastic decrease in redox potential. In fact, it has been 
postulated that the driving force for a protein to create a covalent flavin-protein bond is the increase 
of redox potential rendering an enzyme with a higher oxidative power [20]. Therefore, we set out to 
determine the redox properties of all three 6HDNO variants. 
For that purpose, the xanthine/xanthine oxidase based method developed by Massey [54] 
was used. The enzymes were anaerobically reduced in the presence of a suitable reference dye 
(Table 4.1) and the absorbance data were collected. The ratios between oxidized and reduced 
flavin/dye were represented according to the Minnaert method ([55]. From these plots the redox 
potentials could be calculated. For the His130Cys/Leu138His 6HDNO mutant, no radical 
intermediates could be observed during reductions. The slope of the linear fit in the Nernst plot was 
1.1, indicating a simultaneous 2-electron transfer for both flavoprotein and the dye, when they are in 

















Figure 4.4. Fluorescence emission intensity at 522 nm of native and unfolded wild-type, His130Cys 
and His130Cys/Leu138His compared to bicovalent chitooligosaccharide oxidase. The values 
represent an average of at least 3 measurements with standard errors less tan 5%.
It has been shown that the flavin fluorescence of cysteinyl-FAD can be 
restored after cleavage of the covale t cofactor-prot in linkage. According to Walker 
et al. [45], the Cys-flavin bond can be cleaved by oxidation with performic acid. 
After SDS-PAGE and spraying the gel with performic acid, clear fluorescent bands 
were observed for all three 6HDNO variants. This was not the case when the performic 
acid treatment step was omitted and in this case only wild-type and His130Cys 
6HDNO bands were clear y fluorescent, while the His130Cys/Leu138His band was 
very faint in comparison. The quenching of in-gel fluorescence of the double mutant 





It is well known that modifications of the flavin cofactor as well as changes in 
the flavin microenvironment can influence the redox potential of the cofactor. 
For many flavoenzymes midpoint redox potentials have been determined and it was 
shown that (bi)covalent cofactor binding can dramatically increase the potential of 
a flavin cofactor [20]. The redox potentials measured for bicovalent flavoproteins 
are among the highest ever observed for flavoproteins, typically in the 0 to +200 
mV range. In contrast, noncovalent flavoproteins typically exhibit redox potentials 
in the -400 to 0 mV range. In line with this, it has been observed that removal 
of a covalent flavin-protein bond by site-directed mutagenesis induces a drastic 
decrease in the redox potential. In fact, it has been postulated that the driving 
force for a protein to create a covalent flavin-protein bond is the increase of redox 
potential rendering an enzyme with a higher oxidative power [20]. Therefore, we 
set out to determine the redox properties of all three 6HDNO variants.
For that purpose, the xanthine/xanthine oxidase based method developed by 
Massey [48] was used. The enzymes were anaerobically reduced in the presence 
of a suitable reference dye (Table 4.1) and the absorbance data were collected. 
The ratios between oxidized and reduced flavin/dye were represented according to 
the Minnaert method [57]. From these plots the redox potentials could be calculated. 
For the His130Cys/Leu138His 6HDNO mutant, no radical intermediates could 
be observed during the reductions. The slope of the linear fit in the Nernst plot 
was 1.1, indicating a simultaneous 2-electron transfer for both flavoprotein and 
the dye, when they are in equilibrium. The midpoint redox potential obtained 
from the plot was 11.8 mV. The Nernst plots for the wild-type and His130Cys 
6HDNO gave slopes of 0.46-0.62 for both reference dyes used. That suggests 
a 1-electron reduction of the flavin and 2-electron reduction of the dye. However, 
no flavin radical forms were observed for any of the two 6HDNO variants. 
One possible explanation could be a lack of equilibrium between the reduction 
of the cofactor and the reporter dye during the measurement, but this was ruled 
out by repeating the experiments at different xanthine oxidase concentrations, 
resulting in prolonged reductions lasting for up to 6 hours. Therefore, we conclude 
that 2-electron reduction in these two variants is kinetically inhibited, but the flavin 
radical form is not stabilized thermodynamically. This allows us to use the Nernst 




values of -37 and -35 mV for the wild-type and His130Cys 6HDNO, respectively. 
Compared to the His130Cys/Leu138His 6HDNO mutant, the redox potential 
of both variants is lower by almost 50 mV. These data are in agreement with the 
different FAD binding modes, as the 6HDNO variants: wild-type and His130Cys 
bind FAD monocovalently, while the double mutant is able to create an additional 
covalent attachment to the flavin.
Enzyme activity and stability
Table 4.1 shows the kinetic parameters measured for the three 6HDNO variants. 
All three enzyme variants display significant activity. The wild-type enzyme is by far 
the most active enzyme, showing a specificity constant 10 fold and 100 fold higher 
than the single and double mutant, respectively. The mutations affect both the kcat 
and the KM values, but the kcat is influenced more significantly. This is in line with 
a preserved binding site for the substrate. Interestingly, the wild-type enzyme suffers 
from substrate inhibition while for the mutants no inhibition is observed for the tested 
substrate range. This correlates with the relatively high KM values for the mutants, 
suggesting that the mutations result in a lower affinity for the substrate.
Beside an increase in redox potential, some other roles for (bi)covalent 
flavinylation have been postulated. One of them is to improve protein stability and 
integrity, because the removal of a covalent bond in a natural covalent flavoprotein 
can lead to the production of an incorrectly folded enzyme [58,59], thermal and 
structural instability [10,60] and complete deactivation or decrease in activity 
[10,61,62]. A variety of methods can be used to assess protein stability. Here we 
decided to use the ThermoFluor [47] and ThermoFAD [46] methods, which 
determine the apparent melting temperature of a protein. All three 6HDNO 
enzymes were found to have very similar melting temperatures: wild-type, 
50	 ˚C;	His130Cys,	 47	 ˚C;	 and	His130Cys/Leu138His,	 48	 ˚C.	 For	 the	wild-type 
and His130Cys 6HDNO the melting temperatures did not depend on the 
employed method, ThermoFluor or ThermoFAD. For the double mutant only the 
ThermoFluor method could be used, because the generated flavin fluorescence signal 
was too low. This was most likely caused by the bicovalent attachment of the flavin, 
which alters the fluorescence properties of the flavin (see above). It is interesting 
to note that, although both mutants are somewhat less stable than the wild-type, 





The present study was designed to introduce a second covalent bond in 6HDNO 
and to reveal which features are important in the process of bicovalent flavinylation. 
Wild-type 6HDNO binds FAD in a monocovalent manner via an 8α-N1-histydyl 
linkage, similar to many other flavoproteins in the VAO-family. The FAD-binding 
domain of 6HDNO shows some sequence similarity to bicovalent flavoproteins, 
but lacks conservation of the linking cysteine and the flanking residues (Fig. 4.2A). 
The two major features missing in 6HDNO, namely the covalent cysteine and 
the conserved histidine, were introduced, resulting in two mutants: His130Cys 
and His130Cys/Leu138His. The analysis of the type of covalent binding in all 
three 6HDNO variants showed that a single mutation of the histidine to the 
cysteine is not sufficient for the second bond to be formed between FAD and the 
enzyme. Only when a histidine is introduced in the double mutant His130Cys/
Leu138His 6HDNO, does bicovalent flavinylation take place. Little is known 
about the mechanistic aspects of bicovalent flavinylation, except that it has been 
shown that both bonds are formed independently from each other [10,18-20,35]. 
 The results of this study indicate that the second covalent bond, the Cys-FAD 
linkage, is only formed when a histidine is present near the N1-C2=O locus 
of the isoalloxazine ring. This suggests that there is a need for a positive charge 
to stabilize the negative charge that develops on the isoalloxazine moiety of the 
flavin cofactor during the Cys-FAD flavinylation reaction. The results also suggest 
that the histidyl-FAD bond is formed more easily. This is in line with the observation 
that the majority of covalent flavoproteins are histidyl-FAD containing enzymes. 
It also hints to an evolutionary order of formation of the two covalent FAD-protein 
linkages in VAO-type proteins: first the histidyl-FAD linkage was established, 
followed by the introduction of the cysteinyl-FAD linkage. Such an order of events 
is also seen when performing a multiple sequence alignment of VAO-type proteins. 
The bicovalent flavoproteins form a distinct clade that seem to originate from 
a common monocovalent flavoprotein [49]. 
The introduced histidine in 6HDNO, His138, is at a position that is typically 
occupied by a histidine in natural bicovalent flavoproteins. While we demonstrate 
that the introduced histidine in 6HDNO is beneficial for the formation of a second 
covalent bond between flavin and 6HDNO, research of Wallner et al. [63] showed 




enzyme is not an absolute requirement for bicovalent flavinylation. When His174 
in berberine bridge enzyme is mutated to an alanine, the bicovalent linkage is still 
formed. However, the Cys-flavin bond in the His174Ala berberine bridge enzyme 
mutant [18,35] is lost during anaerobic photoreduction and only slowly reformed 
after addition of oxygen. His174 in berberine bridge enzyme interacts with 
the C2’ hydroxyl group of the ribityl side chain of the flavin that in turn interacts 
with the N1-C2=O locus of the isoalloxazine ring system. This indicates 
the importance of the histidine in stabilization of the reduced form of the cofactor, where 
the negative charge is formed in the N1-C2=O locus. However, in addition to 
the histidine, another amino acid, Tyr456, takes part in hydrogen bond network 
in berberine bridge enzyme and which may be sufficient for mediating formation 
of the Cys-FAD linkage in the absence of His174. In 6HDNO, the corresponding 
tyrosine is not present and this might be the reason, why the introduced histidine 
is essential for the Cys-flavin bond formation.
The significance of (bi)covalent flavin binding has been demonstrated many 
times in mutagenesis studies of mono- and bicovalent flavoenzymes, where 
removal of a covalent linkage resulted in a decrease of the midpoint redox 
potential [20]. It indicates that one of the functions of bicovalent flavin binding 
is to increase the oxidative power of an enzyme. This study produced results 
which corroborate this finding, because the redox potential of bicovalent 6HDNO 
increased compared to the two other monocovalent enzyme variants. However, 
the natural bicovalent flavoenzymes have somewhat higher midpoint redox potentials 
(glucooligosaccharide oxidase +126 mV [19], chitooligosaccharide oxidase +131 mV 
[10], berberine bridge enzyme +132 mV [18]) than the engineered bicovalent 
6HDNO (+12 mV). This is not surprising, because wild-type 6HDNO also 
shows a relatively low midpoint redox potential (-37 mV) when compared to 
other monocovalent VAO-type flavoproteins (p-cresolmethylhydroxylase +84 mV; 
 vanillyl-alcohol oxidase +50 mV; cytokinin dehydrogenase +8 mV; eugenol oxidase 
-2 mV) [20]. Mutations leading to a removal of the Cys-FAD bond in bicovalent 
flavoenzymes usually cause a decrease in redox potential of about 60-80 mV. 
Therefore, the difference of almost 50 mV between monocovalent wild-type and 
bicovalent mutant 6HDNO is in the expected range. Most probably, there are also 
other amino acids in the flavin-binding pocket of bicovalent flavoproteins which 
influence the redox potential via non-covalent interactions. In 6HDNO these 




When considering enzyme functioning, a major drawback of the mutations 
introduced in 6HDNO is that they lead to a decrease in activity of the enzyme. 
A possible explanation for this might be the location of the mutations. The His130 
is substituted by a cysteine while it is located next to the C6 isoalloxazine ring 
locus, which is in direct proximity of the hydride-accepting N5 atom of the 
FAD cofactor. The introduced cysteine also forms a part of the substrate binding 
pocket [54]. Therefore the amino acid replacement may cause perturbations in the 
6-hydroxy-D-nicotine binding and subsequent oxidation. The histidine that was 
introduced in place of leucine 138 is located on the other side of the isoalloxazine 
ring but it mediates the formation of a Cys-FAD covalent bond. The newly formed 
covalent bond, although it increases the redox potential, may induce an altered 
positioning of the isoalloxazine moiety in the active site. This in turn may hamper 
proper positioning of the substrate for optimal hydride transfer. Additionally to 
that, the increased redox potential may not be optimal for catalysis. However, 
both mutations do not cause significant perturbations of the protein structure, 
as all three variants have very similar thermostability, display similar KM values 
and are still active. Future detailed (pre-steady state) kinetic studies should shed 
more light on these aspects of 6HDNO-mediated catalysis. It is worth noting that 
Koetter et al. [54] showed that the active centre in 6HDNO is surprisingly large 
when considering 6-hydroxy-D-nicotine as substrate. They suggested that the real 
physiological 6HDNO substrate may not have been discovered yet. If this is true, 
it would be interesting to see if an increased redox potential in 6HDNO would lead 
to an increase in catalytic activity with the natural substrate.
This study provides new insights into the self-catalytic mechanism of bicovalent 
flavinylation of flavoproteins. We used monocovalent 6HDNO as a prototype 
flavoprotein and were able to introduce an additional second covalent flavin-
protein linkage. Our results indicate that a specific flavin microenvironment is 
required for the formation of a Cys-FAD linkage, which should include a positive 
charge to stabilize a negatively charged flavin flavinylation intermediate (His138 in 
6HDNO). In most known natural bicovalent flavoproteins a histidine is also found 
at the corresponding position. Our study also shows that it is feasible via protein 
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ABSTrACT
Riboflavin (vitamin B2) is a precursor for naturally occurring flavins, 
namely flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN). 
These two cofactors are used by a number of enzymes, called flavoenzymes. 
In order to analyse flavin function, covalent flavin binding process and to create 
enzymes with new catalytic properties chemically modified flavins are often used. 
One of such modifications is isotopic labelling, in particular deuteration. A method 
for specific deuteration of FMN at C8 methyl group is presented. Furthermore, 
FMN is enzymatically converted to riboflavin.




The (bio)chemical properties of flavin cofactors originate from their redox-active 
isoalloxazine moiety, which can catalyse one- or two-electron transfer reactions and 
dioxygen activation [1,2]. In most cases flavin cofactors are bound tightly, but non-
covalently, by the protein. However, covalent bond with the flavin has been found 
in approximately 10% of flavoproteins and in the vast majority the attachment is 
formed with the isoalloxazine ring moiety [3]. Provided that the original flavin 
cofactor can be removed by (local) unfolding of the flavoprotein with non-covalently 
bound flavin, most of so-created apo proteins will accept chemically-modified 
flavins as an alternative cofactor [4]. Creating flavoproteins that contain a modified 
isoalloxazine moiety can be useful in analysis of reaction mechanisms catalysed by 
the corresponding flavoenzymes. When the modification affects the attachment point 
of covalent binding to the flavin, effects on covalent flavinylation can be also probed. 
Furthermore, artificial flavoenzymes with new catalytic properties can be obtained 
by combining flavin derivatives with different protein scaffolds [5,6] (and Chapter 2). 
A large number of flavin derivatives with different substituents at various positions 
in the isoalloxazine ring system have been prepared. More information on their use 
in elucidating the mechanistic details of flavoprotein function and covalent flavinylation 
can be found in recent reviews [7–9].
Flavins are composed of a heterocyclic 7,8-dimethylisoalloxazine ring 
system (Fig. 5.1) and the difference between them concerns the modifications 
and substitutions in tricyclic moiety. The most known flavin molecule is riboflavin 
(vitamin B2), a precursor for natural flavin cofactors. Riboflavin is also often added 
to food as a colouring agent. The most common flavin cofactors present in proteins 
are flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), which 
differ in the group present at the N10 of the flavin. The substituent at the N10 is 
responsible for proper flavin binding to the protein, while the catalytically active 
part is located at isoalloxazine, typically at the C4a-N5 site. The activity of the 
flavin is modulated by the interactions with the amino acids of the hosting protein, 
but it can be also changed by isoalloxazine modifications. Substitutions at the 
C8 methyl group are of special interest, because this group has a functional role 
in many enzymes. For example, it is suggested to take part in electron-transfer 
processes in reductase domains and in photolyases [10,11]. It is also the group 




Chapters 1, 3 and 4). Therefore, many different C8-flavin analogues were tested 
for the correlation between enzyme activity and proper covalent bond formation. 
For example, monoamine oxidases A and B were active only when they were able 
to form the covalent bond with the substituted flavin [12].





                                
Figure 5.1. The structure of naturally occurring flavin cofactors. 
 
The examples presented above demonstrate the power of using chemically-modified flavin 
cofactors for the elucidation of enzyme properties or for tuning enzyme reactivity. On the other 
hand, more subtly modified flavins, in which isotopes are incorporated, can also be valuable probes 
to study flavoproteins. For example, by using isotopically labelled flavins, NMR studies on 
flavoproteins are facilitated [13–23]. The use of isotopes is also a very common approach to unveil or 
study specific kinetic events in an enzyme reaction mechanism. Often, hydrogen-deuterium 
substitution is used, which is expected to slow down the reaction rate when C-H bond breaking is 
involved, causing so called kinetic isotope effect. Interestingly, it has been proposed that 
deprotonation of the C8 methyl group is the first and possibly rate limiting step in the formation of a 
flavin-protein covalent bond [24–28]. Therefore, it would be interesting to study the effect of using 
C8 methyl-deuterated flavin on the process of covalent flavinylation. In this Chapter, the preliminary 






D2O and NaOD were from Sigma-Aldrich, DCl from Acros Organics, Antarctic Phosphatase 




For the deuteration reaction of riboflavin, 100 mg riboflavin was resuspended in 900 µl D2O 
and the pD adjusted with 5% NaOD until riboflavin was completely dissolved. Then the solution was 
heated at 93˚C for approx. 42 hrs. A sample incubated at room temperature was used as a control. 
For the deuteration reaction of FMN, the method of Bullock and Jardetzky was used [29]. 100 
mg FMN was dissolved in 1 ml of 200 mM KPi prepared in D2O and pD adjusted with DCl to 7.5. Then 
the solution was incubated at 90˚C and small samples were collected at different time points for 

























Figure 5.1. The structure of naturally occurring flavin cofactors.
The examples presented above demonstrate the power of using chemically-
modified flavin cofactors for the elucidation f enzyme properties or for tuning 
enzyme reactivity. On the other hand, more subtly modified flavins, in which 
isotopes are incorporated, can also be valuable probes to study flavoproteins. 
For example, by using isotopically labelled flavins, NMR studies on flavoproteins 
are facilitated [13–23]. The use of isotopes is also a very common approach 
to unveil or stu y specific kinetic events in an enzyme reaction mechanism. 
Often, hydrogen-deuterium substitution is used, which is expected to slow down 
the reaction rate when C-H bond breaking is involved, causing a so called kinetic 
isotope effect. Interestingly, it has been proposed that deprotonation of the 
C8 ethyl group is the first and possibly rate limiting step in the formation 
of a flavin-protein covalent bond [24–28]. Therefore, it would be worth to study the 
effect of using C8 methyl-deuter t d flavin on the proc ss of covalent flavinylation. 
In this Chapter, the preliminary results for synthesis of C8 methyl deuterated 
riboflavin and FMN are presented.





D2O and NaOD were from Sigma-Aldrich, DCl from Acros Organics, Antarctic 
Phosphatase from New England BioLabs and TLC Silica gel 60/Kieselguhr F254 
plates were from Merck.
deuteration reaction
For the deuteration reaction of riboflavin, 100 mg riboflavin was resuspended in 
900 µl D2O and the pD adjusted with 5% NaOD until riboflavin was completely 
dissolved.	Then	 the	 solution	 was	 heated	 at	 93˚C	 for	 approx.	 42	 h.	A	 sample	
incubated at room temperature was used as a control.
For the deuteration reaction of FMN, the method of Bullock and Jardetzky 
was used [29]. 100 mg FMN was dissolved in 1 ml of 200 mM KPi prepared in D2O 
and	pD	adjusted	with	DCl	to	7.5.	Then	the	solution	was	 incubated	at	90˚C	and	
small samples were collected at different time points for NMR and ESI-MS analysis.
Nmr analysis
For monitoring the deuteration process, NMR was used. 1H-NMR spectra of the 
flavins were recorded on a Varian AMX400 (400 MHz) in the solution used for 
deuteration reaction.
ESi-mS analysis
For electrospray ionization mass spectrometry experiments, samples of the 
deuteration reaction were prepared in 50% methanol with 10% acetic acid 
(riboflavin) or with 5% formic acid (FMN). The mass spectra were recorded on an 






the reaction was monitored with TLC using 5% Na2HPO4 in 10% methanol 
as resolving system. The plates were inspected visually for the flavins.
rESuLTS ANd diSCuSSiON
deuteration of riboflavin
It	was	 shown	 already	 in	 the	 1960s	 that	 heating	 FMN	 at	 90-95˚C	 in	 a	 buffered	
D2O solution leads to a selective proton exchange between the solvent and the 
C8 methyl group [29]. The authors proposed that the exchange takes place via 
an intermediate with a highly delocalized negative charge in the pyrimidine ring. 
This iminoquinone methide intermediate was later proposed to be an intermediate 
in the reaction of covalent bond formation between the C8 methyl group of FAD 
and the protein amino acid (Fig. 5.2) [30]. To investigate the process of covalent 
flavinylation in more detail, we wanted to synthetize a flavin compound deuterated 







For monitoring the deuteration process, NMR was used. 1H-NMR spectra of the flavins were 




For electrospray ionization mass spectrometry experiments, samples of the deuteration 
reaction were prepared in 50% methanol with 10% acetic acid (riboflavin) or with 5% formic acid 
(FMN). The mass spectra were recorded on an ESI-MS (LCQ Fleet Ion Trap Thermo Fisher Scientific) in 




25 mg/ml FMN was incubated with 5 U/µl Antarctic Phosphatase at 37˚C and the reaction 
was monitored with TLC using 5% Na2HPO4 in 10% methanol as resolving system. The plates were 
inspected visually for the flavins. 
 




It was shown already in the 1960s that heating FMN at 90-95˚C in a buffered D2O solution 
leads to a selective proton exchange between the solvent and the C8 methyl group [29]. The authors 
proposed that the exchange takes place via an intermediate with a highly delocalized negative charge 
in the pyrimidine ring. This iminoquinone methide intermediate was later proposed to be an 
intermediate in the reaction of covalent bond formation between the C8 methyl group of FAD and 
the protein amino acid (Fig. 5.2) [30]. To investigate the process of covalent flavinylation in more 
detail, we wanted to synthetize a flavin compound deuterated at C8 methyl group. 
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Figure 5.2. Formation of the flavin iminoquinone methide by deprotonation at the C8 methyl position. 
 
For that purpose, we chose to prepare a riboflavin deuterated at C8 methyl position, 
although the reaction had only been shown to work for FMN [29]. Riboflavin was chosen because a 
riboflavin-auxotrophic E. coli strain, namely BSV11, carries mutations that render it permeable to this 
type of flavin [31]. Therefore, the modified riboflavin can be used in vivo to express the flavoprotein 
      
iminoquinone ethide
 Figure 5.2. Formation of the flavin iminoquinone methide by deprotonation at the C8 methyl 
position.
For that purpose, we chose to prepare a riboflavin deuterated at C8 methyl 
position, although the reaction had only been shown to work for FMN [29]. 
Riboflavin was chosen because a riboflavin-auxotrophic E. coli strain, namely BSV11, 
carries mutations that render it permeable to this type of flavin [31]. Therefore, 
the modified riboflavin can be used in vivo to express the flavoprotein in its presence. 
Selective Deuteration of Flavin Cofactors
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The low solubility of riboflavin in water was expected to inhibit the exchange 
of protons with the solvent. To overcome this problem, the riboflavin was solubilized 
by the addition of NaOD. First, a riboflavin reference solution was analysed with 
1H-NMR using D2O/KOH as a solvent. Based on the literature [29,32] two signals 
of equal height were assigned to the two methyl groups of the isoalloxazine ring 
of the riboflavin: 2.01 ppm for the C7 and 2.12 ppm for the C8 methyl group. 
After the deuteration reaction, the signal corresponding to the C8 methyl group was 
significantly lower as compared to the signal of the C7 methyl group. However, C8 
protons were still clearly present, indicating that the deuteration was not complete. 
Overall, the spectra of the deuterated compound were of rather low quality when 
compared to the non-deuterated riboflavin. The explanation for this came from ESI-
MS analysis. It was clear that some deuterated riboflavin was formed, because the 
distribution of ion signals changed in favour of higher mass ions (ions at m/z 377 and 
388 were virtually equal), but the conversion was not complete, as the substitution of 
three protons with deuteriums would lead to an increase of m/z by 3. Furthermore, 
the riboflavin ion signals were not much higher than the background signal and the 
same was found for the control incubated at room temperature. This indicates that the 
high pD used to solubilize riboflavin caused its degradation even at room temperature.
deuteration of FmN
Because the problem with solubility of riboflavin rendered the deuteration 
reaction very inefficient, we decided to use FMN for the deuteration reaction. 
Deuterated FMN can subsequently be converted to riboflavin (Fig. 5.3). 
FMN, as a soluble compound, could be used at more neutral pH for the deuteration 
reaction. As can be seen from the 1H-NMR spectra (Fig. 5.4), the signal corresponding 
to	the	C8	methyl	group	[29,32]	decreased	in	the	FMN	sample	incubated	at	90˚C	
and after 20 hours it disappeared completely. This was not observed with the 
sample incubated at room temperature. Here, both methyl groups gave a similar 
NMR signal, indicating that the H-D exchange reaction took place only at relatively 
high temperature. The number of deuteriums introduced was verified by ESI-MS 
(Fig. 5.5). The FMN mass in the heated sample increased indeed by 3 Da within 
20 hours. The deuteration reaction at room temperature only yielded a slight 




confirmed that the deuterium-hydrogen exchange reaction was complete and 




in its presence. The low solubility of riboflavin in water was expected to inhibit the exchange of 
protons with the solvent. To overcome this problem, the riboflavin was solubilized by the addition of 
NaOD. First, a riboflavin reference solution was analysed with 1H-NMR using D2O/KOH as a solvent. 
Based on the literature [29,32] two signals of equal height were assigned to the two methyl groups of 
the isoalloxazine ring of the riboflavin: 2.01 ppm for the C7 and 2.12 ppm for the C8 methyl group. 
After the deuteration reaction, the signal corresponding to the C8 methyl group was significantly 
lower as compared to the signal of the C7 methyl group. However, C8 protons were still clearly 
present, indicating that the deuteration was not complete. Overall, the spectra of the deuterated 
compound were of rather low quality when compared to the non-deuterated riboflavin. The 
explanation for this came from ESI-MS analysis. It was clear that some deuterated riboflavin was 
formed, because the distribution of ion signals changed in favour of higher mass ions (ions at m/z 
377 and 388 were virtually equal), but the conversion was not complete, as the substitution of three 
protons with deuteriums would lead to an increase of m/z by 3. Furthermore, the riboflavin ion 
signals were not much higher than background signal and the same was found for the control 
incubated at room temperature. This indicates that the high pD used to solubilize riboflavin caused 
its degradation even at room temperature. 
 
Deuteration of FMN 
 
Because the problem with solubility of riboflavin rendered the deuteration reaction very 
inefficient, we decided to use FMN for the deuteration reaction. Deuterated FMN can subsequently 
be converted to riboflavin (Fig. 5.3). FMN, as a soluble compound, could be used at more neutral pH 
for the deuteration reaction. As can be seen from the 1H-NMR spectra (Fig. 5.4), the signal 
corresponding to the C8 methyl group [29,32] decreased in the FMN sample incubated at 90˚C and 
after 20 hours it disappeared completely. This was not observed with the sample incubated at room 
temperature. Here, both methyl groups gave a similar NMR signal, indicating that the H-D exchange 
reaction took place only at relatively high temperature. The number of deuteriums introduced was 
verified by ESI-MS (Fig. 5.5). The FMN mass in the heated sample increased indeed by 3 Da within 20 
hours. The deuteration reaction at room temperature only yielded a slight increase in higher mass 
ions. The analysis with both methods, NMR and ESI-MS, confirmed that the deuterium-hydrogen 
exchange reaction was complete and selective for only the C8 methyl group of FMN. 
 
 










Figure 5.4. The methyl region of the 1H-NMR spectra of FMN during the deuteration reaction at (a) 90˚C and (b) 
room temperature (RT). Samples were taken after 0, 1, 2, 4 and 20 hours. C8 and C7 correspond to the C8- and 
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Figure 5.4. The methyl region of the 1H-NMR spectra of FMN during the deuteration reaction at 
(a)	90˚C	and	(b)	room	temperature	(RT).	Samples	were	taken	after	0,	1,	2,	4	and	20	hours.	C8	and	
C7 correspond to the C8- and the C7-methyl hydrogens of the FMN.








Figure 5.5. The FMN region of the electrospray (+) mass spectra of FMN at 0, 1, 2, 4 and 20 hours during the 
deuteration reaction at (a) 90˚C and (b) room temperature (RT). 
 
FMN conversion to riboflavin 
 
In order to dephosphorylate FMN, Antarctic Phosphatase was used and the reaction was 
monitored with thin layer chromatography (TLC). Again, because of the low solubility of riboflavin, it 
was difficult to find resolving conditions for both, riboflavin and FMN. For that reason, TLC was used 
only to estimate the progress of the conversion. After 3 days, the sample of the reaction looked 
similarly on TLC plate when compared to a riboflavin sample. Therefore, the hydrolysed sample was 





The results presented here show that specific deuteration of the C8 methyl group of FMN is 
feasible. We also showed that the deuterated FMN can be converted enzymatically to riboflavin. 
Such selectively-deuterated riboflavin is an interesting compound for investigating covalent 
flavinylation in proteins. Riboflavin can be used in the cells as FAD cofactor precursor. By using 
deuterated riboflavin in combination with riboflavin auxotrophic strains, such as E. coli BSV11 [31], it 
will be possible to study effects of deuteration on the efficiency of covalent flavinylation. 
Alternatively, deuterated riboflavin or FMN can be converted by using FAD synthetase into the FAD 
form. This would allow investigating the effects of C8 deuteration on the kinetics of covalent 
flavinylation. 





FMN_reaction_2 #836-1133 RT: 3.0-4.0 AV: 298 NL: 2.76E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















214.1 479.2 609.0243.2 456.6158.1 377.3 521.1 592.9 765.6 912.7738.8721.6141.1 429.1 652.9 690.9 888.8281.2 782.6 812.6 858.4630.9298.4 543.1 935.7215.2 967.0355.2257.299.2 399.3316.3163.1 984.285.1 198.2
FMN_reaction_2 #835-1130 RT: 3.0-4.0 AV: 296 NL: 2.76E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















510.1479.2 512.1495.2 503.1471.3456.6377.3 521.1445.1 460.3429.1 439.3 527.0 533.2509.3415.3 517.3 537.1481.3 543.1409.3 431.2 551.7478.5399.3371.2 470.5391.3 448.2 462.3453.3380.3 401.4 421.3389.2
FMN_reaction_2 #836-1127 RT: 3.0-4.0 AV: 292 NL: 2.73E2
T: ITMS + c ESI Full ms [50.00-1000.00]





















245.3242.6 258.3256.3236.2 259.2233.1 237.2231.1 255.2230.2 239.2 251.1247.1229.2 235.2 260.2249.1 253.2246.2 248.2 254.3234.2 240.2 241.3228.3 238.3232.2 250.2 252.2241.8
C:\Z_user_data\...\FMN_reaction_4 3/15/2011 2:36:55 PM RT_1
esiPOS_NEG
100 2.41.61.4 2.21.90.50.5 1.8 2.0 2.11.70.3 1.5 1.60.6
0.20.1
FMN_reaction_4 #936-1259 RT: 3.2-4.3 AV: 324 NL: 5.19E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























668.9637.0417.3 772.8 913.9379.4 950.8243.2 788.8536.1 756.8690.9608.9593.0214.2 900.1832.97 8.8 974.0870.7158.1 988.9359.3175.1141.1 316.3286.399.181.2
FMN_reaction_4 #934-1262 RT: 3.2-4.3 AV: 329 NL: 5.20E3
T: ITMS + c ESI Full ms [50.00-1000.00]





















459.3 479.2415.3 496.2 533.1
480.3 517.2416.3 534.1497.2377.3 518.2460.3
481.3417.3 489.2379.4 501.2 511.1 536.1439.3 461.3 527.1399.4 456.7 471.3 520.2 549.1447.2429.2 540.2414.7409.3 478.6 504.2397.3 483.3391.4 419.3376.8 432.3371.2 383.4
FMN_reaction_4 #922-1250 RT: 3.2-4.3 AV: 329 NL: 2.78E2
T: ITMS + c ESI Full ms [50.00-1000.00]





















236.2231.3 258.3242.6237.2 239.1229.3 232.3 255.2 259.2230.3 256.4235.3 246.3 251.2 252.2 253.2241.2233.2 240.3238.3 247.3228.3 248.3 254.3250.3249.2234.3
C:\Z_user data\...\FMN_reaction_6 3/15/2011 3:58:36 PM rt_2
esiPOS_NEG
100
FMN_reaction_6 #919-1178 RT: 3.2-4.1 AV: 260 NL: 4.22E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















378.3 511.1415.3 456.6 608.9243.2 533.1214.2 912.8379.3 652.9316.3 668.9158.1 592.9 950.9766.7750.8690.9141.1 781.6549.1 966.9902.5870.6804.7 847.5359.3298.599.1 988.9281.2198.281.2
FMN_reaction_6 #918-1178 RT: 3.2-4.1 AV: 261 NL: 4.22E3
T: ITMS + c ESI Full ms [50.00-1000.00]





















495.2479.2 489.2378.3 511.1460.2 480.2415.3 456.6 471.2 533.1497.2379.3 517.2490.2439.3 527.1461.3 535.1488.5 503.2409.3 521.2447.2 478.6 549.1429.3417.3399.3391.3 55.4376.7 541.2371.2 437.3421.2385.4 403.3
FMN_reaction_6 #906-1178 RT: 3.2-4.1 AV: 273 NL: 3.08E2
T: ITMS + c ESI Full ms [50.00-1000.00]






















258.3236.2235.3230.2 259.3251.1 256.5232.3229.3 23 .2 237.2 240.3 25 .2239.2 253.2247.2246.3 260.325 .3249.2241.3 250.3238.3 248.328. 234.3 254.3242.6
C:\Z_user_data\...\20110316\FMN_3 3/16/2011 1:22:11 PM rt_4
esiPOS
50
10 3.21.6 2.71.00.2 0.2 0.3 2.82.30.4 2.0 2.81.61.4 3.02.32.01.1 2.71.9 2.11.40.5 1.2 1.8 2.4 2.60.1 2.2
FMN_3 #861-1160 RT: 3.2-4.3 AV: 300 NL: 2.62E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























534.1378.3 652.9415.3243.2 668.9636.9379.3 913.8456.6 951.8772.8299.3 788.7555.0 690.8244.2 756.8571.0 93.03 .3 892.7316. 712.8 832.7 972.9870.6 988.986.2 231.3175.0132.2 213.081.1
FMN_3 #860-1163 RT: 3.2-4.3 AV: 304 NL: 2.62E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























480.2 517.1497.2 534.1378.3 460.2415.3 481.2 518.1
379.3 489.2456.6 498.2439.3 511.1471.3461.2 527.1 536.148 .3417.3 502.2399.3 478.6414.6 520.1441.4 540.2 549.1409.3376.7 381. 391. 447.3430.4 437.3369.4 421.3
FMN_3 #849-1152 RT: 3.2-4.3 AV: 304 NL: 3.08E2
T: ITMS + c ESI Full ms [50.00-1000.00]























255.3 259.3253.3 258.3241.3239.2237.2229.3 232.3 256.5254.4242. 251.3247.2 3.3 252.4235.3 236.2230.4 46.3 260.3240.4228.3 249.3238.4 248.3 250.4234.3




2.92.52.5 2.60.7 2.7 2.90.30.3 2.70.8 0.9 2.41.1 1.2 2.31.41.0 1.31.20.1 2.21.4 1.5 2.11.8 1.9 1.9 2.01.80.1 1.71.5
FMN_2 #866-1151 RT: 3.2-4.2 AV: 286 NL: 2.22E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























378.3 652.94 5 2 535.1
637.0 668.9379.3 951.9243.2 913.8772.8555.0439.3 690.9 788.8756.8 892.7 973.9299. 571.0 710.8593.086.2 832.7 989.9870.7359.3285.3 316.4175.0132.2 21 .079.2
FMN_2 #865-1151 RT: -4.2 AV: 287 NL: 2.22E3
T: ITMS + c ESI Full ms [50.00-1000.00]

























518.2378.3 460.3415.2 481.3 535.1
379.3 519.1498.2 511.2489.2 536.1461.3439.3 502.2456.7 482.3417.3 471.3 527.1399.3 520.2380. 540.1 549.14 1.4414.6409.4391.4 78.6376.7 447.3431.3365.4 421.385. 464.4
FMN_2 # 53-1151 RT: 3.2-4.2 AV: 299 NL: 2.45E2
T: ITMS + c ESI Full ms [50.00-1000.00]




















231.3 245.3 255.3254.4253.2242.6 259.3241.3239.2237.2 258.32 9.3 256.5251.3232.3 236.323 .3 252.4246.3 260.4247.33 .4 249.3235.3 238.4 240.4 250.4234.4 248.3





FMN_reaction_2 #836-1133 RT: 3.0-4.0 AV: 298 NL: 2.76E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















214.1 479.2 609.0243.2 456.6158.1 377.3 521.1 592.9 765.6 912.7738.8721.6141.1 429.1 652.9 690.9 888.8281.2 782.6 812.6 858.4630.9298.4 543. 935.7215.2 967.0355.2257.299.2 399.3316.3163.1 984.285.1 198.2
FMN_reaction_2 #835-1130 RT: 3.0-4.0 AV: 296 NL: 2.76E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















510.1479.2 512.149 .2 50 .1471.3456.6377.3 521.1445.1 460.3429.1 439.3 527.0 533.2509.3415.3 51 .3 537.1481.3 543.1409.3 31 2 551.778.5399.3371.2 470.5391.3 448.2 462.3453.3380.3 401.4 421.3389.2
FMN_reaction_2 #836-1127 RT: 3.0-4.0 AV: 292 NL: 2.73E2
T: ITMS + c ESI Full ms [50.00-1000.00]





















245.3242.6 8.36 3236.2 259.233.1 237.2231.1 25 .2230.2 239.2 251.1247.1229.2 235.2 260.2249.1 253.2246.2 2 8.2 254.3234.2 240.2 241.3228.3 238.3232.2 250.2 252.2241.8
C:\Z_user_data\...\FMN_reaction_3 3/15/2011 2:14:19 PM 90_1
esiPOS_NEG
100 1.9 2.81.81.61.3 2.00.5 0.7 1.40.4 2.82.60.5 2.60.4 0.7 1.4 2.90.3 2.90.20.20.1
FMN_reaction_3 # 28-1253 RT: 3.2-4.3 AV: 326 NL: 3.57E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























534.2498.2415.3379.4 653.9536.1418.380.4 669.9638.0377.4 915.9773.8 953.909.9 692.9214.2 757.9 7 9.8538.2 593.0 729.8 894.7244.3 842.4158.1 8 3.7316.4 976.0141.1 175.199.1 360.4281.281.2
FMN_reaction_3 # 27-1256 RT: 3.2-4.3 AV: 330 NL: 3.57E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























534.2461.3 479.3 498.2415.3 518.2379.4 533.2482.3 536.1418.3 517.3 520.2380.4 499.2377.4 462.3 490.2 512.2503.2440.4 483.3 538.2419.3 528.1400.4 456.7 472.3 551.1445.230.4 448.3 542.2410.4382. 402.4 4 3.3392.4 464.3371.1 423.3
FMN_reaction_3 # 14-1245 RT: 3.2-4.3 AV: 332 NL: 1.39E2
T: ITMS + c ESI Full ms [50.00-1000.00]






















236.2 258.3257.3 259.3237.3 239.2 247.3235.1230.2 255.1 260.3228.3 229.3 240.4 253.2238.4 241.3 251.2231.2 256.4233.1 252.3250.3248.3 249.2 254.3234.4232.3 241.8
C:\Z_user_data\...\FMN_reaction_5 3/15/2011 3:08:22 PM 90_2
esiPOS_NEG
100 1.7 2.50.4 2.6
0.2
0.0
FMN_reaction_5 #924-1241 RT: 3.2-4.3 AV: 318 NL: 3.68E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























535.1519.1 655.0610.0 916.9381.4 670.9214.2 441.3 774.8377.5 953.9752.7595.0 692.9158.1 790.8245. 316.3 729.8538.1 903.5141.1 834.8 873.6 970.099.1 298.5175.1 281.281.2 343.3
FMN_reaction_5 #923-1245 RT: 3.2-4.3 AV: 323 NL: 3.68E3
T: ITMS + c ESI Full ms [50.00-1000.00]
























535.1462.3 519.1495.4 499.2491.2 513.17 .4381.4 415.4 441.3377 5 473.3 503.2 521.2419.3 463. 529.1 538.1456.7 551.1401.4 445.2 484.311 3 542.229.3393.4 433.3371.1 385.4
FMN_reaction_5 #911-1233 RT: 3.2-4.3 AV: 323 NL: 1.35E2
T: ITMS + c ESI Full ms [50.00-1000.00]






















247.3 258.3257.3236.2 242.5 259.3230.2 251.1229.2 237.2 260.3235.2 239.2233.2 255.2253.2231.1 256.3240.4 0.2241.3 249.2 252.2248.3238.2234.2232.3 254.2
C:\Z_user_data\...\FMN_reaction_7 3/15/2011 5:11:37 PM 90_4
esiPOS_NEG
50
100 2.62.40.9 2.62.42.31.51.0 1.6 1.70.7 1.4 2.31.80.9 1.00.6 0.7 1.90.6 1.9 2.1 2.32.00.3 0.3 1.41.10.5 1.20.20.10.1
FMN_reaction_7 #914-1155 RT: 3.2-4.0 AV: 242 NL: 3.54E3
T: ITMS + c ESI Full ms [50.00-1000.00]























536.1379.4 520.1419. 655.9416.5 671.9 917.9538.1214.2 640.0611.9 775.8378.5 442.3 956.9246.3 753.7 791.8693.8158. 5 5.0316.4 737.7 903.6837.3 875.814 .199.1 978.9175. 298.581.2 355.2
FMN_reaction_7 #913-1155 RT: 3.2-4.0 AV: 243 NL: 3.53E3
T: ITMS + c ESI Full ms [50.00-1000.00]























536.1379.4 483.2 492.2 520.1419.3 500.2463.3 480.4416.5 514.1457.5382.4 538.1534.3474 3378.5 530.1484.2442.3420.3 04 2402.4 552.1412.4 450.3 542.2434.3431.3394.4 465.3371.0 391.4
FMN_reaction_7 #901-1155 RT: 3.2-4.0 AV: 255 NL: 1.50E2
T: ITMS + c ESI Full ms [50.00-1000.00]























242.5 259.3236.2 260.3248.3 258.4257.3229.2 251.1237.2 239.2 255.2235.3231.1 233.2230. 249.3 256.4241.2 253.2238.5 240.3232.2 252.2234.3 250.3 254.5241.8
C:\Z_user_data\...\20110316\FMN_1 3/16/2011 11:43:09 AM 90_on
esi OS
100 1.3 1.81.61.4 1.7
0.20.1 0.2 0.4 1.30.5 0.6 1.21.10.90.7 1.00.8
FMN_1 #654-971 RT: 3.2-4.3 AV: 318 NL: 2.93E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















459.6 498.3 514.2482.4382.4 920.0709.5 957.0418.4246.4 536.3 612.1 656.0 672.1 877.0 973.1379.6 791.9769.987.3 598.1185.2 442.4 861.0269.3 807.9747.9132.3 394.4283.4 11.4 574.2175.2 335.379.3 217.2
FMN_1 #653-974 RT: 3.2-4.3 AV: 322 NL: 1.78E3
T: ITMS + c ESI Full ms [50.00-1000.00]






















514.2482.4382.4 499.3418.4 536.3515.2481.5 483.3463.4 513.3497.5492.3 500.3 520.3379.6 4 9.4 537.3474.4442.4 458.5394.4 402.4 417.5383.4 535.4412.4 530.2493.4 552.2491.4464.4 504.3436.3 542.3453.4445.4430.4378.5 421.465 5 369.5 391.4
FMN_1 #641-962 RT: 3.2-4.3 AV: 322 NL: 3.04E2
T: ITMS + c ESI Full ms [50.00-1000.00]























257.4 260.4243.4239.3 248.4241.4 244.242.5 258.4229.3 254.5251.4236.5230.3 233.4231.3 252.6235.3 256.5234.4 249 4228.3 238.3 240.4232.4 250.5
(a) 90˚C
(b) RT
0h                         1h                            2h                         4h                             20h
0h                       1h                            2h                         4h                             20h
Figure 5.5. The FMN region of the electrospray (+) mass spectra of FMN at 0, 1, 2, 4 and 20 hours 
during	the	deuteration	reaction	at	(a)	90˚C	and	(b)	room	temperature	(RT).
FmN conversion to riboflavin
In rde  to dephosphorylate FMN, Antarctic Phosph tase was used and the
reaction was monitored with thin layer chromatography (TLC). Again, because 
of the low solubility of riboflavin, it was difficult to find resolving conditions 
for both, riboflavin and FMN. For that reason, TLC was used only to estimate the 
progress of the conversion. After 3 days, the sample of the reaction looked similarly 
on TLC plate when compared to a riboflavin sample. Therefore, the hydrolysed 
sample was analysed by ESI-MS. This confirmed full conversion as only ions of m/z 





The results presented here show that specific deuteration of the C8 methyl group 
of FMN is feasible. We also showed that the deuterated FMN can be converted 
enzymatically to riboflavin. Such selectively-deuterated riboflavin is an interesting 
compound for investigating covalent flavinylation in proteins. Riboflavin can 
be used in the cells as FAD cofactor precursor. By using deuterated riboflavin 
in combination with riboflavin auxotrophic strains, such as E. coli BSV11 [31], 
it will be possible to study effects of deuteration on the efficiency of covalent 
flavinylation. Alternatively, deuterated riboflavin or FMN can be converted by 
using FAD synthetase into the FAD form. This would allow investigating the effects 
of C8 deuteration on the kinetics of covalent flavinylation.
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ABSTrACT
Putrescine oxidase (PuO) catalyses the oxidative deamination of putrescine into 
4-aminobutanal. An increase in diamine carbon chain length decreases the catalytic 
efficiency (kcat/KM) significantly. The recently elucidated PuO structure has 
shown that Glu324 seems to be important for determining the distance between 
the flavin and the binding site for the positively charged substrate amino group. 
A PuO mutant, E324D, was produced and showed similar activity for putrescine 
and cadaverine. 




Flavoprotein oxidases belong to a family of oxidases that bind FAD or FMN 
as a prosthetic group. They catalyse the two- or four-electron oxidation on a wide 
variety of substrates, such as carbohydrates, alcohols, and amines. Oxidases use 
molecular oxygen as the electron acceptor, which is reduced to hydrogen peroxide 
or water during the reaction. Consequently, they do not need expensive coenzymes 
(e.g. NAD(P)H). What is more, they usually selectively oxidize their substrate 
at a specific position, while other positions stay unchanged. These two properties 
make them ideal for biotechnological applications. For example, a fungal 
monoamine oxidase from Aspergillus niger is used as biocatalyst for the deracemization 
of secondary and tertiary amines [1,2]. Another amine oxidase, D-amino acid 
oxidase, has been applied in several biotechnological processes, like production 
of semisynthetic antibiotics and α-keto acids [3].
Amine oxidations are also important in many biological processes, such as 
lysyl oxidation in the cross-linking of collagen and degradation of polyamines and 
neurotransmitters. Flavin amine oxidases perform oxidative cleavage of the α-CH 
bond of the substrate, coupled with the reduction of FAD. An imine, the product 
of the reaction, is then hydrolysed to the corresponding ketone/aldehyde and 
ammonia. The reduced flavin cofactor reoxidizes spontaneously in the presence 
of molecular oxygen and hydrogen peroxide is formed. Most flavin-containing 
amine oxidases share several structural features. The active site is typically situated 
on the re side of the flavin ring. The substrate amine group is located between two 
aromatic rings forming an “aromatic sandwich” [4], with typical combination of 
Phe/Tyr or Tyr/Tyr, as found for monoamine oxidases and polyamine oxidase [5-7]. 
Another structural motif shared among amine and amino acid oxidases is the 
“Lys-H2O-flavin N5” element, where a water molecule acts as a bridge between 
lysine and the flavin N5 atom [4].
Putrescine oxidase from Rhodococcus erythropolis (PuO) is a recently discovered 
amine oxidase, which catalyses the oxidative deamination of putrescine into 
4-aminobutanal [8]. In addition to putrescine, activity was found with several aliphatic 
diamines (cadaverine, 1,6-hexane-diamine), amino alcohols (4-amino-1-butanol, 
L-ornithine, 2-hydroxyputrescine) and polyamines (spermidine, spermine). 
However, an increase in diamine carbon chain length from 4 to 5 C-atoms decreases 




Shorter diamines (ethylenediamine, 1,3-diaminopropane) and monoamines 
(n-butylamine, aminoethanol) were shown to be strong inhibitors of PuO. 
It has been suggested that a minimum of two amino groups, preferably in a distance 
of 4 carbons from each other, are necessary to be a good substrate for the enzyme 
[8]. The narrow substrate specificity and high selectivity for putrescine can be well 
explained by the recently elucidated structure of PuO active site (Fig. 6.1) [9].
Figure 6.1. The crystal structure of the PuO active site with a bound ligand, modelled 
as 4-aminobutanal. Oxygens are in red and nitrogens in blue. The protein carbon atoms are in green, 
FAD carbons are in yellow, whereas ligand carbon atoms are in grey.
PuO exhibits all above-mentioned structural features of amine oxidases. It has 
a bipartite cavity with approximately equal inner and outer chambers. Putrescine 
occupies the inner space, where its amino group forms H-bonds with the side 
chain of Glu324 and the carbonyl oxygen of Gly172. Together with Met173, these 
two residues make the constriction that separates the two chambers. Glu324 
seems to be important for determining the distance between the flavin and the 
binding site for the positively charged substrate amino group. That explains why 
PuO prefers diamino substrates with amino groups separated by four and five 
C-atoms. It also suggests that Glu324 PuO mutants can be generated with altered 
substrate acceptance profiles, e.g. PuO acting on longer aliphatic diamines and 
polyamines. The importance of Glu324 was previously investigated to some extent 
[8]. The amino acid was mutated into an alanine (PuO E324A) and a leucine residue 
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(PuO E324L). For both mutants the catalytic efficiency for putrescine decreased 
dramatically: 100,000 and 200,000-fold, respectively. In this study, we report on 
a PuO mutant, E324D, that shows similar activity for putrescine and cadaverine.
mATEriALS ANd mEThOdS
Oligonucleotides and horseradish peroxidase were from Sigma-Aldrich. 
PfuTurbo DNA polymerase was from Stratagene. Escherichia coli TOP10 from 
Invitrogen was used as a host for DNA manipulation and protein expression. 
All other chemicals were of analytical grade. The construct was sequenced at GATC 
Biotech (Konstanz, Germany).
The mutant was prepared using the QuikChange site-directed mutagenesis kit 
from Stratagene. pBAD-PuORh [8] was the template. The primers used for this were 
E324D_frw, 5’- GAGGTAGTGCAGGACGTGTACGACAACAC-3’; E324D_rv, 
5’- GTGTTGTCGTACACGTCCTGCACTACCTC -3’. The sites of mutation are 
underlined.
E. coli TOP10 cells containing pBAD-PuORh-E324D were tested for 
overexpression	 of	 the	 protein	 at	 17,	 30	 and	 37˚C.	The	 range	 of	 L-(+)-arabinose	
concentration was 0, 0.0002, 0.002, 0.02, 0.2 and 2% (wt/vol). Soluble and 
insoluble fractions of cell extracts were analysed by SDS-PAGE to determine the best 
conditions of soluble PuO E324D expression. E. coli TOP10 containing pBAD-PuORh-
E324D	were	cultivated	for	3	days	at	17˚C	in	1	L	terrific	broth	medium	containing	 
50 µg/mL ampicillin and 0.002% (wt/vol) L-(+)-arabinose. Protein purification 
was performed as described before using 50 mM KPi pH 8.0 as buffer [8].
Absorbance spectra were recorded in 50 mM KPi buffer pH 8.0 
on a PerkinElmer Lambda Bio40 spectrophotometer. Enzyme concentration was 
determined by measurement of absorbance at 280 nm using ε280 = 63,370 M
-1 
cm-1 (www.expasy.ch/sprot/) and recalculated for monomers containing FAD. 
FAD/ADP content in PuO E324D was assumed to be as for wild-type PuO 
[10]. Oxidase activity was measured by the use of the coupled horseradish 
peroxidase assay as described before at pH 8.0 [8] on a SynergyMx (Biotek) 






In order to change PuO specificity from putrescine toward cadaverine, 
the mutant PuO E324D was constructed, expressed and purified. The protein purity 
was confirmed by SDS-PAGE analysis. The mutant shows a typical flavoprotein 
spectrum, that resembles the one of wild-type PuO [8]. The steady-state kinetic 
parameters with putrescine and cadaverine were determined at pH 8.0 for wild-
type and mutant PuO (Table 6.1). It is clear that wild-type PuO highly prefers 
putrescine over cadaverine as a substrate. An increase in carbon length of the diamine 
from 4 to 5 C-atoms resulted in a 25-fold drop in catalytic efficiency (kcat/KM). 
The values are highly similar for the ones obtained previously in Tris buffer [8]. 
It was suggested that the preferred carbon chain length between two amine groups 
is determined by Glu324: the Glu324-flavin distance determines PuO specificity 
toward diamines and polyamines with two amine groups separated by four carbons. 
Therefore, a decrease in carbon length of the active site residue by one C-atom was 
expected to result in a change of PuO specificity toward the substrates with five 
carbons between the two amine groups (cadaverine). Our results with E324D PuO 
confirm this assumption. The mutant does not show preference for putrescine as 
it is equally active with both cadaverine and putrescine. What is more, the KM for 
cadaverine is lower, which suggests that the mutant has a higher affinity toward the 
five-carbon substrate. However, the turnover rate (kcat) of E324D PuO is lower with 
cadaverine than with putrescine, and also lower when compared to wild-type PuO 
with these substrates. This may suggest that Glu324 is somehow better positioned 
in the active centre to accommodate productive binding of diamine substrates.
Table 6.1. Steady-state kinetic parameters of wild-type and E324D PuO, measured in KPi buffer, pH 8.0.
wild-type E324D
substrate kcat [s
-1] KM [µM] kcat/KM [mM
-1 s-1] kcat [s
-1] KM [µM] kcat/KM [mM
-1 s-1]
putrescine 21.0±0.06 6.4±0.8 3300±350 4.2±0.1 55.7±3.6 75±4
cadaverine 2.8±0.03 20.9±0.9 130±4 1.6±0.01 23.8±0.4 66±1
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Before the structure of PuO was known, the presence of a negatively charged 
amino acid in the active site was already predicted for PuO from Micrococcus rubens, 
as the enzyme was irreversibly inactivated by carbodiimides [11]. The importance 
of Glu324 in PuO from Rhodococcus erythropolis was confirmed by its mutation to 
alanine and leucine [8]. The respective single PuO mutants, E324A and E324L, 
were shown to be poorly active with putrescine. Their catalytic efficiency at pH 9.0 
drops from 5900 mM-1 s-1 for wild-type PuO to 0.05 mM-1 s-1 and 0.03 mM-1 s-1 
for E324A and E324L PuO, respectively. The most significant is the increase in KM 
value for more than 30,000-fold for both mutants, when compared to wild-type 
enzyme. Together with our results on the E324D PuO mutant, it fully confirms 
the significance of a carefully positioned negative charge in active site. When the 
charge is retained but positioned more distant from the flavin cofactor, the enzyme 
still shows significant activity with putrescine and cadaverine. Nevertheless it loses 
the ability to discriminate between these two diamines. When the negative charge 
is removed (e.g. E324A PuO), a dramatic loss of activity is observed. A BLAST 
search in the available sequence databases of NCBI reveals 17 putrescine oxidases 
or probable putrescine oxidases and all of them have glutamate at the same position 
as PuO from Rhodococcus erythropolis. Other more distant homologs seem to have 
rather a hydrophobic corresponding residue. It suggests that the glutamate is 
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ABSTrACT
Putrescine oxidase from Rhodococcus erythropolis (PuO) is a flavin-containing amine 
oxidase from the monoamine oxidase family that performs oxidative deamination 
of aliphatic diamines. In this study we report pre-steady-state kinetic analyses of the 
enzyme with the use of single- and double-mixing stopped-flow spectroscopy and 
putrescine as a substrate. During the fast and irreversible reductive-half reaction no 
radical intermediates were observed, suggesting a direct hydride transfer from the 
substrate to the FAD. The rate of flavin reoxidation depends on the ligand binding; 
when the product was bound to the enzyme the rate was higher than with free 
enzyme species. Similar results were obtained with product-mimicking ligands 
and this indicates that a ternary complex is formed during catalysis. The obtained 
kinetic data were used together with steady-state rate equations derived for ping-
pong, ternary complex and bifurcated mechanisms to explore which mechanism 
is operative. The integrated analysis revealed that PuO employs a bifurcated 
mechanism due to comparable rates of product release from the reduced enzyme 
and reoxidation of the reduced enzyme-product complex.




Redox enzymes catalyse the electron transfer from one substrate to another and 
generally make use of an enzyme-bound cofactor. Most of the oxidoreductases 
employ organic cofactors such as flavins. These enzymes are referred to as flavin-
containing oxidoreductases and include oxidases, dehydrogenases, reductases and 
monooxygenases. Flavoprotein oxidases catalyse two-electron oxidations of a wide 
variety of substrates, including alcohols and amines. They use molecular oxygen 
as an electron acceptor, which is typically reduced to hydrogen peroxide. 
This feature makes flavin-containing oxidases interesting biocatalysts, because they 
do not require an expensive coenzyme (e.g. NAD(P)H). It is also worth noting that 
the reactions catalysed by flavin-containing enzymes do not always share mechanistic 
pathways, which distinguish them from enzymes using other cofactors [1].
Amine oxidases are enzymes that oxidize carbon-nitrogen bonds, mostly 
in amino acids as well as primary and secondary amines. Single C-N bond oxidation 
leads to the formation of a double bond, which is usually followed by hydrolysis and 
the loss of ammonium from primary amines or the cleavage of secondary amines. 
Amine oxidases can be classified based on the chemical identity used for catalysis, 
namely copper/quinone or a flavin cofactor. Most of the flavin-containing amine 
oxidases can be divided into two structural families: the monoamine oxidase (MAO) 
and D-amino acid oxidase (DAAO) families. The MAO family consists of MAO A and 
B [2,3], L-amino acid oxidases (LAAO) [4,5], spermine and polyamine oxidases 
[6,7], histone lysine demethylase LSD1 [8,9] and putrescine oxidase (PuO) [10,11]. 
The DAAO family contains DAAO [12] and enzymes oxidizing glycine or 
N-methylated-amino acids [13-17]. Amine oxidations play many important roles in 
nature, for example in neurotransmission [18], cell growth and differentiation [19] 
and neoplastic cell proliferation [20,21], as well as in biocatalytic applications [22,23].
Although the mechanistic features of the copper/quinone-containing 
oxidases are reasonably well understood [24-26], the debate on flavin-containing 
amine oxidations still continues. From the many mechanisms proposed over the 
years, three have gained the greatest support: (i) the concerted polar nucleophilic 
mechanism [27-29], (ii) the direct hydride transfer mechanism [30,31] and (iii) 
the single electron transfer mechanism [30,32]. This broad spectrum of possible 
mechanisms originates from the ability of the flavin to accept one or two electrons 




equivalent is transferred from the substrate to the flavin, they all lead to the 
oxidized substrate and the reduced flavin, and therefore are called reductive-half 
reactions. In order to close the catalytic cycle the flavin has to transfer electrons 
to an electron acceptor. This happens in an oxidative-half reaction and oxidases use 
molecular oxygen as the electron acceptor. Reoxidation of the flavin can take place 
both before or after the product is released, following a ternary complex or ping-
pong mechanism, respectively (Fig. 7.1). Changes in the redox state of the enzyme 
can be followed by monitoring the flavin absorbance spectra, because oxidized 
FAD strongly absorbs light at wavelengths around 360 and 450 nm, in contrast to 
the reduced form of the flavin which shows no absorption at these wavelengths.
Figure 7.1. Common kinetic mechanisms of flavoprotein oxidases. The upper cycle represents 
a ping-pong mechanism and the lower cycle a ternary complex mechanism. EFlOX = oxidized form 
of enzyme, EFlRED = reduced form of enzyme, S = substrate, P = product.
Putrescine oxidase from Rhodococcus erythropolis (PuO) belongs to the MAO 
family of flavin-containing amine oxidases [10] and it catalyses the oxidation 
of putrescine as well as several other aliphatic diamines, amino alcohols 
and polyamines. Putrescine is by far the best substrate with a kcat of 26.4 s
-1 and a KM 
of 8.2 µM.  The narrow substrate specificity and strong preference for putrescine can 
be explained by the recently elucidated crystal structure of PuO [11]. The enzyme 
has a closed bipartite cavity for substrate binding, with Glu324 determining the 
distance between the positively charged amine group of the substrate and the second 
amine group close to the flavin. PuO also shares all the characteristic features of 
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MAO-type oxidases such as an aromatic sandwich, a conserved pattern of interactions 
with the cofactor and a distorted nonplanar flavin [11,33-35]. Because biogenic amines 
are derived from free amino acids, PuO and other amine oxidases can be used for their 
detection in spoiled food [36,37] and in blood as a cancer marker [38].
So far, the kinetic mechanism of PuO has not been established. Here, we 
present a detailed kinetic analysis of PuO using both single- and double-mixing 
stopped-flow spectrophotometry. The results provide insight into the amine 
oxidation performed by PuO and the importance of product and/or ligand binding 
for the rate of the reoxidation of the protein-bound FAD.
mATEriALS ANd mEThOdS
Chemicals
Escherichia coli TOP10 from Invitrogen was used as a host for DNA 
manipulation and protein expression. All other chemicals were of analytical grade.
Expression and purification
Expression and purification of PuO was performed according to literature 
procedures [10].
Stopped-flow experiments
Pre-steady-state experiments were performed on an Applied Photophysics 
stopped-flow apparatus model SX20. Spectral data were collected at time 
intervals of 1.2 ms using a photo-diode array (PDA) detector and deconvoluted 
with the Pro-K software of Applied Photophysics. From this data, the wavelength 
of 450 nm was selected to follow traces in time with the use of the photomultiplier 
(PM) detector. All solutions were made anaerobic by flushing with nitrogen 
for at least 10 min. The anaerobic preparations of PuO were used for transient kinetic 
analyses and putrescine was used as a substrate. All experiments were performed in 
a	50	mM	KPi	buffer	pH	8.0	at	25	˚C.	All	data	presented	in	this	work	is	an	average	




In all cases the terms reductive and oxidative half-reaction relate to the flavin 
redox state. In the reductive half-reaction measurements, the concentrations 
of PuO in the quartz cell were approximately 5 µM and were at least a 5-fold lower 
than the varying concentrations of putrescine. Equal volumes of anaerobic PuO and 
putrescine were rapidly mixed in the stopped-flow device and spectral changes were 
monitored for 1 s using the PDA detector for global analysis and the PM detector 
at 450 nm to calculate the observed rates. In order to study the oxidative half-
reaction, PuO was anaerobically reduced with 1.2-1.6 equivalents of putrescine 
and incubated for different delay times in sequential mixing stopped-flow aging 
chamber. Subsequently, the reduced PuO was mixed with air saturated buffer and 
spectral changes were monitored using a PDA detector. The reoxidation of PuO 
in the presence of 1 mM ligands, as well as in the absence of ligands, was also 
measured in a single mixing stopped-flow. Traces obtained by PM measurements 
were fitted to a single exponential (Eq. 7.1) or double exponential (Eq. 7.2) function, 
where A(t) represents the absorbance change in time, t is the time in seconds, kobs, 
kobs,1 and kobs,2 are the observed rate constants for the singular or the first and second 
kinetic event, respectively, A and B are corresponding amplitudes and C is the final 
observed value for the absorbance. The observed rates for substrate concentration 
dependent reduction of PuO were fitted using Equation 7.3. The observed rates for 
aging time dependent PuO reoxidation were fitted using Equation 7.4, where t is 
delay time in aging chamber and a, b and kobs,1 are constants.
(Eq. 7.1)
(Eq. 7.2)
   (Eq. 7.3)
    (Eq. 7.4)
Enzyme monitored turnover (EMT) experiments were performed by 
aerobically mixing equal volumes of approximately 10 µM PuO in KPi buffer and 







Pre-steady-state experiments were performed on an Applied Photophysics stopped-flow 
apparatus model SX20. Spectral data were collected at time intervals of 1.2 ms using a photo-diode 
array (PDA) detector and deconvoluted with the Pro-K software of Applied Photophysics. From this 
data, the wavelength of 450nm was selected to follow traces in time with the use of the 
photomultiplier (PM) detector. All solutions were made anaerobic by flushing with nitrogen for at 
least 10 min. The anaerobic preparations of PuO were used for transient kinetic analyses and 
putrescine was used as a substrate. All experiments were performed in a 50 mM KPi buffer pH 8.0 at 
25 ˚C. All data presented in this work is an average value from a minimum of 3-12 measurements. 
In all cases the terms reductive and oxidative half-reaction relate to the flavin redox state. In 
the reductive half-reaction measurements, the concentrations of PuO in the quartz cell were 
approximately 5 µM and were at least a 5-fold lower than the varying concentrations of putrescine. 
Equal volumes of anaerobic PuO and putrescine were rapidly mixed in the stopped-flow device and 
spectral changes were monitored for 1 s using the PDA detector for global analysis and the PM 
detector at 450 nm to calculate the observed rates. In order to study the oxidative half-reaction, PuO 
was anaerobically reduced with 1.2-1.6 equivalents of putrescine and incubated for different delay 
times in sequential mixing stopped-flow aging chamber. Subsequently, the reduced PuO was mixed 
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From the kinetic scheme proposed in Figure 7.1, equations for the change 
in concentration of each enzyme species were derived for the ping-pong, 
ternary complex and bifurcated mechanisms. Under steady-state conditions the 
concentration of each species remains constant and therefore all equations equal 
zero. The equations were solved using the MuPAD Symbolic Math Toolbox add-on 
for MATLAB 5.9.0 software for non-trivial solution. The obtained concentrations 
of the enzyme species were used in the steady-state rate equation in the form 
of a Michaelis-Menten equation (Eq. 7.5), ping-pong (Eq. 7.6), ternary complex 
(Eq. 7.7) and bifurcated mechanism (Eq. 7.8), where ER, EOX, EOXS, ERP and EOXP 
correspond to enzyme-flavin redox state in Figure 7.1.
     (Eq. 7.5)
 (Eq. 7.6)
 (Eq. 7.7)
  (Eq. 7.8)
From these rate equations, the kinetic parameters KM and kcat can be derived 
and the redox state of the flavin in steady-state conditions can be calculated:
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Absorbance spectra were recorded in a 50 mM KPi pH 8.0 buffer at 25 ˚C on a PerkinElmer 
Lambda Bio40 spectrophotometer. Enzyme concentrations were determined by measurement of the 
absorbance at 280 nm using ɛ280 = 63370 M-1cm-1 (http://www.expasy.ch/sprot/) and recalculated for 
monomers containing FAD [11]. The oxidase activity was measured with the use of a horseradish 




The reductive half-reaction 
 
In order to determine the kinetics of flavin reduction in PuO (Scheme 7.1) single mixing 
stopped-flow spectrophotometry was used. Initially the reductive half-reaction was monitored with a 
photodiode array (PDA) upon mixing PuO with varying concentrations of putrescine in the absence of 
oxygen. Deconvolution of the collected spectra revealed that the spectrum of oxidized flavin rapidly 
changed into a spectrum that resembles a fully reduced flavin species and no radical flavin 
intermediates were observed. Thus, if any flavin radical intermediate was formed during the PuO-
catalysed oxidation, its concentration was too low to allow spectral detection. The fast flavin 
reduction is followed by a slow phase which is associated with a significantly smaller absorbance 
change. For more accurate determination of the rates of these two kinetic events, the reductive half-
reactions were also monitored with a photomultiplier (PM) detector set at 450 nm. The collected 
traces could be fitted with a double exponential equation (Eq. 7.2). The first phase, the rate of 
reduction, was dependent on the substrate concentration. This indicates that the binding of 
putrescine is a relatively fast step, because it is complete within the dead time of the stopped-flow 
instrument (approx. 1 ms). Fitting the observed reduction rates at different putrescine 
concentrations (Fig. 7.2) could be performed with Equation 7.3, which indicates that flavin reduction 
is an irreversible process. From the data the rate of reduction (kred) and Kd could be determined: kred = 
252 ± 8 s-1 and Kd = 82 ± 16 µM. The second phase observed during the reductive half-reaction is 
much slower (5 s-1) and appears to be independent of the substrate concentration. This has also been 
observed for other flavoprotein oxidases where a relatively slow kinetic event follows the flavin 
reduction. This second phase usually involves only marginal spectral changes and it is often 
suggested to represent product release and/or a conformational change [39,40]. The observed rates 
of this slow event (5 s-1) are relatively low compared to the kcat (26.4 s-1), indicating that this event 
cannot be a major contributor to the kinetic mechanism of PuO. 
100 (Eq. 7.1 )
Analytical methods
Absorbance	 spectra	were	 recorded	 in	 a	50	mM	KPi	pH	8.0	buffer	 at	 25	 ˚C	on	
a PerkinElmer Lambda Bio40 spectrophotometer. Enzyme concentrations were 
determined by measurement of the absorbance at 280 nm using ε280 = 63,370 M
-1cm-1 
(http://www.expasy.ch/sprot/) and recalculated for monomers containing FAD 
[11]. The oxidase activity was measured with the use of a horseradish peroxidase 
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From the kinetic scheme proposed in Figure 7.1, equations for the change in concentration of 
each enzyme species were derived for the ping-pong, ternary complex and bifurcated mechanisms. 
Under steady-state conditions the concentration of each species remains constant and therefore all 
equations equal zero. The equations were solved using the MuPAD Symbolic Math Toolbox add-on 
for MATLAB 5.9.0 software for non-trivial solution. The obtained concentrations of the enzyme 
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Absorbance spectra were recorded in a 50 mM KPi pH 8.0 buffer at 25 ˚C on a PerkinElmer 
Lambda Bio40 spectrophotometer. Enzyme concentrations were determined by measurement of the 
absorbance at 280 nm using ɛ280 = 63370 M-1cm-1 (http://w w.expasy.ch/sprot/) and recalculated for 
monomers containing FAD [11]. The oxidase activity was measured with the use of a horseradish 




The reductive half-reaction 
 
In order to determine the kinetics of flavin reduction in PuO (Scheme 7.1) single mixing 
stopped-flow spectrophotometry was used. Initially the reductive half-reaction was monitored with a 
photodiode array (PDA) upon mixing PuO with varying concentrations of putrescine in the absence of 
oxygen. Deconvolution of the collected spectra revealed that the spectrum of oxidized flavin rapidly 
changed into a spectrum that resembles a fully reduced flavin species and no radical flavin 
intermediates were observed. Thus, if any flavin radical intermediate was formed during the PuO-
catalysed oxidation, its concentration was too low to allow spectral detection. The fast flavin 
reduction is followed by a slow phase hich is associated with a significantly smaller absorbance 
change. For more accurate determination of the rates of these two kinetic events, the reductive half-
reactions were also monitored with a photomultiplier (PM) detector set at 450 nm. The collected 
traces could be fitted with a double exponential equation (Eq. 7.2). The first phase, the rate of 
reduction, was dependent on the substrate concentration. This indicates that the binding of 
putrescine is a relatively fast step, because it is complete within the dead time of the stopped-flow 
instrument (approx. 1 ms). Fitting the observed reduction rates at different putrescine 
concentrations (Fig. 7.2) could be performed with Equation 7.3, which indicates that flavin reduction 
is an irreversible process. From the data the rate of reduction (kred) and Kd could be determined: kred = 
252 ± 8 s-1 and Kd = 82 ± 16 µM. The second phase observed uring the reductive half-reaction is 
much slower (5 s-1) and appears to be independent of the substrate concentration. This has also been 
observed for other flavoprotein oxidases where a relatively slow kinetic event follows the flavin 
reduction. This second phase usually involves only marginal spectral changes and it is often 
suggested to represent product release and/or a confor ational change [39,40]. The observed rates 
of this slow event (5 s-1) are relatively low compared to the kcat (26.4 s-1), indicating that this event 
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oxygen. Deconvolution of the collected spectra revealed that the spectrum of oxidized flavin rapidly 
changed into a spectrum that resembles a fully reduced flavin species and no radical flavin 
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reduction is followed by a slow phase which is associated with a significantly smaller absorbance 
change. For more accurate determination of the rates of these two kinetic events, the reductive half-
reactions were also monitored with a photomultiplier (PM) detector set at 450 nm. The collected 
traces could be fitted with a double exponential equation (Eq. 7.2). The first phase, the rate of 
reduction, was dependent on the substrate concentration. This indicates that the binding of 
putrescine is a relatively fast step, because it is complete within the dead time of the stopped-flow 
instrument (approx. 1 ms). Fitting the observed reduction rates at different putrescine 
concentrations (Fig. 7.2) could be performed with Equation 7.3, which indicates that flavin reduction 
is an irreversible process. From the data the rate of reduction (kred) and Kd could be determined: kred = 
252 ± 8 s-1 and Kd = 82 ± 16 µM. The second phase observed during the reductive half-reaction is 
much slower (5 s-1) and appears to be independent of the substrate concentration. This has also been 
observed for other flavoprotein oxidases where a relatively slow kinetic event follows the flavin 
reduction. This second phase usually involves only marginal spectral changes and it is often 
suggested to represent product release and/or a conformational change [39,40]. The observed rates 
of this slow event (5 s-1) are relatively low compared to the kcat (26.4 s-1), indicating that this event 
cannot be a major contributor to the kinetic mechanism of PuO. 





In order to determine the kinetics of flavin reduction in PuO (Scheme 7.1) single 
mixing stopped-flow spectrophotometry was used. Initially the reductive half-
reaction was monitored with a photodiode array (PDA) upon mixing PuO with 
varying concentrations of putrescine in the absence of oxygen. Deconvolution of 
the collected spectra revealed that the spectrum of oxidized flavin rapidly changed 
into a spectrum that resembles a fully reduced flavin species and no radical flavin 
intermediates were observed. Thus, if any flavin radical intermediate was formed 
during the PuO-catalysed oxidation, its concentration was too low to allow spectral 
detection. The fast flavin reduction is followed by a slow phase which is associated 
with a significantly smaller absorbance change. For more accurate determination 
of the rates of these two kinetic events, the reductive half-reactions were also 
monitored with a photomultiplier (PM) detector set at 450 nm. The collected 
traces could be fitted with a double exponential equation (Eq. 7.2). The first phase, 
the rate of reduction, was dependent on the substrate concentration. This indicates 
that the binding of putrescine is a relatively fast step, because it is complete within 
the dead time of the stopped-flow instrument (approx. 1 ms). Fitting the observed 
reduction rates at different putrescine concentrations (Fig. 7.2) could be performed 
with Equation 7.3, which indicates that flavin reduction is an irreversible process. 
From the data the rate of reduction (kred) and Kd could be determined: kred = 252 ± 8 s
-1 
and Kd = 82 ± 16 µM. The second phase observed during the reductive half-
reaction is much slower (5 s-1) and appears to be independent of the substrate 
concentration. This has also been observed for other flavoprotein oxidases where 
a relatively slow kinetic event follows the flavin reduction. This second phase usually 
involves only marginal spectral changes and it is often suggested to represent 
product release and/or a conformational change [39,40]. The observed rates 
of this slow event (5 s-1) are relatively low compared to the kcat (26.4 s
-1), indicating 
that this event cannot be a major contributor to the kinetic mechanism of PuO.
Scheme 7.1. Proposed model for the reductive half-reaction of PuO. EFlOX represents the oxidized 


















Figure 7.2. Observed rates for the first phase of the reductive half-reaction plotted against the 
putrescine concentration. The data was fitted with a simple hyperbolic function (Eq. 3). Error bars 
represent standard errors from at least 8 measurements.
The oxidative half-reaction
Single mixing stopped-flow spectrophotometry was also used to determine 
the kinetics of the reoxidation of reduced PuO. In order to analyse the reaction 
of reduced free enzyme (not in complex with the product) with molecular 
oxygen (Scheme 7.2), PuO was first anaerobically reduced with 1.2 equivalents 
of putrescine. The sample was incubated for at least 5 min to assure full flavin 
reduction and release of the product from the enzyme, after which it was mixed 
with air saturated buffer and spectra were obtained with the PDA detector. 
From the analysis of these experiments, the enzyme reoxidation turned out to be 
a single event and no intermediates (e.g. flavin semiquinone) were observed and 
the reaction was further analysed with the PM detector at 450 nm. The obtained 
absorbance traces were fitted with Equation 7.1. The observed first-order rate 
constant for the reaction with oxygen in air saturated buffer when mixed in a 1:1 
ratio with anaerobic enzyme/product solution was 6.6 ± 0.5 s-1 (Table 7.1).
Scheme 7.2. The proposed model for the oxidative half-reaction of reduced free PuO species. 
EFlRED represents the reduced form and EFlOX oxidized form of PuO.
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Table 7.1. The rate of reoxidation of reduced PuO with or without a ligand bound to the active 
site. Anaerobic reduced enzyme/ligand solutions were mixed in 1:1 ratio with O2-containg buffer.
ligand kox [s
-1]
– – 6.6 ± 0.5




n-butylamine [1.0 mM] b NH2 15.8 ± 0.3
4-amino-1-butanol [1.0 mM] b HO
NH2 15.3 ± 0.3
a , these rates were measured by using the double-mixing stopped-flow mode, see Fig. 7.4.
b , a final concentration of 1.0 mM was used for these ligands.
In order to determine the reoxidation rate of the reduced enzyme-product 
complex (EFlREDP), the enzyme is usually pre-incubated with the product before 
it is reduced. However, in case of PuO this approach was not possible because 
the unstable imine product rapidly reacts with water, as it has been shown 
for the opposite reaction of aldehyde and ammonia to give imine and water. 
The reaction is thermodynamically difficult unless water is removed. For that reason, 
sequential stopped-flow was used, where PuO was first mixed with 1.6 equivalents 
of putrescine in an aging chamber in the absence of oxygen to form the reduced 
complex. The solution was further mixed with an air saturated buffer after 
different delay times, ranging from 0.05 s to 10 s. From the determined reduction 
rates it could be estimated that the shortest delay time was still sufficient for full 
enzyme reduction (>99%) before mixing with oxygen. The spectral changes were 




could be observed. Yet, depending on the aging time, one or two phases in flavin 
reoxidation were observed upon deconvolution of the spectra. For the short aging 
times (0.05 to 4.0 s), two phases could be distinguished, while for the longer 
aging times (5.0 to 10 s) only one phase was found (Fig. 7.3). The observed rates 
of oxidation at these long aging times were approximately 5 s-1. At the shorter aging 
times, the rate of the first phase depended on the delay time in the aging chamber and 
when relatively short times were used a higher rate was found. When the observed 
rates were plotted as a function of the delay time, the data could be fitted with 
a single exponential decay equation (Eq. 7.4, Fig. 7.4). Because the measurements 
at different delay times represent oxidation of the reduced enzyme at different levels 
of occupation with the product or decayed product, the reoxidation rates for the reduced 
enzyme (Scheme 7.2) and the reduced enzyme-product complex (Scheme 7.3) 
could be obtained from the single exponential decay fit of the observed rate 
of reoxidation. At a long delay time the product is released from the active site, 
while the rates at a short delay time resemble reoxidation of the product bound to 
the reduced enzyme. After fitting the data, the rate of reoxidation of the product 
bound to the reduced enzyme (EFlREDP) could be extrapolated (30.9 s
-1) and 
the rate of reoxidation of the reduced free enzyme (EFlRED) (5.3 s
-1) could be derived 
(Fig. 7.4). The observed rate of the slow second phase varied between 1-3 s-1 and 
was independent of the delay time in the aging chamber. Such a slow observed rate 
is considered too low to be of significant catalytic relevance. From these rates, the 
observed bimolecular rates of kox1 = 4.3 x 10
4 M-1 s-1 and kox2 = 2.5 x 10
5 M-1 s-1 
could be calculated. These values are in the typical range found for oxidases [41] 
and they suggest that EFlREDP reacts significantly faster with molecular oxygen 
when compared with EFlRED. 



















Figure 7.3. Deconvoluted absorption spectra of reduced (A), intermediate (B) and oxidized 
(C) PuO during reoxidation by molecular oxygen as measured by double-mixing stopped-flow 
spectrophotometry, after a delay time of 4.0 s.
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Figure 7.4. Observed rates for the first phase of the oxidative half-reaction plotted against the delay 
time in the aging chamber in double-mixing stopped-flow mode. Data points represent averages 
from at least 3 measurements and the error bars are standard errors. The data could be fitted with 
a single exponential equation (Eq.7.4) yielding a rate at t=0 (30.9 ± 2.3 s-1),	a	rate	at	t=∞	(5.3	±	




Scheme 7.3. The proposed model for the oxidative half-reaction of the reduced PuO species 
occupied with product. EFlRED represents the reduced form and EFlOX oxidized form of PuO.
To further confirm the observation that PuO is more readily reoxidized when 
the active site is occupied with a ligand (Scheme 7.3), the substrate-reduced enzyme 
was incubated for 5 min with an excess of product-mimicking ligand before mixing 
with dioxygen. This would assure that the enzyme is reduced and complexed with 
a putrescine-like product analogue before monitoring the rate of reoxidation 
by molecular oxygen. n-Butylamine, a strong competitive PuO inhibitor (KI = 120 µM), 
and 4-amino-1-butanol (a poor substrate) [10] were used as PuO ligands. 
The measured reoxidation rates were significantly higher than the rate of the 
reduced free enzyme (Table 7.1). This confirms that ligand binding in PuO indeed 
increases the rate of reoxidation. These results seem to further support the claim 
that PuO may preferentially follow a ternary complex mechanism.
Enzyme monitored turnover
Stopped-flow spectrophotometry can also be used to monitor the redox state 
of the flavin cofactor during steady-state turnover. The extent of flavin reduction 
under steady-state conditions depends on the relative rates of the reductive and 
oxidative half-reactions. Figure 7.5 shows the time course for the redox state 
of the flavin in PuO when mixed with an excess of putrescine. Because the reduction 
rate is very high, a large part of the flavin is already reduced within the dead-time 
of the measurement. The subsequently observed steady-state phase is relatively 
short due to the high kcat of PuO. However, the steady-state phase is clearly 
visible and it was estimated from 7 measurements that 23 % of the flavin was 
in the oxidized form during this phase. After that, the flavin was slowly reduced 
to the fully reduced state due to the depletion of molecular oxygen.
















Figure 7.5. Redox state of the flavin in PuO during turnover of putrescine. The reaction was 
measured at 5.0 µM PuO, 1.0 mM putrescine and 250 µM O2 and it was monitored at 450 nm. 
The absorbance of fully oxidized PuO was determined by measuring the absorbance of the enzyme 
at the same concentration, mixed without substrate. For the sake of clarity, time is presented on 
a logarithmic scale.
mechanistic calculations
The kinetic measurements above showed that the rate of PuO reoxidation is 
significantly higher for the enzyme-product species, suggesting that the enzyme 
follows a ternary complex mechanism. However, the free enzyme species is also 
oxidized at an appreciable rate and therefore a ping-pong mechanism may also be 
(partially) operative during steady-state turnover. In order to address this possibility, 
we derived the equations for the steady-state kinetic parameters and the redox state 
of the flavin during the steady-state turnover for both mechanisms, as well as for the 
bifurcated mechanism (Equations 7.9-7.17). Unfortunately, we could not measure 
the rates of product release directly, because it was impossible to observe the 
kinetic event in the pre-steady-state experiments. However, they can be calculated 
from the experimentally determined kinetic parameters [10] and cofactor redox 
state (this work). We obtained different values for each of the three mechanisms, 
suggesting that neither the ping-pong nor the ternary complex mechanism is valid 




release rates for the bifurcated mechanism were k3 = 13 s
-1 and k4 = 181 s
-1. 
With these rates and all determined individual pre-steady-state rates constants, 
the steady-state kinetic parameters and flavin redox state could be quite 
accurately predicted using the equations derived for a bifurcated mechanism 
(Eq. 7.15-7.17 and Table 7.2). When using the product release rates determined 
for the bifurcated mechanism in the derived equations for the individual 
mechanisms, significantly less accurate predictions of the respective steady-
state parameters were obtained (Table 7.2). Clearly the obtained kinetic data fit 
best with an enzyme that operates via a mixed bifurcated mechanism in which 
both pathways, namely ping-pong and the ternary complex mechanism, play 
a significant role. This is due to the fact that the rate of product release from 
the reduced enzyme is in the same range as the rate of reoxidation of the product-
bound enzyme complex. One should note that these conclusions are only valid 
for conditions at atmospheric oxygen concentrations and with either lower or higher 
oxygen concentrations, the contribution of each individual type of mechanism will 
change. In the 1970s the possibility of a mixed mechanism for flavoprotein oxidases 
was already postulated [42], but remained unsubstantiated until recently when this 
mechanism was confirmed for human spermine oxidase [39].
Table 7.2. Determined and calculated kinetic parameters for PuO. The calculated values were 
obtained from the kinetic constants in Fig. 7.1 and the corresponding Equations 7.9-7.17. 
The values were calculated for k3 = 13 s
-1 and k4 = 181 s
-1 obtained from the equation 
for the bifurcated mechanism. The numbers for the redox state represent the percentage of PuO 
in the oxidized state during the steady-state turnover.
Experimental
Calculated
Ping-pong Ternary complex Bifurcated
kcat [s
-1] 26.4 ± 0.5[10] 5.7 38.9 26.2
KM [µM] 8.2 ± 0.5[10] 1.9 12.7 14.7
Redox state [%] 23 ± 1.5 2.5 37.8 23.1




The purpose of the current study was to determine the mechanistic properties 
of putrescine oxidase, a flavin-containing amine oxidase from the MAO 
family. Members of this flavoprotein oxidase family often display a low level 
of sequence identity, but their structures are homologous and the flavin binding 
site is conserved. However, there has been no agreement on the mechanism which 
amine-oxidizing enzymes follow and a few pathways were proposed for different 
enzymes (see reviews: [43-48]). Recently, the direct hydride transfer mechanism 
has gained support, which came mostly from computational studies on lysine-
specific demethylase 1 (LSD1) and MAO B [49,50]. Furthermore, the other 
mechanisms involve the formation of enzyme intermediates with distinct spectral 
properties and should be detectable in stopped-flow studies. Detection of such 
intermediates failed for many MAO enzymes [46], including our study on PuO. 
We have not observed any intermediates in the reductive half-reaction that could 
hint to alternative mechanisms of amine oxidation. The rate of flavin reduction 
in PuO is significantly higher than the kcat, indicating that the cleavage of the amine 
substrate CH bond is not a rate-limiting step, as in the case of MAO A [51,52], 
MAO B [53] and LSD1 [54].
It is known that flavin reoxidation rates in flavoenzymes often strongly depend 
on whether the active site of the enzyme is occupied by a ligand. For example, 
reduced DAAO and MAO are oxidized approximately ten times faster when 
a product is bound [55,56]. In the case of PuO we observed the same effect. 
The double-mixing stopped-flow spectrophotometry experiments have clearly 
shown that the reoxidation of reduced PuO is faster when the product is still bound 
in the active site, yielding a bimolecular rate constant of 2.5 x 105 M-1 s-1. This is one 
order of magnitude higher than for the reduced free enzyme species. It has been 
suggested that a proper electrostatic environment in front of the C4a-N5 locus 
of the flavin can enhance the formation of radical species intermediates [41,57-60]. 
For DAAO and MAO, the positively charged imine moiety of the bound product 
is in direct contact with the C4a locus of the FAD [2,11,61]. This might stabilize 
the canonical form of the reduced flavin with the highest electron density 
at the C4a locus, which in turn can help in electron transfer to molecular oxygen 
[61]. The faster reoxidation rate of product-bound PuO compared to reoxidation 




However, increased reoxidation rates were also observed with the other ligands, 
n-butylamine and 4-amino-1-butanol. In their case no positive charge is introduced 
close to the C4a-N5 locus of the flavin. Yet, the rates were approximately half of the one 
measured with the product, suggesting that the charge might be not the only 
factor influencing the reactivity with oxygen. Another determinant for oxygen 
reactivity may be the oxygen accessibility of the flavin. It has been shown 
for other flavoproteins that dioxygen molecules diffuse into the active site via 
specific (transient) tunnels [62]. Similarly, ligand binding in PuO may contribute to 
the accessibility for molecular oxygen to reach the reduced flavin [41,62].
The reoxidation rates measured for PuO suggest that the enzyme preferentially 
follows a ternary complex mechanism. However, when taking all kinetic 
parameters into account, it is clear that at atmospheric conditions PuO operates 
via a bifurcated mechanism to which both a ping-pong mechanism and ternary 
complex mechanism contribute. Such an indecisive mechanism has recently also 
been found for human spermine oxidase and therefore may be a common feature 
for amine oxidases. However, one should realize that the contribution of each 
mechanism strongly depends on the available oxygen concentration. At high oxygen 
concentrations PuO will mostly follow the ternary complex mechanism, while 
the ping-pong mechanism becomes more dominant for decreasing O2 concentrations. 
Our calculations have shown that the affinity for putrescine is higher in the ping-
pong mechanism. There is precedence for this theory, because the actinomycete 
R. erythropolis resides in soil and water environments where the oxygen concentration 
is relatively low and this might be the reason for the preservation of a less efficient 
ping-pong mechanism. Whether such an oxygen-dependent switch in the kinetic 
mechanism is of physiological relevance remains to be established.
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ABSTrACT
A bacterial flavin-containing monooxygenase (FMO), fused to phosphite 
dehydrogenase, has been used to explore its biocatalytic potential. The bifunctional 
biocatalyst could be expressed in high amounts in Escherichia coli and was able 
to oxidize indole and indole derivatives into a variety of indigo compounds. 
The monooxygenase also performs the sulfoxidation of a wide range of prochiral 





Flavin containing monooxygenases (FMO) (E.C. 1.14.13.8) represent single-
component flavoprotein monooxygenases that contain a tightly bound FAD cofactor 
[1]. In their catalytic cycle, the flavin cofactor is reduced by NADPH after which 
it reacts with molecular oxygen to form a hydroperoxyflavin intermediate [2–5]. 
This reactive enzyme species is able to perform oxygenation of heteroatom-
containing compounds that are able to reach its active site. In humans, five FMO 
isoforms are present that show a tissue-specific distribution (see some recent 
examples:[6–8]). The role of these oxidative enzymes is thought to be similar to 
that of most human cytochrome P450 monooxygenases: detoxification of drugs and 
other xenobiotics into more hydrophilic metabolites [9,10]. The crucial detoxifying role 
of human FMOs becomes apparent when considering trimethylaminuria, also known as 
fish-odour syndrome. This metabolic disorder is caused by mutations in human FMO3 
and results in accumulation of trimethylamine, causing a “fish odour” [11].
Most of the known FMOs have been shown to be membrane-associated, 
prohibiting facile isolation. As a result, FMOs have rarely been studied for 
biocatalytic purposes (see for example: [12–14]). Some years ago the first bacterial 
FMO, mFMO from Methylophaga sp. Strain SK1, was reported which was shown 
to be a soluble enzyme that could be overexpressed in E. coli [15]. In fact, inspection 
of sequenced bacterial genomes with the aid of an FMO-specific sequence motif 
has revealed a large number of genes that putatively encode soluble FMOs [16]. 
Therefore it is attractive to start exploring this class of monooxygenases.
Little biocatalytic data on mFMO have been reported. mFMO is a homodimer 
with subunits of 54 kDa, showing around 30% sequence identity with the five 
human FMOs [15]. mFMO was shown to be able to convert endogenous indole 
in E. coli cells and this capacity has been optimized to form up to 920 mg indigo 
blue per litre of fermentation broth [17]. It was also shown that the bacterial 
enzyme is able to convert similar substrates when compared with human FMOs, 
e.g. trimethylamine and (S)-(-)-nicotine are efficiently oxidized by mFMO.
Recently we have described the preparation of selfsufficient monooxygenases 
by covalent coupling of Baeyer–Villiger monooxygenases (BVMOs) with the soluble 
NADPH regenerating phosphite dehydrogenase (PTDH) from Pseudomonas stutzeri 
[18]. These bifunctional biocatalysts are able to use phosphite as a cheap and sacrificial 




bifunctional biocatalysts has been developed using a codon-optimized gene encoding 
a His-tagged and thermostable PTDH mutant as a fusion partner [19].
For this exploratory biocatalytic study on mFMO, we have used this newly 
developed expression vector. The produced selfsufficient mFMO was explored 
for the preparation of chiral sulfoxides, target molecules with a high interest due 
to their biological properties and widespread applications in organic synthesis 
[20–23]. Furthermore, we looked into the applicability of mFMO for the preparation 
of indigo derivatives, valuable as dyes or precursors for pharmaceuticals [24,25], 
which have been targeted before with other monooxygenases with varying degrees 
of success (see for example: [26–29]).
ExpErimENTAL
Recombinant PTDH-mFMO was overexpressed and purified following the 
previously described procedure [18]. 1.0 Unit of PTDH-mFMO will oxidize 
1.0 µmol of thioanisole to methyl phenyl sulfoxide per minute at pH 9.0 and 
room temperature in the presence of NADPH. Starting prochiral sulfides 1a, 
6a, 8a were purchased from Sigma–Aldrich–Fluka, 2–5a, 7a, 9–10a, 11a, 16a, 
17a, 19a, 20a and 21a were supplied by Alfa Aesar, 13a, 22a, 23a and 24a were 
obtained from Acros Organics and compound 25a was a product by TCI Europe. 
All the starting indoles were products from Sigma-Aldrich-Fluka, with the 
exception of 4-chloroindole, which was purchased from AcrosOrganics. 
All other reagents and solvents were of the highest quality grade available.
Chemical reactions were monitored by analytical thin layer chromatography 
(TLC), performed on silica gel 60 F254 plates and visualized by UV irradiation. Flash 
chromatography was carried out with silica gel 60 (230–240 mesh). Kinetic parameters 
were measured in a Varian Cary50BioUV/Vis spectrophotometer. Melting points 
were taken on samples in open capillary tubes and are uncorrected. IR spectra were 
recorded on infrared spectrophotometer using KBr pellets. 1H-NMR, 13C-NMR and 
DEPT spectra were recorded with tetramethylsilane (TMS) as the internal standard 
with aDPX (1H: 300.13 MHz; 13C: 75.5MHz) spectrometer. The chemical shift 
values (δ) are given in ppm. Optical rotations were measured using a polarimeter and 
are quoted in units of 10-1 deg cm2 g-1. APCI+ and ESI+ using a chromatograph mass 
detector or EI+ with a mass spectrometer were used to record mass spectra (MS). 




Methyl phenylethyl sulfide 15a was synthesized by treating at 0 °C 
the corresponding thiol with sodium and methyl iodide in dry MeOH, under 
a nitrogen atmosphere (40% yield) [30]. 2- (Methylthio)pyridine 18a was prepared 
by reaction of the corresponding thiol and potassium carbonate with iodomethane and 
triethylamine in CH2Cl2 at 0 °C (99% yield) [31]. p-Acetoxyphenyl methyl sulfide 2c 
was obtained from 2a by acetylation in presence of acetic anhydride and pyridine (90% 
yield). Racemic sulfoxides (±)-1–15b, (±)-18–21b and (±)-23–24b were prepared 
by chemical oxidation of the corresponding sulfides employing hydrogen peroxide and 
methanol (yields higher than 60%). All the synthesised compounds 15a [32], 18a [31], 
1b [30], 2b [33], 3–7b [30], 8b [34], 9–15b [30], 18b [35], 19b [36], 20b [37], 21b [35], 
23b [38], 24b [35] exhibited physical and spectral data in agreement with those reported.
Absolute configurations of sulfoxides 1b [30], 3–7b [30], 9–15b [30], 18b 
[39], 19b [40], 20b [39], 21b [36] were determined by comparison of elution 
order on HPLC with published data, meanwhile the absolute configurations 
of sulfoxide 2b and 8b were established by comparing the retention times on HPLC 
for acetylated 2b and 8b with the ones obtained in the asymmetric sulfoxidations 
of prochiral sulfides 2c and 8a employing (+)-diethyl L-tartrate, Ti(O-i-Pr)4 and 
TBHP. 21 The absolute configuration of compound 23b was obtained by comparing 
the specific rotation value with published data [41], while absolute configuration 
of butyl ethyl sulfoxide 24b was established by analogy with this latest one.
general procedure for the oxidation of indole and derivatives 
employing pTdh-mFmO
A plate with 24 wells was employed. A solution of the corresponding starting 
indoles (5.0 mM) was dissolved in Tris-HCl buffer 50 mM, 35 mM NaCl, 
pH 8.5 containing sodium phosphite (10 mM), NADPH (0.2 mM) and self-
sufficient biocatalyst PTDH-mFMO (4 mM). Reactions were stirred at 25 °C for 
18 h and products formation was observed colorimetrically.
general procedure for the pTdh-mFmO biocatalysed sulfoxidations
Unless otherwise stated, prochiral sulfides 1–25a (5 mM) were dissolved in 




(10 mM), NADPH (0.2 mM) and the self-sufficient biocatalyst PTDH-mFMO 
(4 mM). Reactions were stirred at 25 °C and 250 rpm for the times established. 
Reactions were then stopped, extracted with EtOAc (2 x 0.5 mL), dried onto 
MgSO4 and analysed by GC and/or HPLC in order to determine the conversions and 
the enantiomeric excesses of the sulfoxides (R)- or (S)-1–25b. Control reactions 
in absence of biocatalyst were performed and did not result in any conversion.
rESuLTS ANd diSCuSSiON
The fused PTDH-mFMO could be readily expressed as soluble and bifunctional 
enzyme at high levels. By a one-step purification, 102 mg of pure and soluble 
PTDH-mFMO could be obtained from 1.0 L of culture broth. The bifunctional 
biocatalyst was tested for activity at several temperatures with trimethylamine. 
This revealed that the optimal temperature for activity is 70 °C. However, at this 
temperature the enzyme is quickly inactivated with a total loss of activity after 
2 min. Analysis of the thermostability at 35 °C revealed a half-life of 5 h for mFMO, 
without affecting the activity of PTDH. For further experiments, it was decided 
to perform conversions at 25 °C. It was also established that the enzyme was most 
effective at pH 9.0 (see Supporting Information).
It is known that mFMO is able to form indigo blue from indole [15]. This was 
also clearly visible when growing cells for PTDH-mFMO overproduction: the growth 
medium turned dark blue. To establish whether mFMO can also be used for synthesis 
of other indigo derivatives, isolated PTDH-mFMO was incubated with a range of 
indole derivatives. Visual inspection revealed that all tested indoles were accepted 
as substrate as evidenced by formation of a variety of colours (Fig. 8.1). By steady-
state kinetic analysis the reaction rates for all indole derivatives were determined 
(see Supporting Information). Indole was found to be converted most efficiently.
As mFMO has been shown to convert indoles, a set of substituted aromatic 
sulfides was tested as substrates. Most of the tested sulfides were shown to be 
oxidized and exhibited quite good KM values, ranging from 100 to 600 mM, 
while the kcat values were only modest: ~0.5 s
-1 (see Supporting Information). 
PTDH-mFMO was subsequently assayed for enantioselective oxidation 
of thioanisole derivatives (Table 8.1). Reactions were performed in Tris-HCl 
buffer which contained 1% DMSO in order to dissolve the sulfides. In most cases, 








General procedure for the PTDH-mFMO biocatalysed sulfoxidations 
 
Unless otherwise stated, prochiral sulfides 1–25a (5 mM) were dissolved in a 50 mMTris-HCl 
buffer pH 9.0 (1.0 mL) containing 1% DMSO, sodium phosphite (10 mM), NADPH (0.2 mM) and the 
self-sufficient biocatalyst PTDH-mFMO (4 mM). Reactions were stirred at 25 °C and 250 rpm for the 
times established. Reactions were then stopped, extracted with EtOAc (2 x 0.5 mL), dried onto 
MgSO4 and analyzed by GC and/or HPLC in order to determine the conversions and the enantiomeric 
excesses of the sulfoxides (R)- or (S)-1–25b. Control reactions in absence of biocatalyst were 
performed and did not result in any conversion. 
 
RESULTS AND DISCUSSION 
 
The fused PTDH-mFMO could be readily expressed as soluble and bifunctional enzyme at 
high levels. By a one-step purification, 102 mg of pure and soluble PTDH-mFMO could be obtained 
from 1.0 L of culture broth. The bifunctional biocatalyst was tested for activity at several 
temperatures with trimethylamine. This revealed that the optimal temperature for activity is 70 °C. 
However, at this temperature the enzyme is quickly inactivated with a total loss of activity after 2 
min. Analysis of the thermostability at 35 °C revealed a half-life of 5 h for mFMO, without affecting 
the activity of PTDH. For further experiments, it was decided to perform conversions at 25 °C. It was 
also established that the enzyme was most effective at pH 9.0 (see Supporting Information). 
It is known that mFMOis able to form indigo blue from indole [15]. This was also clearly visible when 
growing cells for PTDH-mFMO overproduction: the growth medium turned dark blue. To establish 
whether mFMO can also be used for synthesis of other indigo derivatives, isolated PTDH-mFMO was 
incubated with a range of indole derivatives. Visual inspection revealed that all tested indoles were 
accepted as substrate as evidenced by formation of a variety of colors (Fig. 8.1). By steady-state 
kinetic analysis the reaction rates for all indole derivatives were determined (see Supporting 






Figure 8.1. PTDH-mFMO catalyzed oxidation of indole and indole derivatives into indigoid dyes. 
4-Cl 5-Cl 6-Cl 7-Cl 5-Br 
5-NO2 5-OH 5-Me 2-Me 5-OMe 
Figure 8.1. PTDH-mFMO catalysed oxidation of indole and indole derivatives into indigoid dyes.
Table 8.1. Sulfoxidation of thioanisole derivatives catalysed by the fused PTDH-mFMO biocatalyst.[a]
S
X
PTDH-mFMO / Tris-HCl pH 9.0
Phosphite / NADPH




1-10a (R)- or (S)-1-10b
Sulfide X time [h] c [%][b] e.e. [%][c]
1a H 8 95 35 (S)
2a p-OH 15 37 81 (S)
3a p-OMe 15 78 70 (S)
4a p-Me 15 66 92 (S)
5a p-Cl 15 80 95 (S)
6a m-Cl 15 69 15 (R)
7a o-Cl 15 81 75 (R)
8a p-COMe 15 8 21 (R)
9a p-CN 15 50 22 (S)
10a p-NO2 15 47 37 (S)
[a] For reaction details, see Experimental Section.
[b] Determined by GC.




The most effective conversion was found with thioanisole 1a, yielding 95% 
of (S)-methyl phenyl sulfoxide 1b after 8 h, albeit with a moderate enantiomeric 
excess (e.e. = 35%). Substituents in the aromatic ring decreased the enzymatic 
activity. PTDH-mFMO was able to oxidize methyl p-tolyl sulfide (4a) and 
p-chlorophenyl methyl sulfide (5a) into the corresponding sulfoxides (S)-4–5b 
with high enantiomeric excesses (e.e. >90%). Good enantioselectivities were also 
obtained in the oxidation of the p-hydroxy (2a), p-methoxy (3a) and o-chloro 
(7a) derivatives, while the chlorosubstitution in the meta-position (6a) as well as 
the presence of electron-withdrawing groups (8–10a) had a negative effect 
on the selectivity of the formed sulfoxide.
As well as oxidation of thioanisole derivatives, some other aromatic sulfides 
were also tested. As indicated in Table 8.2, the oxidation of phenyl ethyl sulfide 
(11a) and its propyl analogue (12a) led to a significant loss in conversion when 
compared to thioanisole, but the corresponding (S)-sulfoxides can be obtained 
with much better enantiomeric excess (e.e. = 79%). (S)-Benzyl methyl sulfoxide 
(S)-13b and the ethyl derivative 14b were formed with excellent or good 
conversions, respectively, while the biocatalyst showed a poor enantioselectivity 
for these compounds. When the sulfur atom was further away from the phenyl 
moiety (15a) a good enzymatic activity and moderate enantioselectivity was 
observed. No oxidation was achieved for those sulfides presenting one (methyl 
naphthyl sulfide, 16a) or two bulky substituents (benzyl phenyl sulfide, 17a). 
PTDH-mFMO has also been tested in the synthesis of heteroaromatic chiral 
sulfoxides, important chiral auxiliaries in asymmetric catalysis. Methyl 2-pyridyl 
sulfide, 2-furfurylmethyl methyl sulfide and 2-(methylthio)thiophene were 
converted into the corresponding sulfoxides with high conversions (around 80%). 
(S)-18b and (S)-20b were obtained with moderate enantiomeric excess, while 
the formation of (R)-l9b occurred with a low selectivity.
As mFMO has been shown to be active on aliphatic amines, PTDH-mFMO 
was also tested with several aliphatic sulfides. This has revealed that it displays 
a relatively low activity and selectivity for the oxidation of cycloalkyl alkyl 
sulfides (21a). Sulfoxidation of tetrahydro-2H-thiopyran (22a) did not take place, 
even after long reaction times. Finally, we focused on the biooxidation of linear 
aliphatic sulfides. It was found that alkyl butyl sulfides 23a and 24a were oxidized 
with moderate conversion and good enantiomeric excesses in order to obtain 




sulfide structure had a negative effect on the reactivity, as no reaction was observed 
in the oxidation of n-octyl methyl sulfide 25a.
Table 8.2. PTDH-mFMO catalysed synthesis of chiral sulfoxides starting from 
the corresponding sulfide.[a]
Sulfide Sulfoxide t [h] c [%][b] e.e. [%][c]
11a S
O
15 15 79 (S)
12a S
O
24 12 71 (S)
13a SO 8 91 17 (S)
14a SO 8 75 15 (S)
15a S
O









O 15 72 20 (R)
20a S S O 15 76 50 (S)
21a S
O
15 14 20 (R)
23a SO 15 52 85 (R)
24a SO 15 71 77 (R)
[a] For reaction details, see Experimental Section.
[b] Determined by GC.




PTDH-mFMO was also tested in the oxidation of racemic sulfoxides. 
Incubating racemic methyl phenyl sulfoxide (±)-1b with this biocatalyst led to 
a moderate conversion, with only 8% of the final sulfone while 1b remained 
racemic. No sulfoxide oxidation was observed for compounds (±)-4b, (±)-5b and 
(±)-7b after long reaction times.
The close homology of FMOs and BVMOs [1] inspired us to test substrates 
that are readily oxidized by the latter type of enzymes. However, after long reaction 
times, no product formation was observed in the presence of different ketones 
(2-octanone, cyclohexanone and acetophenone) or phenylboronic acid.
In a previous report, the influence of the organic cosolvents on the oxidation 
of prochiral sulfides catalysed by BVMOs has been described [42]. Short alkyl 
chain alcohols as cosolvents were shown to result in an increase or even a reversal 
in enantioselectivity for some BVMOs. To probe this effect on mFMO, oxidation 
of 1a was performed in the presence of several organic cosolvents (5% v/v) 
with different physico-chemical properties. All the cosolvents tested led to 
lower conversions and/or enantiomeric excesses (see Supporting Information), 
with the exception of the reaction in 5% hexane. For this cosolvent, (S)-1b was 
recovered with a 48% e.e. and 62% extent, while 28% of methyl phenyl sulfone 
1c was formed. Sulfoxidation with a combination of 1% DMSO and 5% hexane 
occurred only with 24% conversion and 34% e.e. for (S)-1b. From the data 
it becomes clear that 5% hexane has an activating effect on the oxidation of the 
sulfoxide 1b, while the presence of DMSO in the reaction medium inhibits 
sulfoxide oxidation, as can be shown in the experiments developed by employing 
PTDH-mFMO in the biooxidation of (±)-1b (entries 6–8, Table 8.3). Thus, the 
increase in the enantiomeric excess observed when working in 5% hexane is due 
to the desymmetrization of prochiral 1a combined with the kinetic resolution of 
1b. n-Hexane presents a somewhat similar structure to 1-octylamine, which has 
been described as a specific activator in human FMOs (see for example: [43,44]). 
The presence of 3 mM of this additive led to a higher conversion while it did not 




Table 8.3. Effect of cosolvent  in the sulfoxidation of 1a.[a]
Entry Sulf. Cosolvent c [%][b] e.e. (S)-1b [%][c]
1 1a None 48 (2) 33
2 1a 1% DMSO 95 (5) 35
3 1a 5% Hexane 1% DMSO 90 (28) 48
4 1a 5% Hexane 24 34
5 1a 3 mM OctNH2 76 (7) 27
6 (±)-1b 1% DMSO 8 5
7 (±)-1b 5% Hexane 61 72
8 (±)-1b 5% Hexane 1% DMSO 9 5
[a] Reaction time: 8 h. For other reaction details, see Experimental Section.
[b] Determined by GC. In brackets, the amount of sulfone formed.
In order to show that this bifunctional enzyme can be used as an effective 
biocatalyst, we set up a semipreparative experiment, in which sulfide 5a was used 
as model substrate. Sulfoxidation was performed by incubating 100 mg of prochiral 
5a in the presence of PTDH-mFMO (4.0 mM), sodium phosphite as cosubstrate, 
NADPH (0.2 mM) and dioxygen as oxidant. After 24 h, (S)-5b was achieved with 
a 90% conversion and 95% enantiomeric excess. The sulfoxide product was isolated 
by column chromatography, to afford 77% isolated yield.
CONCLuSiONS
A novel fused oxidative biocatalyst has been overexpressed in E. coli, isolated and 
purified. PTDH-mFMO was found to be able to oxidize indole and analogues into 
the corresponding indigoid pigments which represent interesting dyes and bioactive 
compounds. The bifunctional dehydrogenase-FMO system has been applied for the 
first time in the biocatalysed sulfoxidation of prochiral sulfides. Depending on the 
substrate structure, excellent enantioselectivities can be achieved. The data show 
that bacterial FMOs represent an unexplored and interesting class of oxidative 
biocatalysts which may be of use for synthetic purposes. The availability of the 







Asymmetric oxidation of sulfide 8a employing the Kagan methodology [45]
Ti(O-i-Pr)4 (10 mmoles) and (R,R)-DET (+)-diethyl L-tartrate (20 mmoles) were 
dissolved at room temperature in 50 mL of CH2Cl2 under nitrogen atmosphere. 
Distilled water (5 mmoles) was then added dropwise. Stirring was maintained 
until the yellow solution formed became homogeneous and sulfide 8a was 
added (5 mmoles). The resulting mixture was cooled to – 20 °C and a 5.5 M 
TBHP (tert-butyl hydroperoxide) solution in decane (5.5 mmoles) was added. 
After four hours, additional water was added dropwise (50 mmoles). A strong 
stirring was maintained for 1 hour at – 20 °C and then for one additional hour 
at room temperature. The gel obtained was filtrated and washed with CH2Cl2 (10 mL). 
The filtrate was kept in the presence of a mixture of NaOH (5%) in brine (30 mL) 
for 1 hour and then extracted with CH2Cl2 (3×20 mL). The organic phase was 
dried over Na2SO4 and concentrated to give the crude product, which was purified 
by flash chromatography using a mixture of CH2Cl2/MeOH (95:5) as eluent 
in order to give 4-acetylphenyl methyl sulfoxide (R)-8b.
(R)-4-acetylphenyl methyl sulfoxide, (R)-8b: Yield 40% (344 mg). 
[α]D
25= +90.2 (c 1.0, acetone), e.e. = 87%.
Asymmetric oxidation of sulfide 2a employing the Kagan methodology
p-Hydroxyphenyl methyl sulfide 2a was acylated with acetic anhydride and 
pyridine in order to obtain p-acetoxyphenyl methyl sulfide 2c (90% yield). 
This substrate was oxidised by the methodology previously described except for 
an acidification step with HCl 1.0 M before the extraction with CH2Cl2, obtaining 
(R)- p-acetoxyphenyl methyl sulfoxide in 16% yield and e.e. = 30% after purification 
by flash chromatography using a mixture of CH2Cl2 / MeOH (95:5) as eluent.
p-Acetoxyphenyl methyl sulfide (2c). (90% yield). White solid. 
Mp: 43-44 °C IR (KBr): ν 2924, 1760, 1489, 1370, 1202, 739 cm-1. 1H-NMR 
(300.13 MHz, CDCl3, 25 °C): δ 2.21 (s, 3H), 2.39 (s, 3H), 6.97 (d, 
3JH,H 6.8 Hz, 
2H), 7.21 (d, 3JH,H 6.8 Hz, 2H). 
13C-NMR (75.5 MHz, CDCl3, 25 °C): δ 15.6 




(CO). (EI+, m/z): 182 (M+, 41%), 140 (100), 125 (44), 96 (13), 43 (33). HRMS 
(ESI+): calcd. for C9H10NaO2S (M+Na)
+: 205.0295; found: 205.0294.
Biocatalysed sulfoxidation of thioanisole at different pHs
Thioanisole (1a) (5 mM) was dissolved in a Tris-HCl 50 mM buffer (pH from 6.0 
to 10.0) containing sodium phosphite (10 mM), NADPH (0.2 mM) and the self-
sufficient biocatalyst PTDH-mFMO (4 µM). Reactions were stirred at 25 °C and 
250 rpm for 8 h. Crude mixtures were then stopped, extracted with EtOAc  
(2 x 0.5 mL), dried onto MgSO4 and analysed by GC and HPLC in order to 
determine the conversions and the optical purities of (S)-1b, as shown in Figure S8.1. 
Control reactions in absence of biocatalyst were performed for all substrates, not 






















Figure S8.1. Effect of pH in the conversion (●) and in the enantiomeric excess (■) for the 
PTDH-mFMO biocatalysed oxidation of thioanisole 1a. The values represent an average of at least 
3 measurements with standard errors less than 5%.
Biocatalysed sulfoxidation of thioanisole in presence of organic cosolvents
Thioanisole (1a) (5 mM) was dissolved in a Tris-HCl 50 mM buffer pH 9.0 containing 
a 5% v/v of organic cosolvent (1.0 mL), sodium phosphite (10 mM), NADPH 




stirred at 25 °C and 250 rpm for 8 h. Crude mixtures were then stopped, extracted 
with EtOAc (2 x 0.5 mL), dried onto MgSO4 and analysed by GC and HPLC 
in order to determine the conversions and the optical purities of (S)-1b. 
Control reactions in absence of biocatalyst were performed for all substrates, 
not observing formation of the final products.
PTDH-mFMO catalysed oxidation of racemic sulfoxides (±)-1b, (±)-4-5b and (±)-7b
Sulfoxides (±)-1b, (±)-4-5b or (±)-7b (5 mM) were dissolved in a Tris-HCl buffer 
pH 9.0 containing 1% DMSO and the organic cosolvent when stated (final volume 
1.0 mL), sodium phosphite (10 mM), NADPH (0.2 mM) and the self-sufficient 
biocatalyst PTDH-mFMO (4 µM). Reactions were stirred at 25 °C and 250 rpm 
for the times established. Reactions were then stopped, extracted with EtOAc 
(2 x 0.5 mL), dried onto MgSO4 and analysed by GC and/or HPLC in order 
to determine the conversions and the optical purities of the remaining sulfoxides. 
Control reactions in absence of biocatalyst were performed for all substrates, 
not observing formation of the final products.
Table S8.1. Effect of organic cosolvents in the biocatalysed oxidation of thioanisole employing 
PTDH-mFMO.
Entry Cosolvent c [%][a] e.e. [%][b]
1 None 48 33
2 1% DMSO 95 35
3 5% DMSO 21 29
4 5% DMF 22 29
5 5% MeOH 45 18
6 5% 1,4-dioxane ≤	3 n.d.
7 5% iPrOH 22 18
8 5% tBuOMe 12 15
9 5% Toluene 9 26
10 5% 2-octanol 45 36
[a] Measured by GC. [b] Determined by HPLC. n.d. not determined
Kinetic data
PTDH-mFMO concentration were measured photometrically by monitoring 
the absorption of the FAD-cofactor at 450 nm (ε450 = 11.3 mM
-1 cm-1) after treating 





The enzymatic activity of PTDH-mFMO for the oxidation of indole and its derivatives, 
trimethylamine, sulfides 1a, 3a, 5a, 9a, 13a, 21a and 24a, coenzymes NADPH 
and NADP+ and sodium phosphite were determined spectrophotometrically 
by monitoring NADPH consumption or formation at 340 nm (ε340 = 6.22 mM
-1cm-1).
Stock solutions of sulfides 1a, 3a, 5a, 9a, 13a, 21a and 24a (250 mM) and indoles 
(1.0 M) were made in 1,4-dioxane meanwhile 10 mM NADP+, NADPH, sodium 
phosphite and trimethylamine (500 mM) stock solutions were prepared in Tris-HCl 
(50 mM, 35 mM NaCl, pH 8.5) buffer. A reaction mixture (1.0 mL) usually contained 
Tris-HCl (25 mM, 35 mM NaCl, pH 9.0 for the sulfides and pH 8.5 for indoles, 
trimethylamine, NADPH and NADP+), 100 µM NADPH, 1% v/v 1,4-dioxane for 
the measurements of the sulfides and indoles, and 0.17-1.00 µM PTDH-mFMO.
Table S8.2. Steady-state kinetic parameters for PTDH-mFMO.
Compound KM [µM] kcat [s
-1] kcat/KM [M
-1s-1]
NADP+ 19±3 6.3±0.11 330,000
NADPH 11±1 5.0±0.03 460,000
Sodium phosphite 1600±25 3.6±0.02 2,200
Trimethylamine 8±1 4.7±0.10 590,000
Thioanisole 170±8 0.45±0.01 2,600
4-Chlorothioanisole 87±6 0.25±0.02 2,900
4-Methoxythioanisole 220±15 0.23±0.01 1,000
4-Cyanothioanisole 590±10 0.29±0.01 490
Benzyl methyl sulfide 470±12 0.34±0.01 720
Cyclohexyl methyl sulfide 350±13 0.19±0.01 540


















a For all compounds, standard deviations (average 4 measures) were below ±5.0%.
Table S8.4. Determination of conversion values and enantiomeric excesses by GC.
Substrate Program[a] Column tR [min] sulfides tR [min] sulfoxides
1a 70/10/190 B 3.2 5.9
2a 100/5/3/200 B 8.6 19.6
3a 70/10/190 B 6.1 9.3
4a 70/0/10/190 B 4.5 7.4
5a 70/0/10/190 B 5.5 8.2
6a 70/0/10/190 B 5.5 7.4
7a 70/0/10/190 B 5.5 5.5
8a 100/5/3/130 B 12.6 19.4
9a 70/0/10/190 B 7.4 9.4
10a 70/0/10/190 B 8.9 10.6
11a 70/0/10/190 B 3.8 7.1
12a 70/0/10/190 B 4.7 8.2
13a 70/0/10/190 B 4.1 7.6
14a 70/0/10/190 B 4.4 7.7
15a 70/5/3/150 B 12.7 24.5
18a 70/5/3/200 B 5.4 12.9
19a 70/0/10/190 B 2.4 5.2
20a 70/5/3/130 B 8.7 16.6
21a 70/5/3/150 B 4.6 16.4
23a 50/5/3/200 A 12.2 31.4 (S), 31.8 (R)
24a 50/5/3/200 A 14.2 33.1(S), 35.4 (R)




gC and hpLC Analyses
The following columns were used for the determination of conversions and 
enantiomeric excesses of the sulfoxides by GC: A: Restek RT-BetaDEXse 
(30 m x 0.25 mm x 0.25 µm, 12 psi N2) and B: Hewlett Packard HP-1 
(30m x 0.32 mm x 0.25µm, 12.2 psi N2).
For the determination of the enantiomeric excesses of the sulfoxides by HPLC, 
the following columns were employed: column A: Chiralcel OB-H (0.46 cm x 25 cm), 
column B: Chiralcel OD (0.46 cm x 25 cm), column C: Chiralpak IA (0.46 cm x 25 cm), 
column D: Chiralcel OD-H (0.46 x 25 cm) and column E: Chiralcel OJ-H 
(0.45 cm x 25 cm), all of them are from Daicel.
Table S8.5. Determination of enantiomeric excesses by HPLC.
Substrate Column Flow rate [mL min-1] T [ºC] Eluent
[a] Retention time 
[min]
1b B 0.8 25 n-hexane-IPA 9:1 13.6 (R); 16.8 (S)
2b[b] C 0.7 20 n-hexane-EtOH 95:5[c] 38.7 (R); 39.9 (S)
3b D 1.0 25 n-hexane-IPA 9:1 15.2 (R); 17.1 (S)
4b A 0.5 20 n-hexane-IPA 9:1 20.6 (R); 22.9 (S)
5b A 0.5 20 n-hexane-IPA 8:2 18.5 (S); 28.3 (R)
6b A 0.8 30 n-hexane-IPA 8:2 10.8 (R); 14.6 (S)
7b A 0.5 20 n-hexane-IPA 8:2 17.2 (S); 29.6(R)
8b E 0.7 30 n-hexane-EtOH 8:2 21.9 (S); 23.5 (R)
9b C 1.0 30 n-hexane-IPA 8:2 20.7 (R); 23.0 (S)
10b A 1.0 25 n-hexane-IPA 8:2 39.1 (S); 50.0 (R)
11b B 0.5 20 n-hexane-IPA 9:1 18.1 (R); 22.2 (S)
12b A 1.0 25 n-hexane-IPA 8:2 13.5 (S); 16.7 (R)
13b B 0.8 25 n-hexane-IPA 9:1 18.3 (R); 19.8 (S)
14b B 1.0 25 n-hexane-IPA 9:1 17.7 (R); 19.1 (S)
15b A 1.0 25 n-hexane-IPA 8:2 40.2 (S); 42.7 (R)
18b A 1.0 25 n-hexane-IPA 9:1 16.6 (S); 29.8 (R)
19b A 1.0 25 n-hexane-IPA 8:2 12.6 (S); 14.3 (R)
20b A 0.5 25 n-hexane-IPA 92:8 21.4 (S); 26.5 (R)
21b A 0.7 25 n-hexane-IPA 8:2 8.1 (R); 9.7 (S)
[a] Experiments were performed with isocratic eluent. [b] Compound 2b was derivatised into the 
corresponding acetate, compound 2c. [c] Starting flow 95:5 n-hexane-EtOH, increased polarity 
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Enzymology is a very large and interdisciplinary research field with strong interplay 
between topics such as protein chemistry, physiology, cell and molecular biology, 
synthetic and analytical chemistry, biochemistry, bioinformatics, structural 
biophysics, statistics and probably many more. The unique catalytic properties 
of an enzyme, like its specificity, selectivity, rate of chemical reaction and regulation, 
arise from its physiological role it plays in the respective living organism. Therefore, 
enzymes have been the subject of intense research in order to unveil their functions 
in metabolism and their shortcomings leading to different diseases. Having said 
that, enzymes are a very common target in medicine and pharmaceutical industry 
research. What is interesting to note, they have been used since ancient times 
for the production of wine, cheese and bread through the use of yeast. At the 
end of the 20th century enzymology entered a new era of protein engineering. 
This was due to a spectacular development in determining protein structures, gene 
manipulation and sequencing, as well as in computing power and software that 
can predict the impact of mutations introduced to an enzyme. This also opened 
the road to enzyme design for industrial purposes and nowadays many enzymes 
have been successfully applied and still a lot of research effort is spent on further 
development in this field. This thesis was intended to study the structure, activity 
and mechanism of several enzymes belonging to an oxidoreductases family. They all 
depend on a flavin cofactor which plays a pivotal role in the reactions they catalyse.
An overview of chemical reactions catalysed by cofactor containing enzymes 
is presented in Chapter 2. Cofactors have been acquired by enzymes in order to 
broaden their catalytical scope and are mostly exploited by oxidoreductases, the class 
of enzymes performing redox reactions. Selective enzymatic redox reactions are 
especially interesting for industrial processes, because they are not easily accessible 
by conventional chemical approaches. Furthermore, the capabilities of cofactor 
containing enzymes can be extended by the redesign of natural cofactors or by the 
design of new cofactor types. Such efforts will benefit from the well-developed 
methods of protein scaffold engineering to accept and tightly bind modified or new 
ligands. This field of enzyme engineering, which combines protein engineering and 
cofactor redesign, is highly valuable because it may generate totally new biocatalysts.
In this thesis, two different approaches of cofactor engineering have 




scaffold performed on two different model enzymes, putrescine oxidase (PuO) 
and 6-hydroxy-D-nicotine oxidase (6HDNO). For the first design, described 
in Chapter 3, PuO from Rhodococcus erythropolis was chosen, because it is a soluble 
homodimeric protein that binds flavin adenine dinucleotide (FAD) tightly, but 
in a non-covalent manner. The crystal structure elucidated by our collaborators 
in Pavia, Italy, revealed that PuO shows the structural features characteristic 
for other amine oxidases, in particular for the sequence-related human monoamine 
oxidases A and B. Surprisingly, this also includes the conservation of the flavin-binding 
site, although PuO binds the flavin non-covalently, in contrast to the monoamine 
oxidases. One of the mysteries regarding PuO is the competitive binding of ADP 
versus FAD in about half of wild-type monomers, which renders such monomer 
inactive. Based on the crystal structure, the residues that are responsible for this 
feature were identified. By replacing one of these residues, enzyme preparations 
were obtained in almost 100% FAD-bound form. Moreover, a triple mutant has 
been designed and prepared that formed a covalent 8α-S-cysteinyl-FAD linkage, 
similarly to monoamine oxidases.
Bicovalent flavoproteins are a recently discovered group of interesting enzymes, 
not only because of their unusual cofactor binding mode, but also because of their 
open active sites and bulky substrates they can accept. In Chapter 4 we presented 
a sequence alignment of bicovalent flavoproteins, in which we have identified 
a conserved sequence region that is different from monocovalent flavoproteins. 
On this basis, the second model enzyme for covalent flavin-protein bond engineering 
was chosen: 6-hydroxy-D-nicotine oxidase (6HDNO). 6HDNO is a monocovalent 
flavoenzyme for which a crystal structure is available. In order to introduce 
a second cofactor-protein linkage, two amino acid replacements have been designed. 
The introduced cysteine forms a covalent bond with FAD as found in natural 
bicovalent flavoproteins, while the second mutation was found to be essential to 
facilitate formation of the cysteinyl linkage. The introduced histidine is supposed to 
stabilize a negative charge of the isoalloxazine ring during the process of covalent 
bond formation. The bicovalent 6HDNO mutant was found to be still active and 
showed a higher midpoint redox potential when compared with wild-type 6HDNO. 
This was expected, because the previous studies on bicovalent flavoenzymes have 
shown that they have extremely high redox potentials. It also confirmed that 
covalent flavinylation is typically a self-catalytic process. The successful introduction 




this protein engineering approach could be also considered in case of flavoproteins 
that loose flavin easily, rendering them inactive, like for example glucose oxidase. 
Furthermore, it could be utilized to develop more stable protein molecules, better 
suited for biocatalytic purposes.
The abovementioned approach of covalent flavin-protein bond engineering 
was based on the idea of linking the protein scaffold with the FAD naturally present 
in the enzyme. On the other hand, a lot of information can be obtained by using 
chemically modified flavins and reconstituting them into the flavin binding site 
in the studied flavoprotein. In Chapter 5 the method for a specific deuteration 
of the C8 methyl group of FMN is presented. Furthermore the deuterated FMN 
can be converted enzymatically to riboflavin, which can be used in the cells as FAD 
cofactor precursor. The deuterated riboflavin used in combination with riboflavin 
auxotrophic strains would be an interesting approach to study effects of deuteration 
on the efficiency of covalent flavinylation. Furthermore, deuterated FMN can be 
converted by FAD synthetase into FAD, which would allow investigating the effects 
of C8 deuteration on the kinetics of covalent flavinylation directly with proteins 
purified or prepared as apo protein.
In addition to flavin-protein interaction engineering, also an investigation 
of the substrate specificity and catalytic properties of PuO is described. 
The elucidated structure of the enzyme (Chapter 3) explained the strong 
preference for aliphatic diamines by PuO. A glutamate residue present in the active 
site of PuO seems to be important for determining the distance between the flavin 
and the binding site for the positively charged substrate amino group, which is 
4 carbon chain length as in putrescine. Previous studies have shown the importance 
of the glutamate for the activity of PuO by substitution to hydrophobic residues. 
In Chapter 6, we report on a PuO mutant, in which the charge is retained but 
positioned more distant from the flavin cofactor (glutamate-aspartate replacement). 
The enzyme still shows significant activity with putrescine and cadaverine, but it loses 
the ability to discriminate between these two diamines and for both substrates similar 
catalytic efficiencies are observed. The sequence comparison between (putative) 
putrescine oxidases and other more distant homologs suggests that the glutamate 
is a conserved residue that can be used to annotate putrescine oxidase sequences.
So far, the kinetic mechanism of PuO has not been established. In Chapter 7 
we present a detailed kinetic analysis of PuO using both single- and double-mixing 




half reaction is fast and irreversible. A direct hydride transfer from putrescine 
to the FAD was proposed for PuO, because no radical intermediates were observed 
in the reductive half-reaction. Ligand binding was found to influence the rate 
of flavin reoxidation; when the product was bound to the enzyme the rate was higher 
than with free enzyme species and similar results were obtained with product-
mimicking ligands. This indicates that a ternary complex is formed during catalysis. 
The bound product might deliver a proper electrostatic environment for flavin 
reoxidation or it may increase accessibility of the flavin for dioxygen. The obtained 
kinetic data were used together with steady-state rate equations derived for ping-
pong, ternary complex and bifurcated mechanisms to explore which mechanism 
is operative. The integrated analysis revealed that at atmospheric conditions PuO 
operates via a bifurcated mechanism due to comparable rates of product release 
from the reduced enzyme and reoxidation of the reduced enzyme-product complex. 
However, at high oxygen concentrations PuO will mostly follow the ternary 
complex mechanism, while the ping-pong mechanism becomes more dominant 
at decreased O2 concentrations. This might be an adaptation of R. erythropolis 
for living in environments with low oxygen concentration.
Because PuO shows narrow substrate specificity for aliphatic diamines and 
polyamines, it could be used in diagnostic applications in the detection of cancer 
and spoiled food. The high level of expression and the resolved structure of PuO 
are excellent starting points for substrate scope engineering, especially since the 
enzyme is robust and can accommodate several mutations at the same time.
In addition to flavoprotein oxidases, we also wanted to gain insight into 
a biocatalytic scope of a bacterial flavin-containing monooxygenase (mFMO) 
(Chapter 8). The enzyme was fused to phosphite dehydrogenase (PTDH-mFMO) 
and could be expressed in high amounts in Escherichia coli. The bifunctional biocatalyst 
was able to oxidize indole and indole derivatives into a variety of colourful indigo 
compounds. Furthermore, the monooxygenase performed the sulfoxidation 
of a wide range of prochiral sulfides, showing moderate to good enantioselectivities 
in forming chiral sulfoxides. The fused bifunctional dehydrogenase-mFMO system 
represents an interesting oxidative biocatalyst that could be used for synthetic 





Enzymologie is een groot en interdisciplinair onderzoeksgebied met een sterke 
wisselwerking tussen onderwerpen zoals eiwitchemie, fysiologie, cel- en moleculaire 
biologie, synthetische en analytische chemie, biochemie, bio-informatica, 
structurele biofysica, en statistiek. De unieke katalytische eigenschappen van een 
enzym, zoals zijn specificiteit, selectiviteit, snelheid van de chemische reactie 
en regulatie, vloeien voort uit de fysiologische rol die het speelt in het levende 
organisme. Enzymen zijn daarom onderwerp van intensief onderzoek om hun 
functies te onthullen in de stofwisseling en de tekortkomingen die tot verschillende 
ziekten kunnen leiden. Daardoor zijn zij een veel voorkomend doelwit in de 
geneeskunde en de farmacie. Het is interessant om op te merken dat enzymen al 
sinds de oudheid gebruikt zijn voor de productie van wijn, kaas en brood door het 
gebruik van gist. Aan het eind van de 20e eeuw is een nieuw tijdperk aangebroken 
voor enzymologie. Dit werd mogelijk gemaakt door spectaculaire ontwikkelingen 
in het bepalen van eiwitstructuren, genmanipulatie en sequencing. Ook de 
toenemende computerkracht en nieuwe software die de gevolgen van mutaties, 
geïntroduceerd in een enzym, kunnen voorspellen hebben hieraan bijgedragen. 
Dit opende de weg naar het ontwerpen van enzymen voor industriële doeleinden. 
Tegenwoordig worden veel enzymen succesvol in de industrie toegepast en nog 
steeds wordt veel inspanning geleverd om dit gebied verder te ontwikkelen. 
Dit proefschrift is bedoeld om de structuur, de activiteit en het mechanisme te 
bestuderen van een aantal oxidatieve enzymen. Ze zijn allemaal afhankelijk van een 
flavine cofactor, die een centrale rol speelt in de reacties die ze katalyseren.
Een overzicht van chemische reacties die gekatalyseerd worden door 
cofactor bevattende enzymen wordt beschreven in hoofdstuk 2. Cofactoren 
worden gebruikt door enzymen om hun katalytische mogelijkheden te verbreden 
en worden meestal geëxploiteerd door oxidoreductases, de klasse van enzymen 
die redoxreacties uitvoert. Selectieve enzymatische redoxreacties zijn vooral 
interessant voor industriële processen, omdat het niet gemakkelijk is om 
deze selectiviteit te verkrijgen met gebruikelijke chemische benaderingen. 
De mogelijkheden van de cofactor die enzymen bevatten kunnen worden 
uitgebreid door het aanpassen van natuurlijke cofactoren of door het ontwerp 
van nieuwe cofactor types. Dergelijke inspanningen zullen profiteren van de 




nieuwe liganden accepteren en sterk binden. Dit veld van enzymontwerp, dat 
protein engineering en cofactor herontwerp combineert, is zeer waardevol. Het is 
namelijk mogelijk om op deze manier totaal nieuwe biokatalysatoren te genereren. 
In dit proefschrift zijn twee verschillende benaderingen onderzocht waarop de 
cofactor aangepast kan worden. Een daarvan was de covalente binding van flavine 
aan de protein scaffold, uitgevoerd op twee verschillende type enzymen, namelijk 
putrescine oxidase (PuO) en 6-hydroxy-D-nicotine oxidase (6HDNO). Voor het 
eerste ontwerp, beschreven in hoofdstuk 3, is gekozen voor PuO afkomstig 
uit Rhodococcus erythropolis, omdat het een oplosbaar homodimeer eiwit is dat 
flavine adenine dinucleotide (FAD) sterk, maar op niet-covalente wijze bindt. De 
kristalstructuur is opgehelderd door onze samenwerkingspartners in Pavia, Italië, 
en het bleek dat PuO de structuurelementen bevat die kenmerkend zijn voor andere 
amine oxidases, met name de in sequentie verwante humane monoamine oxidases 
A en B. Verrassenderwijs is ook de flavine-bindingsplaats geconserveerd, hoewel 
PuO de flavine niet-covalent bindt, in tegenstelling tot de monoamine oxidases. 
Een van de mysteries betreffende PuO is de competitieve binding van ADP versus 
FAD in ongeveer de helft van de wild-type monomeren, die de desbetreffende 
monomeren inactief maakt. Gebaseerd op de kristalstructuur, werden de residuen 
die verantwoordelijk zijn voor deze functie geïdentificeerd. Door het vervangen 
van een van deze residuen, werden enzympreparaten verkregen in bijna 100% FAD-
gebonden vorm. Daarnaast is een drievoudige mutant ontworpen en geprepareerd 
die een covalente 8α-S-cysteïnyl-FAD koppeling bevat, vergelijkbaar met de 
covalente binding van FAD in de humane monoamine oxidases.
Bicovalente flavoproteïnen zijn een recent ontdekte groep interessante 
enzymen, niet alleen vanwege hun ongewone cofactor bindingsmodus, maar ook 
omdat ze vanwege hun open actieve centra zeer grote substraten accepteren. In 
hoofdstuk 4 presenteren we een sequence alignment van bicovalente flavoproteinen, 
waarin we een geconserveerde sequentie regio hebben geïdentificeerd die verschilt 
van monocovalente flavoproteïnen. Op basis hiervan is het tweede modelenzym 
voor het ontwerpen van covalente flavine-eiwit bindingen gekozen: 6-hydroxy-D-
nicotine-oxidase (6HDNO). 6HDNO is een monocovalent flavo-enzym waarvan 
een kristalstructuur beschikbaar is. Om een tweede cofactor-eiwit binding te 
introduceren, zijn twee aminozuren vervangen. De geïntroduceerde cysteïne 
vormt nu inderdaad een covalente binding met FAD, zoals in natuurlijke bicovalente 




van de cysteïnyl-flavine koppeling te vergemakkelijken. De geïntroduceerde 
histidine wordt verondersteld een negatieve lading van de isoalloxazine ring te 
stabiliseren tijdens het vormen van de covalente binding. De bicovalente 6HDNO 
mutant bleek nog steeds actief te zijn en vertoonde een hogere redoxpotentiaal 
in vergelijking met wild-type 6HDNO. Dit werd ook verwacht, omdat eerdere 
onderzoeken naar bicovalente flavo-enzymen hebben aangetoond dat zij een zeer 
hoge redoxpotentiaal bezitten. Het bevestigde ook dat covalente flavinylering een 
zelf-katalytisch proces is. De succesvolle introductie van een (tweede) covalente 
flavine-eiwit binding in PuO en 6HDNO toonde aan dat deze protein engineering 
aanpak ook kan worden overwogen in het geval van flavoproteinen die gemakkelijk 
de flavine cofactor verliezen en daardoor inactief worden, zoals bijvoorbeeld 
glucose oxidase. Bovendien kan het worden gebruikt om stabielere eiwitmoleculen 
te ontwikkelen, die beter geschikt zijn voor biokatalytische doeleinden.
De bovenstaande benadering om covalente flavine-eiwit bindingen te 
ontwerpen is gebaseerd op het koppelen van de specifieke protein scaffold met de FAD 
cofactor, dat natuurlijk aanwezig is in het enzym. Anderzijds kan veel informatie 
worden verkregen door chemisch gemodificeerde flavines te reconstitueren in 
de flavine bindingsplaats van de bestudeerde flavine-proteïne. In hoofdstuk 5 
is de methode gepresenteerd waarmee de C8 methylgroep van FMN specifiek 
gedeutereerd kan worden. Verder kan de gedeutereerde FMN enzymatisch worden 
omgezet in riboflavine, dat in cellen gebruikt kan worden als FAD cofactor precursor. 
De gedeutereerde riboflavine, in combinatie met riboflavine auxotrofe stammen, 
zou een interessante benadering zijn om de effecten van deuteringsgraad op de 
efficiëntie van covalente flavinylering te bestuderen. Bovendien kan gedeutereerd 
FMN worden omgezet door FAD synthetase in FAD. Dit maakt het mogelijk om 
de effecten van de C8 deuteringsgraad op de kinetiek van covalente flavinylation 
rechtstreeks te bestuderen met gezuiverde enzymen waar het FAD uit is verwijderd 
of eiwitten die al in de FAD-loze vorm gezuiverd worden.
Naast flavine-eiwitinteractie ontwerp is ook een onderzoek naar de 
substraatspecificiteit en katalytische eigenschappen van PuO beschreven. De 
opgehelderde structuur van het enzym (hoofdstuk 3) verklaart de sterke 
voorkeur van PuO voor alifatische diamines. Een glutamaat residu in het actieve 
centrum van PuO lijkt belangrijk te zijn voor het bepalen van de afstand tussen de 
flavine en de bindingsplaats voor de positief geladen aminogroep van het substraat, 




belang van dit glutamaat residu aangetoond voor de activiteit van PuO door 
substitutie met hydrofobe residuen. In hoofdstuk 6 rapporteren we over een PuO 
mutant, waarin de lading wordt behouden, maar verder van de flavine cofactor 
wordt gepositioneerd. Dit wordt gedaan door de glutamaat door een  aspartaat te 
vervangen. Het enzym vertoont nog steeds significante activiteit met putrescine 
en cadaverine, maar heeft het vermogen om onderscheid te maken tussen deze 
twee diamines verloren en vertoont voor beide substraten soortgelijke katalytische 
efficiëntie. De vergelijking van de sequenties van (vermeende) putrescine 
oxidases en andere, minder verwante homologen suggereert dat de glutamaat een 
geconserveerd residu is, dat kan worden gebruikt om putrescine oxidase sequenties 
te annoteren.
Tot dusver is het kinetische mechanisme van PuO niet onderzocht. 
In hoofdstuk 7 presenteren we een gedetailleerde kinetische analyse van PuO 
met behulp van zowel single als double-mixing stopped flow spectrofotometrie en 
met putrescine als substraat. De reductieve half-reactie is snel en niet reversibel. 
Een directe overdracht van een hydride van putrescine naar FAD is voorgesteld 
voor PuO, omdat er geen radicaal-intermediairen werden waargenomen in de 
reductieve half-reactie. Het binden van een ligand beïnvloedt de snelheid van 
flavine reoxidatie: wanneer het product was gebonden aan het enzym, was de 
snelheid hoger dan bij vrij enzym en vergelijkbare resultaten werden verkregen 
met liganden die lijken op het product. Dit geeft aan dat een ternair complex wordt 
gevormd tijdens de katalyse. Het gebonden product kan een goede elektrostatische 
omgeving leveren voor flavine reoxidatie of het kan de toegankelijkheid van de 
flavine voor zuurstof verhogen. De verkregen kinetische gegevens werden gebruikt 
in combinatie met steady-state vergelijkingen, afgeleid voor ping-pong, ternair 
complex en een mix van deze mechanismen, om te onderzoeken welk mechanisme 
wordt gevolgd. Uit de geïntegreerde analyse bleek dat bij atmosferische 
omstandigheden PuO werkt via beide mechanismen (ping-pong en ternair complex 
mechanismen) omdat vergelijkbare snelheden werden gevonden voor product 
dissociatie van het gereduceerde enzym en reoxidatie van het gereduceerde 
enzym-product complex. Echter, bij hoge zuurstofconcentraties zal PuO vooral 
een ternair complex mechanisme volgen, terwijl het ping-pong mechanisme meer 
dominant wordt bij verlaagde O2 concentraties. Dit kan een aanpassing zijn van 
R. erythropolis voor het leven in omgevingen met een lage zuurstofconcentratie. 




polyamines, kan het worden gebruikt in diagnostische toepassingen bij kanker 
of de detectie van bedorven voedsel. Het hoge niveau van expressie en de 
opgehelderde structuur van PuO zijn uitstekende uitgangspunten voor substraat 
scope engineering, vooral omdat het enzym robuust is en meerdere mutaties op 
hetzelfde moment kan accommoderen.
Naast flavo-eiwit oxidases, wilden we ook inzicht krijgen in de biokatalytische 
reikwijdte van een bacteriële flavine-bevattende monooxygenase (mFMO) 
(hoofdstuk 8). Het enzym werd gefuseerd aan fosfiet dehydrogenase (PTDH-
mFMO) en kon in grote hoeveelheden in Escherichia coli tot expressie worden 
gebracht. De bifunctionele biokatalysator kon indool en indoolderivaten oxideren 
in naar een verscheidenheid aan kleurrijke indigo verbindingen. Bovendien kon 
de monooxygenase de sulfoxidatie van diverse prochirale sulfiden uitvoeren, met 
matige tot goede enantioselectiviteit bij het vormen van chirale sulfoxiden. Het 
gefuseerde bifunctionele dehydrogenase-mFMO systeem blijkt een interessante 
oxidatieve biokatalysator die kan worden gebruikt voor synthetische doeleinden, 
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your PhD! Piet, thanks for your help with MS and especially with stopped-flow, 
but also for all the small and big repairs, thanks to which the lab can still function! 
Martijn! Je was een goede begeleider. Dzięki! Edwin, thanks for being my career 
coach and good luck with yours! The same Danny, thanks for your advices on my 
CV, and most of all for a lot of help in the beginning of my PhD. And of course for 
introducing me to the Friday borrels! Good luck with your new career! Sebastian, 




your career and in a married life! Anett, thank you for all advices in the lab and good 
luck as a professor! Marcus, thanks for the borrels and all the fun and jokes that you 
always bring and good luck with your (second) PhD! Elisa, it was a pleasure to share 
office and go for trips with you. Good luck with your postdoc! Sandra, thanks for 
all your help with administrative and financial issues! Alessandro, it was very nice 
to work with you. Good luck with your PhD! Samin, you were great officemate 
and I enjoyed all the conversations with you. Good luck in Pakistan! Geoffrey! 
Danke schön für gutes Essen kochen und für mit mir Deutsch zu sprechen ;) 
Ich verstehe dich nicht. Good luck with your postdoc! Maarten and Remko, thanks 
for the lab and cv advices! Hesam, I always admired your calmness and patience 
and open-mindedness! Good luck with your PhD! Jeroen, thanks for very nice 
correction of Hugo’s Dutch translation of the Summary. Good luck with your 
studies! Chris, Robert, Nikola, Hein, Patricia, Hania, Ciprian, Alene, Marleen, 
Roga, Dana, Peter, Wu, Marzena, Thai, Arif, Cyntia, Antonija, Yaser, Geeske and 
Hemant, thank you all!
There was a bunch of people who were not so much related to my PhD work, 
but in many other ways they contributed to happy PhD life of me. Some of them I 
would like to mention here:
Dearest Sylwia, a.k.a. Een Snoepje, a.k.a. Babcia Snoepcia (inne pominę ;)! 
Wielkie dzięki za objawienie się w czasie mojego pobytu w Groningen! 
Czas,	 który	 udało	 nam	 się spędzić	 razem	 był	 bardzo	 intensywny	 i	 nawet	 jeśli 
zdarzało	nam	 się spotkać	w	 złym	humorze,	 to	nie	dało	 rady,	 terapia	 śmiechowa 
zawsze	 pomagała.	 Dzięki za udostępnianie mi swojej kozetki, wspieranie mnie 
i wiarę we mnie! No i oczywiście za “udany” wyjazd do Jordanii :) Powodzenia 
na postdocu w Niemczech!
Jacek and Wojtek! Wy byliście	 jednymi	 z	 moich	 pierwszych	 przyjaciół	 
w Groningen i dzięki wielkie za wszelkie obiady, imprezy i wypady samochodowe 
do Polski. Jaca, pamiętasz, że	to	właśnie	Ty	kazałeś mi iść na moje pierwsze PhD 
interview?! Hahaha! Powodzenia w karierze naukowej i zawodowej dla Was obu!
Kamil! Nie wiem, czy pamiętasz, ale spotkaliśmy się już w 2008 roku w czasie 
mojego	projektu	z	Erasmusa,	a	Ty	jeszcze	wtedy	psułeś rzeczy w labie ;) Bardzo 
się cieszę, że po kilku latach byliśmy	współpracownikami	choć przez krótki czas, 
kiedy to w końcu mogliśmy się nagadać. Dzięki wielkie za wszelkie rady życiowe 
i obiektywne spojrzenie na rzeczy bieg. Dużo sukcesów w fotografii i trzymam 




Magda! Dzięki	 za	 wszystkie	 lunche	 i	 długie	 rozmowy	 na	 każdy temat :) 
Powodzenia w finalizacji Twojego PhD i w szukaniu pracy!
Kuba! Dzięki za zawsze zdystansowane i sarkastyczne opinie o moich 
problemach,	 które	 skutecznie	 sprowadzały	 mnie	 na	 ziemię. No i oczywiście 
za wszelkie specjalne dostawy z Polski, bez których Polak obejść się nie może :) 
Powodzenia z PhD!
Najdroższa Rodzinko! Oczywiście	teza	ta	by	nigdy	nie	powstała	bez	Waszego	
wsparcia. Dziękuję, że	 zawsze	mogłam	czuć się w Waszych domach jak u siebie 
w domu!
Wojtek! Dzięki za umilanie mi pobytów w Polsce i wszelkie mniej lub bardziej 
poważne	rozmowy	przy	piwie	albo	i	bez	:)	Powodzenia	z	małym	Karczątkiem!
Bartuzy!	 Paulina	 i	 Łukasz!	 Dzięki	 za	Wasze	 zawsze	 przemiłe	 towarzystwo	 
na imprezach w Beijum, czy to u Was czy u Aśki i niepowtarzalne poczucie humoru :) 
Paulina, nigdy nie wyjdę z podziwu jak boski chleb pieczesz! Powodzenia 
z Waszymi karierami!
Marcin! Również wielkie dzięki	 za	 zawsze	 przemiłe	 i	 uraczone	 pysznym	
jedzeniem goszczenie mnie w Beijum. Powodzenia z karierą!
Sarah! I’ve been always happy to have you around, even though you broke all 
the records of being late :) Thanks for treating me well with carrots. Good luck 
with your PhD!
Audrey! I enjoyed all parties and beers with you and wish all the best with 
your career and a bit more sunshine in your life!
I would also like to express my warm thanks to Ana Rioz, Brenda, Bastian, 
Justyn and Tonia for all the great moments we had together!
Of course, my big thanks go to all the people that wanted to play volleyball 
with me on Sundays: Manuel, Paulina, Hesam, Willem, Sarah, Sebastian, Nina, 
Victor and Audrey.
If you read this book (at least this last part), it means that I must have enjoyed 
small chats with you on the corridor, in the city or probably some beers together. 
Thanks for that and see you!
Gosia   
